----------
Model: gpt-4o-mini
Temperature: 0.5
Prompt: input_variables=['agent_scratchpad', 'options', 'question', 'tool_names', 'tools'] input_types={} partial_variables={} messages=[HumanMessagePromptTemplate(prompt=PromptTemplate(input_variables=['agent_scratchpad', 'options', 'question', 'tool_names', 'tools'], input_types={}, partial_variables={}, template='Solve the question answering task alternating between Question, Thought, Action, Input and Observation steps.\nYou only have access to the following tools: {tools}\n\nUse the following format:\nQuestion: the input question you must answer\nThought: you should always think about what to do. Break the problem down into subproblems and smaller steps and decide which action to take.\nAction: the action to take, must be one of [{tool_names}]. If no action is needed, return your Final answer instead.\nAction Input: the input to the action\nObservation: the output of the action.\n... (this Thought/Action/Action Input/Observation can repeat any number of times)\nFinal Answer: A/B/C/D\n\nBegin!\nQuestion: {question}\nOptions: {options}\nThought: {agent_scratchpad}'), additional_kwargs={})]
----------
[{"0": {"question": "A 35-year-old woman comes to your office with a variety of complaints. As part of her evaluation, she undergoes laboratory testing which reveals the presence of anti-centromere antibodies. All of the following symptoms and signs would be expected to be present EXCEPT:", "options": {"A": "Pallor, cyanosis, and erythema of the hands", "B": "Blanching vascular abnormalities", "C": "Hypercoagulable state", "D": "Heartburn and regurgitation"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "anti-centromere antibodies symptoms scleroderma", "log": "To solve this question, I need to analyze the symptoms and signs associated with the presence of anti-centromere antibodies, which are commonly associated with conditions like limited scleroderma (also known as CREST syndrome). I will break down the symptoms associated with this condition and compare them with the options provided to identify which one is least likely to be present.\n\n1. **Option A**: \"Pallor, cyanosis, and erythema of the hands\" - These symptoms are consistent with scleroderma, where patients often experience changes in blood flow to the hands.\n2. **Option B**: \"Blanching vascular abnormalities\" - This is also consistent with scleroderma, as patients may experience Raynaud's phenomenon, leading to blanching of the fingers.\n3. **Option C**: \"Hypercoagulable state\" - This is not a typical finding in patients with anti-centromere antibodies and limited scleroderma. Hypercoagulability is more associated with other autoimmune conditions or specific risk factors.\n4. **Option D**: \"Heartburn and regurgitation\" - Gastrointestinal involvement is common in scleroderma, including esophageal dysmotility leading to heartburn.\n\nBased on this analysis, it seems that \"Hypercoagulable state\" (Option C) is the symptom least likely to be present in a patient with anti-centromere antibodies.\n\nAction: search_docs  \nAction Input: \"anti-centromere antibodies symptoms scleroderma\"  ", "type": "AgentAction"}}, "therapy, addition of angiotensin II receptor blockers, calcium channel blockers, and direct renin inhibitors should be considered. Anecdotal evidence indicates responses to endothelin-1 receptor blockers and prostacyclins. Up to two-thirds of patients with scleroderma renal crisis go on to dialysis. The outcome of scleroderma renal crisis is worse in patients with antibodies to topoisomerase I compared to those with antibodies to RNA polymerase III. Substantial renal recovery can occur following scleroderma renal crisis, and dialysis can be discontinued, in 30\u201350% of the patients. Kidney\n\ndaily. Patients with lcSSc or anticentromere antibodies rarely develop scleroderma renal crisis. Because there is an association between glucocorticoid use and scleroderma renal crisis, prednisone should be used in high-risk SSc patients only when absolutely required and at low doses (<10 mg/d).\n\nof patients with scleroderma renal crisis may require dialysis support, with recovery of renal function in 50% (median time, 1 year). Glomerulonephritis and vasculitis associated with antineutrophil cytoplasmic antibodies and systemic lupus erythematosus have been described in patients with scleroderma. An association has been found with a speckled pattern of antinuclear antibodies and with antibodies to RNA polymerases I and III. Anti-U3-RNP may identify young patients at risk for scleroderma renal crisis. Anticentromere antibody, in contrast, is a negative predictor of this disorder.\n\nresulting in a vicious cycle that culminates in accelerated hypertension. Risk factors for scleroderma renal crisis include African-American race, male gender, and dcSSc with extensive and progressive skin involvement. Up to 50% of patients with scleroderma renal crisis have anti-RNA polymeraseIIIantibodies.Palpabletendonfrictionrubs,pericardialeffusion, new unexplained anemia, and thrombocytopenia may be harbingers of impending scleroderma renal crisis. High-risk patients with early SSc should be counseled to check their blood pressure daily. Patients with lcSSc or anticentromere antibodies"]]},"1": {"question": "An 8-year-old boy is brought to the pediatrician because his mother is concerned about recent behavioral changes. His mother states that she has started to notice that he is slurring his speech and seems to be falling more than normal. On exam, the pediatrician observes the boy has pes cavus, hammer toes, and kyposcoliosis. Based on these findings, the pediatrician is concerned the child has a trinucleotide repeat disease. Which of the following trinucleotide repeats is this child most likely to possess?", "options": {"A": "CGG", "B": "GAA", "C": "CAG", "D": "GCC"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Friedreich's ataxia symptoms GAA trinucleotide repeat\" \n", "log": "To answer the question, I need to analyze the symptoms and findings presented in the case. The child exhibits slurred speech, increased falls, pes cavus, hammer toes, and kyphoscoliosis. These symptoms suggest a possible neurological or muscular disorder. \n\nThe mention of \"trinucleotide repeat disease\" indicates that I should consider conditions associated with specific trinucleotide repeat expansions. The most relevant conditions based on the options provided are:\n\n- **CGG**: Associated with Fragile X syndrome.\n- **GAA**: Associated with Friedreich's ataxia, which can present with similar symptoms such as gait disturbances and scoliosis.\n- **CAG**: Associated with Huntington's disease, but typically presents in adulthood.\n- **GCC**: Not commonly associated with a well-known trinucleotide repeat disorder.\n\nGiven the symptoms and the age of the child, Friedreich's ataxia (associated with GAA) is a strong candidate. I will proceed to search for more information regarding the symptoms and their association with trinucleotide repeat disorders to confirm this hypothesis.\n\nAction: search_docs\nAction Input: \"Friedreich's ataxia symptoms GAA trinucleotide repeat\" \n", "type": "AgentAction"}}, "Genetic testing for the length of the GAA trinucleotide repeat segment in FXN is available.\n\nThe classic form of Friedreich\u2019s ataxia has been mapped to 9q13q21.1, and the mutant gene, frataxin, contains expanded GAA triplet repeats in the first intron. There is homozygosity for expanded GAA repeats in >95% of patients. Normal persons have 7\u201322 GAA repeats, and patients have 200\u2013900 GAA repeats. A more varied clinical syndrome has been described in compound heterozygotes who have one copy of the GAA expansion and the other copy a point mutation in the frataxin gene. When the point mutation is located in the region of the gene that encodes the amino-terminal half of frataxin, the\n\nFriedreich ataxia is an autosomal recessive disorder that generally manifests in the first decade of life with gait ataxia, followed by hand clumsiness and dysarthria. Most patients develop pes cavus and kyphoscoliosis, and there is a high incidence of cardiac disease and diabetes. The disease usually is caused by a GAA trinucleotide repeat expansion in the gene encoding frataxin, a protein that regulates cellular iron levels, particularly in the mitochondria. The repeat expansion results in decreased protein levels through transcriptional silencing; decreased frataxin leads to mitochondrial\n\ncommon condition in this group, is caused by expansion of trinucleotide repeats in TBP, the gene that encodes the TATA box binding protein involved in regulating transcription; this condition is identical to spinocerebellar ataxia (SCA) 17 (Chap. 451e), and most patients present primarily with ataxia rather than chorea. Mutations of the C9Orf gene associated with amyotrophic lateral sclerosis have also been reported in some individuals with an HDL phenotype."]]},"2": {"question": "A 36-year-old man is brought to the emergency department by his wife 20 minutes after having a seizure. Over the past 3 days, he has had a fever and worsening headaches. This morning, his wife noticed that he was irritable and demonstrated strange behavior; he put the back of his fork, the salt shaker, and the lid of the coffee can into his mouth. He has no history of serious illness and takes no medications. His temperature is 39\u00b0C (102.2\u00b0F), pulse is 88/min, and blood pressure is 118/76 mm Hg. Neurologic examination shows diffuse hyperreflexia and an extensor response to the plantar reflex on the right. A T2-weighted MRI of the brain shows edema and areas of hemorrhage in the left temporal lobe. Which of the following is most likely the primary mechanism of the development of edema in this patient?", "options": {"A": "Release of vascular endothelial growth factor", "B": "Cellular retention of sodium", "C": "Breakdown of endothelial tight junctions", "D": "Increased hydrostatic pressure"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "mechanism of edema in brain injury or infection", "log": "To answer the question, I need to determine the primary mechanism of edema development in the context of the clinical scenario presented. The patient exhibits signs of a central nervous system issue, likely related to infection or inflammation, given the fever, headache, seizure, and MRI findings of edema and hemorrhage in the left temporal lobe.\n\nI will break down the potential mechanisms of edema:\n1. **Release of vascular endothelial growth factor (VEGF)**: This can lead to increased vascular permeability and edema, often seen in inflammatory conditions.\n2. **Cellular retention of sodium**: This typically leads to generalized edema but is less specific to the brain and may not be the primary mechanism here.\n3. **Breakdown of endothelial tight junctions**: This is a common mechanism in neuroinflammation and can lead to increased permeability of the blood-brain barrier, resulting in edema.\n4. **Increased hydrostatic pressure**: This is less likely in this scenario as there is no indication of heart failure or venous obstruction.\n\nGiven the clinical context and the MRI findings, the most likely mechanism for the edema in this patient is the breakdown of endothelial tight junctions, leading to increased permeability and resultant edema.\n\nAction: search_docs\nAction Input: \"mechanism of edema in brain injury or infection\" ", "type": "AgentAction"}}, "The presence of intracranial hypertension has also been associated with a higher incidence of infarction. Marmarou and colleagues demonstrated that brain swelling after head injury is essentially the result of edema and not of an increase in cerebral blood volume, as has long been postulated. In children, and in some cases in adults, the cerebral edema may be massive and lead to secondary brainstem compression.\n\ncompromised in ischemia, trauma, infection, and metabolic derangements. Vasogenic edema results from abnormal permeability of the BBB, and typically develops rapidly following injury. Cytotoxic edema results from cellular swelling, membrane breakdown, and ultimately cell death. Clinically significant brain edema usually represents a combination of vasogenic and cytotoxic components. Edema can lead to increased ICP as well as tissue shifts and brain displacement or herniation from focal processes (Chap. 328). These tissue shifts can cause injury by mechanical distention and compression in\n\nfactors from mechanical ones. Because any toxic agent or inflammatory response in the subarachnoid space has free access via Virchow-Robin spaces and thereby to the superficial parts of the brain and spinal cord, direct parenchymal injury may follow. Perivascular reactions of subpial vessels, as in infectious processes, would be a plausible mechanism of injury to optic nerves and spinal cord, where long stretches of myelinated fibers abut the pia.\n\ncerebral edema irrespective of AMS. This finding is in keeping with case reports of suddenly symptomatic brain tumors and of cranial nerve palsies without AMS at high altitudes. Vasogenic edema may become cytotoxic (intracellular) in severe HACE."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "vasogenic edema mechanism in brain infections", "log": "The information gathered from the observation supports the idea that vasogenic edema is a significant factor in brain injury, especially in cases of infection or trauma. The breakdown of the blood-brain barrier (BBB) leads to increased permeability, which results in vasogenic edema. This aligns with the clinical presentation of the patient, who is exhibiting signs consistent with a central nervous system infection or inflammation, as indicated by the fever, headache, seizure, and MRI findings.\n\nTo further solidify my understanding, I will conduct another search to find more specific information about the mechanisms of edema, particularly in the context of infections or inflammatory processes in the brain.\n\nAction: search_docs\nAction Input: \"vasogenic edema mechanism in brain infections\" ", "type": "AgentAction"}}, "The use of high-potency glucocorticosteroids has a beneficial effect on the vasogenic edema associated with tumors, both primary and metastatic, sometimes beginning within hours. Probably these steroids act directly on the endothelial cells, reducing their permeability. Steroids also shrink normal brain tissue, thus reducing overall intracranial pressure. Drugs such as dexamethasone also reduce the vasogenic edema associated with brain abscess and head injury, but their usefulness in these cases and in large cerebral infarctions, contusions, and hemorrhage is less clear; in fact, most\n\ncompromised in ischemia, trauma, infection, and metabolic derangements. Vasogenic edema results from abnormal permeability of the BBB, and typically develops rapidly following injury. Cytotoxic edema results from cellular swelling, membrane breakdown, and ultimately cell death. Clinically significant brain edema usually represents a combination of vasogenic and cytotoxic components. Edema can lead to increased ICP as well as tissue shifts and brain displacement or herniation from focal processes (Chap. 328). These tissue shifts can cause injury by mechanical distention and compression in\n\nPATHOPHYSIOLOGY Brain Edema Swelling, or edema, of brain tissue occurs with many types of brain injury. The two principal types of edema are vasogenic and cytotoxic. Vasogenic edema refers to the influx of fluid and solutes into the brain through an incompetent blood-brain barrier (BBB). In the normal cerebral vasculature, endothelial tight junctions associated with astrocytes create an impermeable barrier (the BBB), through which access into the brain interstitium is dependent upon specific transport mechanisms. The BBB may be compromised in ischemia, trauma, infection, and metabolic\n\nFIGURE 441e-19 CNS vasculitis (Chap. 446). Axial noncontrast CT (A) demonstrates a large hyperdense intraparenchymal hematoma surrounded by hypodense vasogenic edema in the right parietal lobe. Axial T2-weighted MRI (B) demonstrates a large hypointense intraparenchymal hematoma surrounded by hyperintense vasogenic edema in the right parietal lobe. Conventional angiography (C) demonstrates multiple segments of intracranial arterial narrowing, some of which have associated adjacent areas of focal arterial dilatation. These abnormalities are suggestive of vasculitis."]]},"3": {"question": "A 35-year-old woman presents to the ER with shortness of breath, cough, and severe lower limb enlargement. The dyspnea was of sudden onset, started a week ago, and increased with exercise but did not disappear with rest. Her cough was dry, persistent, and non-productive. She has a family history of maternal hypertension. Her vital signs include heart rate 106/min, respiratory rate 28/min, and blood pressure 140/90 mm Hg. On physical examination, thoracic expansion was diminished on the right side with rhonchi and crackles on the lower two-thirds of both sides, with left predominance. A systolic murmur was heard on the tricuspid foci, which increased in intensity with inspiration. There was jugular engorgement when the bed was placed at 50\u00b0. Palpation of the abdomen was painful on the right hypochondrium, with hepatomegaly 4 cm below the lower coastal edge. Hepatojugular reflux was present. Soft, painless, pitting edema was present in both lower limbs up until the middle third of both legs. Lung computed tomography (CT) and transthoracic echocardiogram were performed and detected right heart failure and severe pulmonary fibrosis. What is the most likely diagnosis?", "options": {"A": "Left-sided heart failure", "B": "Coronary artery disease", "C": "Budd-chiari syndrome", "D": "Cor pulmonale"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "cor pulmonale diagnosis symptoms", "log": "To answer the question, I need to analyze the clinical presentation and the findings from the examination and tests. The patient exhibits signs of right heart failure, including jugular venous distension, hepatomegaly, and lower limb edema. The presence of severe pulmonary fibrosis and the right heart failure suggest a problem related to the lungs or pulmonary circulation.\n\n1. **Left-sided heart failure** typically leads to pulmonary congestion rather than right heart failure symptoms.\n2. **Coronary artery disease** primarily affects the coronary arteries and would not explain the pulmonary fibrosis and right heart failure directly.\n3. **Budd-Chiari syndrome** involves hepatic venous outflow obstruction, which could explain the hepatomegaly and jugular engorgement, but it does not directly correlate with pulmonary symptoms.\n4. **Cor pulmonale** is right heart failure due to lung disease, which aligns with the findings of severe pulmonary fibrosis and right heart failure.\n\nBased on this analysis, the most likely diagnosis is cor pulmonale due to the severe pulmonary fibrosis and the signs of right heart failure.\n\nAction: search_docs  \nAction Input: \"cor pulmonale diagnosis symptoms\"  ", "type": "AgentAction"}}, "Once patients with chronic pulmonary or pulmonary vascular disease develop cor pulmonale, the prognosis worsens. Although chronic obstructive pulmonary disease (COPD) and chronic bronchitis are responsible for approximately 50% of the cases of cor pulmonale in North America (Chap. 314), any disease that affects the pulmonary vasculature (Chap. 304) or parenchyma can lead to cor pulmonale (Table 279-4). Primary pulmonary vascular disorders are relatively rare causes of cor pulmonale, but cor pulmonale is extremely common with these conditions, given the magnitude of pulmonary hypertension\n\nCor pulmonale can be acute in onset, as with pulmonary embolism, or can have a slow and insidious onset when due to prolonged pressure overload in the setting of chronic lung and pulmonary vascular disease (see\n\nTable 11.3\n\nMORPHOLOGYInacute cor pulmonale, therightventricleusuallyshowsonlydilation;ifanembolismcausessuddendeath,theheartmayevenbeofnormalsize.Chronic cor pulmonale ischaracterizedbyrightventricular(andoftenrightatrial)hypertrophy.Inextremecases,thethicknessoftherightventricularwallmaybecomparabletoorevenexceedthatoftheleftventricle(\n\nhypoxia, the circulatory bed undergoes varying degrees of vascular remodeling, vasoconstriction, and destruction. As a result, pulmonary artery pressures and RV afterload increase, setting the stage for cor pulmonale (Table 279-4). The systemic consequences of cor pulmonale relate to alterations in cardiac output as well as salt and\n\nCor pulmonale develops in response to acute or chronic changes in the pulmonary vasculature and/or the lung parenchyma that are sufficient to cause pulmonary hypertension. The true prevalence of cor pulmonale is difficult to ascertain. First, not all patients with chronic lung disease will develop cor pulmonale, which may be subclinical in compensated individuals. Second, our ability to diagnose pulmonary hypertension and cor pulmonale by routine physical examination and laboratory testing is relatively insensitive. However, advances in 2-D echo/Doppler imaging and biomarkers (BNP) can make"]]},"4": {"question": "A 5-year-old boy is brought in by his parents for recurrent abdominal pain. The child has been taken out of class 5 times this past week for abdominal pain that resulted in him being sent home. The mother reports that her son's stools have remained unchanged during this time and are brown in color, without blood, and with normal consistency and scent. She also notes that while at home he seems to be his usual self and does not complain of any symptoms. Of note she presents to you that she has been preparing her son's lunches which consist of couscous, vegetables, fried rice, and chicken. The patient denies difficulty with producing stool and does not complain of any functional pain. The child's vitals and labs including BMP and CBC are unremarkable and within normal limits. An abdominal exam is performed and there is no tenderness upon palpation, and the abdomen is soft and non-distended. After a conversation with the child exploring his symptoms, which of the following is the next step in management for this child?", "options": {"A": "Increase oral hydration and fiber intake", "B": "Check the stool for fecal red blood cells and leukocytes", "C": "Begin treatment with ciprofloxacin", "D": "Begin cognitive behavioral therapy"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of recurrent abdominal pain in children", "log": "To solve this question, I need to analyze the case of the 5-year-old boy with recurrent abdominal pain. The key points to consider include:\n\n1. The child has recurrent abdominal pain but is otherwise healthy at home and has normal stool characteristics.\n2. His vitals and lab results are normal, and there is no tenderness in the abdomen during the examination.\n3. The symptoms appear to be related to his school environment, as he does not complain of any issues at home.\n\nGiven these observations, the abdominal pain could be functional in nature, possibly related to stress or anxiety about school. Therefore, the management options should be evaluated accordingly.\n\n- Option A (Increase oral hydration and fiber intake) may help if constipation were a concern, but the child denies difficulty with stool production and has normal stool characteristics.\n- Option B (Check the stool for fecal red blood cells and leukocytes) seems unnecessary given the normal stool description and lack of concerning symptoms.\n- Option C (Begin treatment with ciprofloxacin) is inappropriate as there is no indication of bacterial infection.\n- Option D (Begin cognitive behavioral therapy) is a reasonable approach if the abdominal pain is related to anxiety or stress, particularly since the pain occurs in a school setting.\n\nBased on this analysis, the most appropriate next step in management appears to be cognitive behavioral therapy.\n\nAction: search_docs  \nAction Input: \"management of recurrent abdominal pain in children\"  ", "type": "AgentAction"}}, "of life and are diagnosed by incidental discoveries of hypertension or abdominal masses, back or flank pain is a frequent symptom in ~60% of patients with ADPKD. The pain may result from renal cyst infection, hemorrhage, or nephrolithiasis. Gross hematuria resulting from cyst rupture occurs in ~40% of patients during the course of their disease, and many of them will have recurrent episodes. Flank pain and hematuria\n\nFunctional chest pain can be seen in 10% of school-aged children and adolescents. Other common pain disorders are musculoskeletal pains (limb pain and back pain), fibromyalgia, and complex regional pain syndrome type I (previously known as reflex sympathetic dystrophy).\n\nReassurance is the primary treatment of pain disorder.Symptom diaries, including the events that precede and follow the pain episode, aid in initial assessment and ongoingmanagement of the problem. Minimizing secondary psychological consequences of recurrent pain syndromes isimportant.\n\npain often is worst in the morning and often prevents or delays children from attending school. Irritable bowel syndrome (IBS) is a subset of functional abdominal pain, characterized by onset of pain at the time of a change in stool frequency or consistency, a stool pattern fluctuating between diarrhea and constipation, and relief of pain with defecation. Symptoms in IBS are linked to gut motility. Pain is commonly accompanied in both groups of children by school avoidance, secondary gains, anxiety about imagined causes, lack of coping skills, and disordered peer relationships (Table 126-5).\n\ndistal esophagus either 360o (i.e., Nissen)  or to lesser degrees (i.e., Thal or Toupet). At present, the stan-dard approach in most children is to perform these procedures laparoscopically whenever possible. In children with feeding difficulties and in infants under 1 year of age, a gastrostomy tube should be placed at the time of surgery. Early postoperative complications include pneumonia and atelectasis, often due to inadequate pulmonary toilet and pain control with abdominal splinting. Late postoperative complications include wrap break-down with recurrent reflux, which may require"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "cognitive behavioral therapy for children with abdominal pain", "log": "The search did not provide specific guidance on the management of recurrent abdominal pain in children, but it did mention that reassurance is a primary treatment for pain disorders, particularly when the pain is functional in nature. Given the context of the 5-year-old boy, who exhibits abdominal pain primarily in a school setting and has normal physical and lab findings, it aligns with the idea that the pain may be stress-related.\n\nI need to consider the options again in light of this information:\n- **Option A** (Increase oral hydration and fiber intake) still seems less relevant since the child does not have constipation.\n- **Option B** (Check the stool for fecal red blood cells and leukocytes) remains unnecessary given the normal stool characteristics.\n- **Option C** (Begin treatment with ciprofloxacin) is still inappropriate due to the absence of infection.\n- **Option D** (Begin cognitive behavioral therapy) fits well with the need to address potential anxiety or stress related to school.\n\nGiven that reassurance and addressing psychological aspects are crucial in managing functional abdominal pain, the best next step remains cognitive behavioral therapy.\n\nAction: search_docs  \nAction Input: \"cognitive behavioral therapy for children with abdominal pain\"  ", "type": "AgentAction"}}, "Psychotherapeutic interventions such as cognitive behavioral therapy appear to be as effective as antidepressant treatment for mild to moderate forms of depression. However, cognitive behavioral therapy tends to take longer to be effective and is generally more expensive than antidepressant treatment. Psychotherapy is often combined with antidepressant treatment, and the combination appears more effective than either strategy alone.\n\nB. Anxiety Disorders\n\nto remove intercourse as one of the ways the couple interact sexually, explanation of basic cognitive behavioral therapy (CBT)\n\nSpecify:\n\nWithout behavioral disturbance: If the cognitive disturbance is not accompanied by any clinically significant behavioral disturbance.\n\nWith behavioral disturbance (specify disturbance): If the cognitive disturbance is ac- companied by a clinically significant behavioral disturbance (e.g., psychotic symptoms, mood disturbance, agitation, apathy, or other behavioral symptoms).\n\nthe problem of interpreting low-level lead exposure in children with blood lead concentrations below 45 mcg/dL is the observation by Rogan and colleagues that treatment with succimer, while successful in reducing lead levels, did not improve cognitive or behavioral function."]]},"5": {"question": "A 5-day-old male newborn is brought to the emergency department 1 hour after having a seizure. It lasted approximately 1 minute, and involved blinking and lip-smacking movements as well as left-sided jerking of the hand and foot. His mother says she measured a temperature of 38.2\u00b0C (100.7\u00b0F) at that time. He has had increasing difficulty feeding since yesterday. He was born at 39 weeks' gestation and weighed 3189 g (7 lb, 1 oz); he currently weighs 2980 g (6 lb, 9 oz). The mother's prenatal course was significant for gonorrhea infection diagnosed early in pregnancy and treated with ceftriaxone and azithromycin combination therapy. The boy appears irritable and lethargic. His temperature is 36.0\u00b0C (96.8\u00b0F). Examination shows clusters of vesicular lesions with an erythematous base on the patient's face and trunk. There is profuse lacrimation. Laboratory studies show:\nLeukocyte count 16,200/mm3\nSegmented neutrophils 25%\nBands 5%\nLymphocytes 65%\nMonocytes 3%\nEosinophils 2%\nSerum\nGlucose 80 mg/dL\nA lumbar puncture is performed. Cerebrospinal fluid analysis shows a leukocyte count of 117/\u03bcL, a protein concentration of 52 mg/dL, and a glucose concentration of 58 mg/dL. Results of blood cultures are pending. Which of the following is the most appropriate pharmacotherapy?\"", "options": {"A": "IV ganciclovir", "B": "Pyrimethamine", "C": "IV acyclovir", "D": "IV vancomycin"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "IV acyclovir treatment for viral infections in newborns", "log": "To determine the most appropriate pharmacotherapy for the 5-day-old male newborn, I need to analyze the symptoms and laboratory findings presented in the case. The key points include:\n\n1. The newborn has a fever (38.2\u00b0C), irritability, lethargy, and vesicular lesions on the face and trunk, which suggest a viral infection.\n2. The leukocyte count in the cerebrospinal fluid (CSF) is elevated (117/\u03bcL), with a predominance of lymphocytes (65%). This suggests a viral etiology rather than bacterial meningitis.\n3. The mother's history of gonorrhea treatment is relevant, but the symptoms and CSF findings point more towards a viral infection.\n4. The vesicular lesions and the CSF findings are suggestive of herpes simplex virus (HSV) infection, which is common in newborns and can lead to encephalitis.\n\nGiven these considerations, the most appropriate treatment for suspected viral encephalitis, specifically HSV infection, is IV acyclovir.\n\nNow, I will proceed to confirm this by searching for relevant guidelines or information regarding the treatment of viral infections in newborns, particularly focusing on the use of acyclovir for HSV.\n\nAction: search_docs\nAction Input: \"IV acyclovir treatment for viral infections in newborns\"", "type": "AgentAction"}}, "Acyclovir is available in IV, oral, and topical forms, while valacyclovir is available in an oral formulation. IV acyclovir is effective in the treatment of mucocutaneous HSV infections in immunocompromised hosts, in whom it reduces time to healing, duration of pain, and virus shedding. When administered prophylactically during periods of intense immunosuppression (e.g., related to chemotherapy for leukemia or transplantation) and before the development of lesions, IV acyclovir reduces the frequency of HSV-associated disease. After prophylaxis is discontinued, HSV lesions recur. IV acyclovir\n\nis discontinued, HSV lesions recur. IV acyclovir is also effective in the treatment of HSV encephalitis.\n\nMany aspects of mucocutaneous and visceral HSV infections are amenable to antiviral chemotherapy. For mucocutaneous infections, acyclovir and its congeners famciclovir and valacyclovir have been the mainstays of therapy. Several antiviral agents are available for topical use in HSV eye infections: idoxuridine, trifluorothymidine, topical vidarabine, and cidofovir. For HSV encephalitis and neonatal herpes, IV acyclovir is the treatment of choice.\n\nIII. Neonatal HSV infections: Oral acyclovir (60 mg/kg per day, divided into 3 doses) is given. The recommended duration of IV treatment is 21 days. Monitoring for relapse should be undertaken. Continued suppression with oral acyclovir suspension should be given for 3\u20134 months.\n\nIV. Visceral HSV infections\n\nA. HSV esophagitis: IV acyclovir (15 mg/kg per day) is given. In some patients with milder forms of immunosuppression, oral therapy with valacyclovir or famciclovir is effective.\n\nB. HSV pneumonitis: No controlled studies exist. IV acyclovir (15 mg/kg per day) should be considered."]]},"6": {"question": "A 30-year-old woman presents to the clinic for a 3-month history of painful hair loss. She was in her usual state of health until about 3 months ago when she started to develop some painfully itchy spots across her scalp. Since that time these spots have lost hair and scarred, with new spots continuing to form. On further questioning, she shares that, for the last couple of years, she has generally felt poorly, specifically noting intermittent fevers, muscle and joint pains, and fatigue. On physical exam, she has several erythematous and scaly plaques across her scalp. These areas have no hair growth, but some do demonstrate hyperpigmentation. Which of the following is the most likely diagnosis?", "options": {"A": "Alopecia areata", "B": "Discoid lupus erythematosus (DLE)", "C": "Tinea capitis", "D": "Trichotillomania"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will perform a search to confirm the symptoms and diagnosis related to Discoid lupus erythematosus (DLE).", "tool_input": "search_docs(query='Discoid lupus erythematosus symptoms and diagnosis') \n", "log": "To solve this question, I need to analyze the symptoms presented in the case. The patient has painful hair loss with itchy spots on the scalp that have formed scars and continue to develop. Additionally, she experiences systemic symptoms such as intermittent fevers, muscle and joint pains, and fatigue. The physical exam reveals erythematous and scaly plaques on the scalp with no hair growth and some areas showing hyperpigmentation.\n\nNow, I will evaluate the provided options:\n\n- **Alopecia areata**: This condition typically presents with sudden hair loss in patches but does not usually cause scarring or systemic symptoms like fever and joint pain.\n- **Discoid lupus erythematosus (DLE)**: This condition can cause scarring alopecia and is associated with systemic symptoms such as fatigue, joint pain, and skin lesions.\n- **Tinea capitis**: This fungal infection usually presents with hair loss but is not typically associated with scarring or systemic symptoms like those described.\n- **Trichotillomania**: This is a psychological condition where individuals pull out their hair, leading to patchy hair loss, but it does not explain the systemic symptoms.\n\nGiven the combination of scarring alopecia, systemic symptoms, and the appearance of the scalp lesions, the most likely diagnosis is **Discoid lupus erythematosus (DLE)**.\n\nAction: I will perform a search to confirm the symptoms and diagnosis related to Discoid lupus erythematosus (DLE).\nAction Input: search_docs(query='Discoid lupus erythematosus symptoms and diagnosis') \n", "type": "AgentAction"}}, "I will perform a search to confirm the symptoms and diagnosis related to Discoid lupus erythematosus (DLE). is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "search_docs(query='Discoid lupus erythematosus symptoms and diagnosis') \n", "log": "I need to perform a search to gather more information about Discoid lupus erythematosus (DLE) and its associated symptoms to confirm my diagnosis. \n\nAction: search_docs  \nAction Input: search_docs(query='Discoid lupus erythematosus symptoms and diagnosis') \n", "type": "AgentAction"}}, "The term subacute cutaneous lupus erythematosus refers to a group intermediate between SLE and lupus erythematosus localized only to skin. The skin rash in this disease tends to be widespread and superficial. Most patients have mild systemic symptoms similar to those in SLE. There is a strong association with antibodies to the SS-A antigen and with the HLA-DR3 genotype.\n\nwomen with scleroderma and 10 percent with systemic lupus erythematosus\n\ndisorders, such as systemic lupus erythematosus and HIV infection. The peripheral nerves show segments of demyelination and remyelination (\n\nNote: Data are compiled from multiple studies.\n\ncomplicating systemic lupus erythematosus and the antiphospholipid antibody syndrome."]]},"7": {"question": "A 68-year-old man is admitted to the intensive care unit after open abdominal aortic aneurysm repair. The patient has received 4 units of packed red blood cells during the surgery. During the first 24 hours following the procedure, he has only passed 200 mL of urine. He has congestive heart failure and hypertension. Current medications include atenolol, enalapril, and spironolactone. He appears ill. His temperature is 37.1\u00b0C (98.8\u00b0F), pulse is 110/min, respirations are 18/min, and blood pressure is 110/78 mm Hg. Examination shows dry mucous membranes and flat neck veins. The remainder of the examination shows no abnormalities. Laboratory studies show a serum creatinine level of 2.0 mg/dL and a BUN of 48 mg/dL. His serum creatinine and BUN on admission were 1.2 mg/dL and 18 mg/dL, respectively. Further evaluation of this patient is most likely to reveal which of the following findings?", "options": {"A": "Decreased urine osmolarity", "B": "Leukocyte casts", "C": "Low urine sodium", "D": "Proteinuria"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "prerenal azotemia urine sodium findings\" \n", "log": "To solve this question, I need to analyze the clinical scenario presented. The patient has undergone surgery and is showing signs of acute kidney injury (AKI) with a significant increase in serum creatinine and BUN. Given the patient's history of congestive heart failure and the medications he is on, it is important to determine the likely cause of his AKI and the expected findings in urine studies.\n\n1. **Understanding the Patient's Condition**: The patient has received multiple units of blood, has low urine output (200 mL in 24 hours), and shows signs of dehydration (dry mucous membranes and flat neck veins). These factors suggest that the patient may be experiencing prerenal azotemia due to volume depletion.\n\n2. **Evaluating the Options**:\n   - **A: Decreased urine osmolarity**: This would typically be seen in cases of tubular injury or renal causes of AKI, not prerenal azotemia.\n   - **B: Leukocyte casts**: This finding is associated with acute interstitial nephritis or pyelonephritis, which does not seem to fit the clinical picture.\n   - **C: Low urine sodium**: In prerenal azotemia, the kidneys conserve sodium in response to perceived low volume, leading to low urine sodium levels.\n   - **D: Proteinuria**: This is more common in intrinsic renal injury rather than prerenal causes.\n\n3. **Conclusion**: Based on the patient's presentation, the most likely finding in further evaluation would be low urine sodium, as this aligns with the expected renal response to prerenal azotemia.\n\nAction: search_docs \nAction Input: \"prerenal azotemia urine sodium findings\" \n", "type": "AgentAction"}}, "Poor cardiac output accompanied by decreased renal blood flow may cause prerenal azotemia and oliguria/anuria. Severe hypotension may produce acute tubular necrosis and acute renal failure. Prerenal azotemia is corrected when blood volume deficits are replaced or myocardial contractility is improved, but acute tubular necrosis does not improve immediately when shock is corrected. Prerenal azotemia is associated with a serum BUN-to-creatinine ratio of greater than 10:1 and a urine sodium level less than 20 mEq/L; acute tubular necrosis has a BUN-to-creatinine ratio of 10:1 or less and a urine\n\nto severe. In oliguric states, differentiationbetween prerenal azotemia and acute tubular necrosis may beaided by determining the urine osmolality and fractional excretionof sodium (see Table 165-2). Renal ultrasound is often helpful in determining the AKI category (see Table 165-2). Renal biopsy is indicated in select cases only.\n\nProlonged renal hypoperfusion may lead to acute tubular necrosis (ATN), an intrinsic renal disease that is discussed below. The urinalysis and urinary electrolyte measurements can be useful in distinguishing prerenal azotemia from ATN (Table 61-2). The urine Na and osmolality of patients with prerenal azotemia can be predicted from the stimulatory actions of norepinephrine, angiotensin II, ADH, and low tubule fluid flow rate. In prerenal conditions, the tubules are intact, leading to a concentrated urine (>500 mosmol), avid Na retention (urine Na concentration, <20 mmol/L; fractional\n\nfiltration. The most common clinical conditions associated with prerenal azotemia are hypovolemia, decreased cardiac output, and medications that interfere with renal autoregulatory responses such as nonsteroidal anti-inflammatory drugs (NSAIDs) and inhibitors of angiotensin II (Fig. 334-2). Prerenal azotemia may coexist with other forms of intrinsic AKI associated with processes acting directly on the renal parenchyma. Prolonged periods of prerenal azotemia may lead to ischemic injury, often termed acute tubular necrosis (ATN). By definition, prerenal azotemia involves no parenchymal damage"]]},"8": {"question": "A 44-year-old with a past medical history significant for human immunodeficiency virus infection presents to the emergency department after he was found to be experiencing worsening confusion. The patient was noted to be disoriented by residents and staff at the homeless shelter where he resides. On presentation he reports headache and muscle aches but is unable to provide more information. His temperature is 102.2\u00b0F (39\u00b0C), blood pressure is 112/71 mmHg, pulse is 115/min, and respirations are 24/min. Knee extension with hips flexed produces significant resistance and pain. A lumbar puncture is performed with the following results:\n\nOpening pressure: Normal\nFluid color: Clear\nCell count: Increased lymphocytes\nProtein: Slightly elevated\n\nWhich of the following is the most likely cause of this patient's symptoms?", "options": {"A": "Cryptococcus", "B": "Group B streptococcus", "C": "Herpes simplex virus", "D": "Neisseria meningitidis"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Cryptococcus HIV meningitis symptoms lumbar puncture results\" \n", "log": "To determine the most likely cause of this patient's symptoms, I need to analyze the clinical presentation and lumbar puncture results. The patient is HIV positive and presents with confusion, fever, headache, and muscle aches. The lumbar puncture shows normal opening pressure, clear fluid, increased lymphocytes, and slightly elevated protein.\n\n1. **Cryptococcus**: Commonly associated with HIV/AIDS, typically presents with increased lymphocytes and can cause meningitis.\n2. **Group B streptococcus**: Usually seen in neonates or immunocompromised adults, but less likely in this case due to the age and presentation.\n3. **Herpes simplex virus**: Can cause encephalitis, but typically presents with more severe symptoms and often has a higher opening pressure and may show red blood cells.\n4. **Neisseria meningitidis**: Typically presents with purulent fluid and often has a high opening pressure, which is not the case here.\n\nGiven the patient's HIV status, the clear fluid with increased lymphocytes and slightly elevated protein strongly suggests a viral or fungal etiology, with Cryptococcus being the most likely due to its association with immunocompromised states.\n\nAction: search_docs\nAction Input: \"Cryptococcus HIV meningitis symptoms lumbar puncture results\" \n", "type": "AgentAction"}}, "which cannot be clinically differentiated from other viral meningitides (Chap. 165), usually resolves spontaneously within 2\u20134 weeks; however, in some patients, signs and symptoms may become chronic. Aseptic meningitis may occur any time in the course of HIV infection; however, it is rare following the development of AIDS. This suggests that clinical aseptic meningitis in the context of HIV infection is an immune-mediated disease. Cryptococcus is the leading infectious cause of meningitis in patients with AIDS (Chap. 239). While the vast majority of these are due to C. neoformans, up to 12%\n\nof fungal meningitis may require large volumes of CSF for culture of sediment. If standard lumbar puncture is unrewarding, a cervical cisternal tap to sample CSF near to the basal meninges may be fruitful.\n\nAs already indicated, the lumbar puncture is an indispensable part of the examination of patients with the symptoms and signs of meningitis or of any patient in whom this diagnosis is suspected. Bacteremia is not a contraindication to lumbar puncture. The dilemma concerning the risk of promoting transtentorial or cerebellar herniation by lumbar puncture, even without a cerebral mass, as indicated in Chaps. 2 and 16, has been settled in favor of performing the tap if there is a reasonable suspicion of meningitis.\n\nThe highest estimates of risk of lumbar puncture come from studies such as those of Rennick, who reported a 4 percent incidence of clinical worsening among 445 children undergoing lumbar puncture for the diagnosis of acute meningitis; most other series give a lower number. It must be pointed out that cerebellar tonsillar herniation may occur in fulminant meningitis independent of lumbar puncture; therefore the risk of the procedure may be even less than usually stated. In an attempt to determine the utility of the CT scan performed prior to a lumbar puncture, Hasbun and colleagues were able"]]},"9": {"question": "A 8-month-old boy is brought to the physician for the evaluation of shortening of his arms and legs. The parents report that they have also noticed that their son's head is progressively enlarging. The patient was born at term via vaginal delivery. There is no personal or family history of serious illness. His immunizations are up-to-date. He is at the 3rd percentile for height, 25th percentile for weight, and 95th percentile for head circumference. Examination shows macrocephaly and prominent brow bones. The extremities are short and plump. Muscle strength is 3/5 in all muscle groups. Deep tendon reflexes are 4+ bilaterally. An x-ray of the lateral skull shows midfacial hypoplasia and frontal prominence. X-rays of the spine shows abnormally narrow interpedicular distance. Which of the following is the most appropriate next step in management?", "options": {"A": "Growth hormone therapy", "B": "Levothyroxine therapy", "C": "CT scan of the head", "D": "Bisphosphonate therapy\n\""}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "8-month-old boy macrocephaly skeletal dysplasia management options", "log": "To solve this medical case, I need to analyze the symptoms and findings presented. The patient is an 8-month-old boy with significant macrocephaly, short and plump extremities, muscle weakness, hyperreflexia, and specific x-ray findings indicating midfacial hypoplasia and spinal abnormalities. These signs suggest a possible diagnosis of a skeletal dysplasia, such as achondroplasia or another form of dwarfism.\n\nThe next step in management should focus on further evaluating the condition to confirm the diagnosis or rule out other potential issues. Given the presence of macrocephaly and the skeletal findings, a CT scan of the head would be the most appropriate next step to assess for any abnormalities in the brain or skull that could be contributing to the symptoms.\n\nAction: search_docs\nAction Input: \"8-month-old boy macrocephaly skeletal dysplasia management options\" ", "type": "AgentAction"}}, "A. Galactosidase\n\nB. Glucuronidase\n\nC. Iduronidase\n\nD. Mannosidase\n\nE. Sulfatase\n\nCorrect answer = E. Degradation of glycoproteins follows the rule: last on, first off. Because sulfation is the last step in the synthesis of this sequence, a sulfatase is required for the next step in the degradation of the compound shown.\n\n4.3. An 8-month-old boy with coarse facial features, skeletal abnormalities, and delays in both growth and development is diagnosed with I-cell disease based on his presentation and on histologic and biochemical testing. I-Cell disease is characterized by:\n\nis a serious obstacle to healing. Malnutrition and skeletal dysplasia also hinder fracture healing.\n\npostoperative adjuvant chemotherapy options generally following treatment patterns used in the management of colon cancer.\n\nhe normal range for the FL to abdominal circumference (AC) ratio is generally 20 to 24 percent. A dramatically foreshortened FL or a FL-to-AC ratio below 18 percent prompts evaluation for a skeletal dysplasia (p. 210)."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "skeletal dysplasia management in infants macrocephaly short extremities", "log": "The search did not yield relevant information regarding the specific management options for the 8-month-old boy with macrocephaly and skeletal dysplasia. I need to refine my search to focus more directly on the management of skeletal dysplasia in infants, particularly in relation to the symptoms presented.\n\nAction: search_docs\nAction Input: \"skeletal dysplasia management in infants macrocephaly short extremities\" ", "type": "AgentAction"}}, "Caused by a defect in cartilage-derived bone, achondroplasia (ACH) is the most common skeletal dysplasia in humans. The bony abnormalities lead to short stature, macrocephaly, a flat midface with a prominent forehead, and rhizomelic shortening of the limbs. The disorder occurs in approximately 1 in 12,000 births.\n\nIII. MULTINODULAR GOITER\n\nA. Enlarged thyroid gland with multiple nodules (Fig. 15.2)\n\nB. Due to relative iodine deficiency\n\nC. Usually nontoxic (euthyroid)\n\nD. Rarely, regions become TSH-independent leading to T release and hyperthyroidism ('toxic goiter').\n\nI. CRETINISM\n\nA. Hypothyroidism in neonates and infants\n\nB. Characterized by mental retardation, short stature with skeletal abnormalities, coarse facial features, enlarged tongue, and umbilical hernia 1. Thyroid hormone is required for normal brain and skeletal development.\n\nand cartilage, such as those found in spondyloepiphyseal dysplasia congenita, spondyloepimetaphyseal dysplasia congenita, hypochondrogenesis/achondrogenesis type II, and Kniest\u2019s syndrome. The highest incidence of COL2A1 mutations, however, occurs in patients with the distinctive features of Stickler\u2019s syndrome, which is characterized by skeletal changes, orofacial abnormalities, and auditory abnormalities. Most of the mutations in COL2A1 are premature stop codons that produce haploinsufficiency. In addition, some patients with Stickler\u2019s syndrome or a closely related syndrome have mutations\n\nis a serious obstacle to healing. Malnutrition and skeletal dysplasia also hinder fracture healing."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "next steps in management for skeletal dysplasia in infants", "log": "The search results provided some information about skeletal dysplasia, specifically mentioning achondroplasia and its characteristics, but did not directly address management options for the 8-month-old boy's condition. The symptoms including macrocephaly, short extremities, and the x-ray findings suggest a need for further imaging to rule out any associated complications or to confirm a diagnosis.\n\nGiven the context, the most logical next step in management remains a CT scan of the head to evaluate for any potential cranial abnormalities or complications related to the macrocephaly and skeletal dysplasia.\n\nAction: search_docs\nAction Input: \"next steps in management for skeletal dysplasia in infants\" ", "type": "AgentAction"}}, "C. Inosine monophosphate synthesis\n\nThe next nine steps in purine nucleotide biosynthesis leading to the synthesis of inosine monophosphate ([IMP] whose base is hypoxanthine) are illustrated in Figure 22.7. IMP is the parent purine nucleotide for AMP and GMP. Four steps in this pathway require ATP as an energy source, and two steps in the pathway require N10-formyl-THF as a one-carbon donor (see p. 267). [Note: Hypoxanthine is found in tRNA (see Fig. 32.9 on p. 453).]\n\nD. Synthetic inhibitors\n\nCaused by a defect in cartilage-derived bone, achondroplasia (ACH) is the most common skeletal dysplasia in humans. The bony abnormalities lead to short stature, macrocephaly, a flat midface with a prominent forehead, and rhizomelic shortening of the limbs. The disorder occurs in approximately 1 in 12,000 births.\n\nPalivizumab is a humanized monoclonal antibody directed against an epitope in the A antigen site on the F surface protein of RSV. It is licensed for the prevention of RSV infection in high-risk infants and children, such as premature infants and those with bronchopulmonary dysplasia or congenital heart disease. A placebo-controlled trial using once-monthly intramuscular injections (15 mg/kg) for 5 months beginning at the start of the RSV season demonstrated a 55% reduction in the risk of hospitalization for RSV in treated patients, as well as decreases in the need for supplemental oxygen, the\n\nand cartilage, such as those found in spondyloepiphyseal dysplasia congenita, spondyloepimetaphyseal dysplasia congenita, hypochondrogenesis/achondrogenesis type II, and Kniest\u2019s syndrome. The highest incidence of COL2A1 mutations, however, occurs in patients with the distinctive features of Stickler\u2019s syndrome, which is characterized by skeletal changes, orofacial abnormalities, and auditory abnormalities. Most of the mutations in COL2A1 are premature stop codons that produce haploinsufficiency. In addition, some patients with Stickler\u2019s syndrome or a closely related syndrome have mutations"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of skeletal dysplasia in infants CT scan recommendations", "log": "The search did not yield relevant information regarding the specific next steps in management for the 8-month-old boy with macrocephaly and skeletal dysplasia. The previous searches focused on general information about skeletal dysplasia, but I need to specifically find guidelines or recommendations for imaging or interventions in cases like this.\n\nAction: search_docs\nAction Input: \"management of skeletal dysplasia in infants CT scan recommendations\" ", "type": "AgentAction"}}, "will demonstrate findings on a sinus CT scan, and many patients with presumed sinusitis will have negative findings.19 CT scan has excellent negative predic-tive value when performed in the setting of active symptoms. Thus, if a patient complains of rhinosinusitis-like symptoms but has no specific physical (endoscopic) findings, and the scan Figure 18-6.\u2002 Nasal endoscopy is commonly performed in the clinic setting to aid in the diagnosis and management of rhinosinusitis.Brunicardi_Ch18_p0613-p0660.indd   61801/03/19   5:22 PM 619DISORDERS OF THE HEAD AND NECKCHAPTER 18Figure\n\nIn SCLC patients, current staging recommendations include a CT scan of the chest and abdomen (because of the high frequency of hepatic and adrenal involvement), MRI of the brain (positive in 10% of asymptomatic patients), and radionuclide bone scan if symptoms or signs suggest disease involvement in these areas (Fig. 107-5). Although there are less data on the use of CT-PET in SCLC, the most recent American College of Chest Physicians Evidence-Based Clinical Practice Guidelines recommend PET scans in patients with clinical stage I SCLC who are being considered for curative intent surgical 513\n\nFIGURE 371-2 A. Acute necrotizing pancreatitis: computed tomography (CT) scan. Contrast-enhanced CT scan showing acute pancreatitis with necrosis. Arrow shows partially enhancing body/tail of pancreas surrounded by fluid with decreased enhancement in the neck/body of the pancreas. B. Acute fluid collection: CT scan. Contrast-enhanced CT scan showing fluid collection in the retroperitoneum (arrow) compressing the air-filled stomach arising from the pancreas in a patient with asparaginase-induced acute necrotizing pancreatitis. C. Walled-off pancreatic necrosis: CT scan. CT scan showing marked\n\nFIGURE 308e-29 CT scan of diffuse, bilateral \u201cground-glass\u201d opacities. This finding is consistent with fluid density in the alveolar space.\n\nFIGURE 308e-31 CT scan of ARDS demonstrates \u201cground-glass\u201d opacities with more consolidated areas in the dependent lung zones.\n\nAtlas of Chest Imaging\n\nFIGURE 308e-32 Three examples of air bronchograms (red arrows) on chest CT. BRONCHIECTASIS AND AIRWAY ABNORMALITIES\n\nFIGURE 308e-33 Cystic fibrosis with bronchiectasis, apical disease.\n\nFIGURE 308e-34 CT scan of diffuse, cystic bronchiectasis (red arrows) in a patient with cystic fibrosis."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "skeletal dysplasia CT scan management recommendations", "log": "The search results did not provide specific management guidelines for skeletal dysplasia in infants, particularly regarding the need for imaging like a CT scan in this context. However, based on the clinical presentation of the 8-month-old boy\u2014macrocephaly, short extremities, muscle weakness, and x-ray findings\u2014it is reasonable to conclude that further imaging is warranted to assess for potential intracranial abnormalities and confirm the diagnosis.\n\nGiven the significant clinical findings and the need for a thorough evaluation, the most appropriate next step in management remains a CT scan of the head to rule out any complications or additional conditions associated with the skeletal dysplasia.\n\nAction: search_docs\nAction Input: \"skeletal dysplasia CT scan management recommendations\" ", "type": "AgentAction"}}, "is a serious obstacle to healing. Malnutrition and skeletal dysplasia also hinder fracture healing.\n\nFIGURE 371-2 A. Acute necrotizing pancreatitis: computed tomography (CT) scan. Contrast-enhanced CT scan showing acute pancreatitis with necrosis. Arrow shows partially enhancing body/tail of pancreas surrounded by fluid with decreased enhancement in the neck/body of the pancreas. B. Acute fluid collection: CT scan. Contrast-enhanced CT scan showing fluid collection in the retroperitoneum (arrow) compressing the air-filled stomach arising from the pancreas in a patient with asparaginase-induced acute necrotizing pancreatitis. C. Walled-off pancreatic necrosis: CT scan. CT scan showing marked\n\nwill demonstrate findings on a sinus CT scan, and many patients with presumed sinusitis will have negative findings.19 CT scan has excellent negative predic-tive value when performed in the setting of active symptoms. Thus, if a patient complains of rhinosinusitis-like symptoms but has no specific physical (endoscopic) findings, and the scan Figure 18-6.\u2002 Nasal endoscopy is commonly performed in the clinic setting to aid in the diagnosis and management of rhinosinusitis.Brunicardi_Ch18_p0613-p0660.indd   61801/03/19   5:22 PM 619DISORDERS OF THE HEAD AND NECKCHAPTER 18Figure\n\nA CT scan demonstrated further complications."]]},"10": {"question": "A 70-year-old woman, gravida 5, para 5, comes to the physician for the evaluation of sensation of vaginal fullness for the last six months. During this period, she has had lower back and pelvic pain that is worse with prolonged standing or walking. The patient underwent a hysterectomy at the age of 35 years because of severe dysmenorrhea. She has type 2 diabetes mellitus and hypercholesterolemia. Medications include metformin and atorvastatin. Vital signs are within normal limits. Pelvic examination elicits a feeling of pressure on the perineum. Pelvic floor muscle and anal sphincter tone are decreased. Pelvic examination shows protrusion of posterior vaginal wall with Valsalva maneuver and vaginal discharge. Which of the following is the most likely diagnosis?", "options": {"A": "Bartholin gland cyst", "B": "Atrophic vaginitis", "C": "Infectious vulvovaginitis", "D": "Enterocele"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Enterocele diagnosis symptoms'", "log": "To determine the most likely diagnosis for this patient, I need to analyze the symptoms and medical history provided. The key symptoms include:\n\n1. Sensation of vaginal fullness for the last six months.\n2. Lower back and pelvic pain that worsens with prolonged standing or walking.\n3. History of hysterectomy at age 35.\n4. Decreased pelvic floor muscle and anal sphincter tone.\n5. Protrusion of the posterior vaginal wall with Valsalva maneuver.\n6. Vaginal discharge.\n\nGiven these symptoms, I can rule out some options:\n\n- **Bartholin gland cyst**: Typically presents as a lump or swelling in the vaginal area, not necessarily with the described fullness or back pain.\n- **Atrophic vaginitis**: Common in postmenopausal women, but usually presents with dryness, itching, or irritation rather than fullness or protrusion.\n- **Infectious vulvovaginitis**: Would likely present with more pronounced discharge and irritation, not just fullness and protrusion.\n\nThe symptom of protrusion of the posterior vaginal wall with Valsalva maneuver suggests a structural issue, likely involving pelvic organ prolapse. The feeling of vaginal fullness and pelvic pain aligns with an enterocele, which is a type of prolapse where the small intestine bulges into the vaginal wall.\n\nThus, the most fitting diagnosis is likely an enterocele.\n\nAction: search_docs\nAction Input: 'Enterocele diagnosis symptoms'", "type": "AgentAction"}}, "Diagnostic Criteria 292.0 (F15.93)\n\nA. Prolonged daily use of caffeine.\n\nB. Abrupt cessation of or reduction in caffeine use, followed within 24 hours by three (or more) of the following signs or symptoms:\n\nHeadache.\n\nMarked fatigue or drowsiness.\n\nDysphoric mood. depressed mood, or irritability.\n\nDifficulty concentrating.\n\nFlu\u2014 like symptoms (nausea vomiting, or muscle pain/stiffness).\n\nC. The signs or symptoms' In Criterion B cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.\n\nor treat- ment. It is often difficult (and somewhat arbitrary) to determine which diagnosis is the principal diagnosis or the reason for visit, especially when, for example, a substance- related diagnosis such as alcohol use disorder is accompanied by a non-substance-related diagnosis such as schizophrenia. For example, it may be unclear which diagnosis should\n\nRate per 100,000 population\n\nYear of diagnosis Year of diagnosis\n\nfactor replacement therapy. Prenatal diagnosis and carrier diagnosis are possible using molecular techniques."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Symptoms and diagnosis of enterocele'", "log": "The output from the action did not provide relevant information regarding the symptoms or diagnosis of enterocele. I need to gather more specific information related to enterocele to confirm my diagnosis.\n\nAction: search_docs  \nAction Input: 'Symptoms and diagnosis of enterocele'  ", "type": "AgentAction"}}, "sensitive and specific for the diagnosis of chlamydial and gonococcal infection; they are now the preferred type of specimen for screening and diagnosis of these infections.\n\nAbsence of identified alternative diagnosis\n\nLevel 3 of diagnostic certainty\n\nAbsence of limb weakness\n\nMonophasic illness pattern and interval between onset and nadir of weakness between 12 h and 28 days and subsequent clinical plateau\n\nAbsence of identified alternative diagnosis\n\nThe diagnosis and treatment of ischemic heart disease are discussed in Chap. 293. Stroke diagnosis and management are discussed in Chap. 330. The diagnosis and management of DVT and pulmonary embolus are discussed in Chap. 300. Jeffrey I. Weitz 143\n\nAntiplatelet, Anticoagulant, and fibrinolytic Drugs\n\nto increase. Therefore, the appropriate diagnosis and management of lipoprotein disorders is of critical importance in the practice of medicine. This chapter reviews normal lipoprotein physiology, the pathophysiology of disorders of lipoprotein metabolism, the effects of diet and other environmental factors that influence lipoprotein metabolism, and the practical approaches to the diagnosis and management of lipoprotein disorders."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Enterocele clinical features diagnosis'", "log": "The output did not provide relevant information regarding enterocele symptoms or diagnosis again. I need to refine my search to focus specifically on the clinical features and diagnostic criteria for enterocele.\n\nAction: search_docs  \nAction Input: 'Enterocele clinical features diagnosis'  ", "type": "AgentAction"}}, "by geno-type-phenotype correlations, with specific mutations leading to particular clinical manifestations. The salient clinical and genetic features of these syndromes are outlined in Table 38-8. Some clinical features of MEN2B patients are shown in Fig. 38-20.Table 38-8Clinical and genetic features of medullary thyroid cancer syndromesSYNDROMEMANIFESTATIONSRET MUTATIONSMEN2A\u00a0MTC, pheochromocytoma, primary hyperparathyroidism, lichen planus amyloidosis\u00a0Exon 10\u2014codons 609, 611, 618, 620Exon 11\u2014codon 634 (more commonly associated with pheochromocytoma and primary hyperparathyroidism)MEN2BMTC,\n\nbe found in women without clinical or laboratory features of PCOS.\n\nThe majority of clinical signs and symptoms observed in Cushing\u2019s syndrome are relatively nonspecific and include features such as obesity, diabetes, diastolic hypertension, hirsutism, and depression that are commonly found in patients who do not have Cushing\u2019s. Therefore, careful clinical assessment is an important aspect of evaluating suspected cases. A diagnosis of Cushing\u2019s should be considered when several clinical features are found in the same patient, in particular when more specific features are found. These include fragility of the skin, with easy bruising and broad (>1 cm),\n\nconversion of serine to clinical features in more severe cases are those of anemia. Anorexia is"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Enterocele symptoms diagnosis clinical features'", "log": "The output from the action still did not provide relevant information regarding the clinical features or diagnostic criteria for enterocele. I need to conduct another search that specifically targets the diagnosis and symptoms associated with enterocele.\n\nAction: search_docs  \nAction Input: 'Enterocele symptoms diagnosis clinical features'  ", "type": "AgentAction"}}, "Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and are sufficiently severe to warrant clinical attention.\n\nintoxication or withdrawal. If the obsessive\u2014compulsive and related disorder symptoms persist for a substantial period of time, other causes for the symptoms should be considered. The substance/ medication-induced ob- sessive-compulsive and related disorder diagnosis should be made in addition to a diagnosis of substance intoxication only when the symptoms in Criterion A predominate in the clinical picture and are sufficiently severe to warrant independent clinical attention\n\nmade if the sleep disturbance occurs only during a delirium (Criterion D). The symptoms must cause clinically significant dis- tress or impairment in social, occupational, or other important areas of functioning (Crite\u2014 rion E). This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and when the symptoms warrant independent clinical attention.\n\nThe substance/medication-induced anxiety disorder diagnosis should be made in- stead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A are predominant in the clinical picture and are sufficiently severe to warrant independent clinical attention."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Enterocele symptoms and diagnosis overview'", "log": "The outputs from my previous searches have not provided relevant information regarding the symptoms or diagnosis of enterocele. I need to refine my search strategy to find more specific clinical details about enterocele, focusing on its symptoms, how it presents, and any diagnostic criteria that may be relevant.\n\nAction: search_docs  \nAction Input: 'Enterocele symptoms and diagnosis overview'  ", "type": "AgentAction"}}, "When worrisome symptoms and signs are present (Table 21-2), rapid diagnosis and management are critical.\n\nfood. The presentation may be impressively dramatic and engaging, and the symptoms re- ported inconsistently. In factitious disorder imposed on another, the caregiver describes symptoms consistent with avoidant/restrictive food intake disorder and may induce physical symptoms such as failure to gain weight. As with any diagnosis of factitious dis- order imposed on another, the caregiver receives the diagnosis rather than the affected in- dividual, and diagnosis should be made only on the basis of a careful, comprehensive assessment of the affected individual, the caregiver, and their\n\nDiagnosis Traditionally, the diagnosis of PID is based on a triad of symptoms and signs, including pelvic pain, cervical motion and adnexal tenderness, and the presence of fever. It is recognized that there is wide variation in many symptoms and signs among women with this condition, which makes the diagnosis of acute PID difficult. Many women with PID exhibit subtle or mild symptoms that are not readily recognized as PID. Consequently, delay in diagnosis and therapy probably contributes to the in\ufb02ammatory sequelae in the upper reproductive tract (36).\n\nintoxication or withdrawal. If the obsessive\u2014compulsive and related disorder symptoms persist for a substantial period of time, other causes for the symptoms should be considered. The substance/ medication-induced ob- sessive-compulsive and related disorder diagnosis should be made in addition to a diagnosis of substance intoxication only when the symptoms in Criterion A predominate in the clinical picture and are sufficiently severe to warrant independent clinical attention"]]},"11": {"question": "A 1-year-old boy is brought to the physician by his parents for the evaluation of recurrent seizures. He is at the 5th percentile for height and 10th percentile for weight. Examination shows coarse pale hair, inelastic hypopigmented skin, and generalized hypotonia. Laboratory studies show low serum ceruloplasmin levels. Decreased activity of which of the following enzymes is most likely responsible for this patient's condition?", "options": {"A": "Prolyl hydroxylase", "B": "Lysyl oxidase", "C": "Glucocerebrosidase", "D": "Homogentisate oxidase"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Menkes disease lysyl oxidase deficiency'", "log": "To answer the question, I need to analyze the symptoms and laboratory findings provided. The patient is a 1-year-old boy with recurrent seizures, growth failure (5th percentile for height and 10th for weight), coarse pale hair, inelastic hypopigmented skin, and generalized hypotonia. The laboratory studies indicate low serum ceruloplasmin levels, which suggests a disorder related to copper metabolism.\n\nThe symptoms and low serum ceruloplasmin point towards a condition like Menkes disease, which is associated with decreased activity of certain enzymes involved in collagen synthesis and copper metabolism. \n\nThe options given are enzymes that are involved in various metabolic pathways:\n- Prolyl hydroxylase is involved in collagen synthesis.\n- Lysyl oxidase is also involved in collagen and elastin cross-linking.\n- Glucocerebrosidase is related to Gaucher disease.\n- Homogentisate oxidase is involved in the metabolism of phenylalanine and tyrosine.\n\nGiven that the symptoms align more closely with a condition affecting collagen synthesis and the presence of low ceruloplasmin, I suspect that the decreased activity of lysyl oxidase is most likely responsible for this patient's condition.\n\nAction: search_docs  \nAction Input: 'Menkes disease lysyl oxidase deficiency'  ", "type": "AgentAction"}}, "As a water-soluble vitamin, vitamin C is not stored. Cross-linking of collagen by lysyl oxidase requires copper, not vitamin C.\n\npost-translational modification that requires hydroxylation of lysine residues in collagen by the enzyme lysyl oxidase. Because lysyl oxidase is a vitamin C-dependent enzyme, children with ascorbate deficiency have skeletal deformities, and people of any age with vitamin C deficiency heal poorly and bleed easily because of \u201cweak\u201d collagen. Genetic defects in collagens cause diseases such as osteogenesis imperfecta and certain forms of Ehlers-Danlos syndrome (Chapter 7).\n\nVascular type (fragile tissues including vessels [eg, aorta], muscles, and organs that are prone to rupture [eg, gravid uterus]): mutations in type III procollagen (eg, COL3A1).\n\nX-linked recessive connective tissue disease caused by impaired copper absorption and transport due to defective Menkes protein (ATP7A, vs ATP7B in Wilson disease). Low copper levels (vs high levels in Wilson disease). Leads to \u0090 activity of lysyl oxidase (copper is a necessary cofactor) \u2022 defective collagen. Results in brittle, \u201ckinky\u201d hair, growth retardation, hypotonia, \u2022 risk of cerebral aneurysms.\n\nthe gene coding for a metalloproteinase that cleaves the C-propeptide of type I procollagen, and PLOD2 (LH2, lysyl oxidase 2), which is involved in establishing collagen cross-links. In addition to these mutations that affect the collagen assembly pathway, mutations have been characterized in genes involved in the regulation of bone formation and mineralization such as SP7 (osterix), IFITM5, WNT1, and TMEM38B (Table 427-2)."]]},"12": {"question": "A 2-year-old boy is presented to the pediatrician due to poor weight gain and easy fatigability. His mother states that the patient barely engages in any physical activity as he becomes short of breath easily. The prenatal and birth histories are insignificant. Past medical history includes a few episodes of upper respiratory tract infection that were treated successfully. The patient is in the 10th percentile for weight and 40th percentile for height. The vital signs include: heart rate 122/min and respirations 32/min. Cardiac auscultation reveals clear lungs and a grade 2/6 holosystolic murmur loudest at the left lower sternal border. The remainder of the physical examination is negative for clubbing, cyanosis, and peripheral edema. Which of the following is the most likely diagnosis in this patient?", "options": {"A": "Atrial septal defect (ASD)", "B": "Ventricular septal defect (VSD)", "C": "Coarctation of aorta", "D": "Tetralogy of Fallot (TOF)"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Ventricular septal defect (VSD) symptoms diagnosis", "log": "To solve this question, I need to analyze the symptoms and signs presented in the case of the 2-year-old boy. The key details to consider include:\n\n1. **Poor weight gain and easy fatigability**: These can indicate a chronic condition affecting the child's ability to thrive.\n2. **Shortness of breath with minimal activity**: This suggests a potential cardiac issue.\n3. **Holosystolic murmur**: This is particularly important, as it can indicate certain types of congenital heart defects.\n4. **Vital signs**: The heart rate is slightly elevated, and the respiratory rate is also increased, which may indicate a compensatory mechanism due to some underlying condition.\n\nNext, I will evaluate the options provided:\n\n- **Atrial septal defect (ASD)**: Typically presents with a systolic ejection murmur rather than a holosystolic murmur. Symptoms may include fatigue and exercise intolerance, but the murmur is not characteristic.\n- **Ventricular septal defect (VSD)**: Often presents with a holosystolic murmur and can lead to heart failure in young children, which aligns with the symptoms of poor weight gain and easy fatigability.\n- **Coarctation of aorta**: Usually presents with hypertension in the upper body and hypotension in the lower body, not typically with a holosystolic murmur.\n- **Tetralogy of Fallot (TOF)**: Characterized by a different set of murmurs and cyanosis, which is not present in this case.\n\nGiven the presence of a holosystolic murmur and the symptoms described, the most likely diagnosis is a Ventricular Septal Defect (VSD).\n\nAction: search_docs  \nAction Input: \"Ventricular septal defect (VSD) symptoms diagnosis\"  ", "type": "AgentAction"}}, "Ventricular Septal Defect. This is the most common congenital cardiac anomaly and is found in approximately 1 in 300 births (Cragan, 2009; Dolk, 2010). Even with adequate visualization, the prenatal detection rate of ventricular septal defect (VSD) is low. A defect may be appreciated in the membranous or muscular portion of the interventricular septum in the four-chamber view, and color Doppler demonstrates flow through the defect. Imaging of the left ventricular outflow tract may show discontinuity of the interventricular septum as it becomes the wall of the aorta (see Fig. 10-29). Fetal VSD\n\nCoarctation of Tricuspid Atrial septal HLH the aorta atresia defect\n\nHLH, Hypoplastic left heart syndrome; TAPVR, total anomalous pulmonary venous return.\n\nFigure 143-1 Ventricular septal defect. AO, Aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery; RA, right atrium; RV, right ventricle.\n\n0 20 40 60 80 100 120Pressure (mmHg)AV valve closes Aortic valve opens S1 A2 a c Aortic pressure Ventricular pressure Atrial pressure Aortic stenosis, pulmonic stenosis,   atrial septal defect Ventricular septal defect, mitral   regurgitation, tricuspid stenosis Mitral valve prolapse Aortic regurgitation, pulmonic regurgitation Mitral stenosis, tricuspid stenosis Patent ductus arteriosus Systolic ejection Holosystolic Pansystolic Regurgitant Late systolic Early diastolic Mid-diastolic Continuous AV valve opens Aortic valve closes v Isovolumic contraction\n\nbranous) portion of the interventricular septum.\n\nB.The left-ventricular outflow tract view of the same fetus demonstrates a break (arrow) in continuity between the interventricular septum and the anterior wall of the aorta.\n\nFIGURE 10-29 Ventricular septal defect. A.oln this four-chamber view of a 22-week fetus, a defect (arrow) is noted in the superior (mem"]]},"13": {"question": "A 13-month-old girl is brought to the physician because of a pruritic rash for 2 days. The girl's mother says she noticed a few isolated skin lesions on her trunk two days ago that appear to be itching. The girl received her routine immunizations 18 days ago. Her mother has been giving her ibuprofen for her symptoms. The patient has no known sick contacts. She is at the 71st percentile for height and the 64th percentile for weight. She is in no acute distress. Her temperature is 38.1\u00b0C (100.6\u00b0F), pulse is 120/min, and respirations are 26/min. Examination shows a few maculopapular and pustular lesions distributed over the face and trunk. There are some excoriation marks and crusted lesions as well. Which of the following is the most likely explanation for these findings?", "options": {"A": "Antigen contact with presensitized T-lymphocytes", "B": "Reactivation of virus dormant in dorsal root ganglion", "C": "Crosslinking of preformed IgE antibodies", "D": "Replication of the attenuated vaccine strain"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "replication of the attenuated vaccine strain rash after immunization\"  \n", "log": "To solve this question, I need to analyze the clinical scenario presented. The key points are:\n\n1. The patient is a 13-month-old girl with a pruritic rash that has developed after receiving routine immunizations 18 days ago.\n2. The rash consists of maculopapular and pustular lesions on the face and trunk, with some excoriation marks and crusted lesions.\n3. The girl has a fever and is in no acute distress.\n\nNext, I need to consider the likely causes of the rash in the context of recent vaccinations. Given her age and the timing of the rash, it is possible that she received vaccinations such as the varicella or MMR (measles, mumps, rubella) vaccine, both of which can cause mild rashes due to the replication of the vaccine strain.\n\nNow, I will evaluate the options provided:\n\n- **A**: Antigen contact with presensitized T-lymphocytes - This typically relates to allergic reactions, which doesn't fit the vaccination context.\n- **B**: Reactivation of virus dormant in dorsal root ganglion - This is more relevant to herpes zoster, which is not likely here.\n- **C**: Crosslinking of preformed IgE antibodies - This is indicative of an allergic reaction, not related to vaccination.\n- **D**: Replication of the attenuated vaccine strain - This is a plausible explanation for the rash following vaccination, especially if she received a live attenuated vaccine.\n\nGiven the context of recent immunizations, the most likely explanation for the findings is related to the replication of the attenuated vaccine strain.\n\nAction: search_docs  \nAction Input: \"replication of the attenuated vaccine strain rash after immunization\"  \n", "type": "AgentAction"}}, "Active Immunization The first live attenuated measles vaccine was developed by passage of the Edmonston strain in chick embryo fibroblasts to produce the Edmonston B virus, which was licensed in 1963 in the United States. Further passage of Edmonston B virus produced the more attenuated Schwarz vaccine that currently serves as the standard in much of the world. The Moraten (\u201cmore attenuated Enders\u201d) strain, which was licensed in 1968 and is used in the United States, is genetically closely related to the Schwarz strain.\n\nSeveral mumps virus vaccines are used throughout the world; in the United States, only the live attenuated Jeryl Lynn strain is used. Current recommendations are that mumps vaccine be administered as part of the combined trivalent measles-mumps-rubella vaccine (M-M-R\u00ae II) or the quadrivalent measles-mumps-rubella-varicella vaccine (ProQuad\u00ae). Monovalent vaccine is no longer produced for the U.S. market but is available in other countries.\n\nimmunosuppression Live-virus vaccines elicit an immune response due to replication of the attenuated (weakened) vaccine virus that is contained by the recipient\u2019s immune system. In persons with compromised immune function, enhanced replication of vaccine viruses is possible and could lead to disseminated infection with the vaccine virus. For this reason, live-virus vaccines are contraindicated for persons with severe immunosuppression, the definition of which may vary with the vaccine. Severe immunosuppression may be caused by many disease conditions, including HIV infection and hematologic\n\nhe live attenuated J eryl-Lynn vaccine strain is part of the MMR vaccine-measles, mumps, and rubella. This vaccine is contraindicated in pregnancy according to the CDC (McLean, 2013). No malformations attributable to MMR vaccination in pregnancy have been reported, but pregnancy should be avoided for 30 da) s after mumps vaccination. The vaccine may be given to susceptible women postpartum, and breastfeeding is not a contraindication."]]},"14": {"question": "A 65-year-old man was picked up by the security personnel for voiding urine and defecating at an inappropriate place in the community. On questioning, he was making offensive remarks and behaving inappropriately. On physical examination, the physician observed an ataxic gait and amnesia. Initial urine drug screen is negative for any drugs of abuse. Which is the most likely pathological finding present in this patient?", "options": {"A": "Drug abuse", "B": "Lewy bodies", "C": "Pick bodies", "D": "Amyloid plaques"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Lewy bodies pathology in elderly patients with ataxic gait and cognitive issues'", "log": "To answer the question, I need to analyze the symptoms and signs presented in the scenario. The patient is a 65-year-old man exhibiting inappropriate behavior, ataxic gait, and amnesia, along with a negative urine drug screen for drugs of abuse. \n\n1. **Identify the symptoms**: The inappropriate behavior and cognitive issues (amnesia) could suggest a neurodegenerative disorder. The ataxic gait points towards possible cerebellar involvement.\n\n2. **Consider the options**:\n   - **A: Drug abuse** - This is unlikely since the urine drug screen is negative.\n   - **B: Lewy bodies** - This is associated with Lewy body dementia, which can present with cognitive fluctuations, visual hallucinations, and parkinsonism, including gait issues.\n   - **C: Pick bodies** - These are associated with frontotemporal dementia, which typically presents with personality changes and social withdrawal rather than ataxia.\n   - **D: Amyloid plaques** - These are primarily associated with Alzheimer's disease, which often presents with memory issues but not typically with ataxic gait.\n\n3. **Narrow down the options**: Given the ataxic gait and the combination of cognitive and behavioral symptoms, Lewy bodies (Option B) seem to be the most fitting pathological finding in this case.\n\nAction: search_docs  \nAction Input: 'Lewy bodies pathology in elderly patients with ataxic gait and cognitive issues'  ", "type": "AgentAction"}}, "Older patients with cognitive impairment from neurodegenerative diseases appear to be particularly prone to falls and injury. There is a growing body of literature on the use of attentional resources to manage gait and balance. Walking is generally considered to be unconscious and automatic, but the ability to walk while attending to a cognitive task (dual-task walking) may be compromised in frail elderly individuals with a history of falls. Older patients with deficits in executive function may have particular difficulty in managing the attentional resources needed for dynamic balance when\n\ngait and imbalance draw attention to the disease and worsen slowly for several years before cognitive manifestations become evident. The general decrepitude in appearance that accompanies the middle and late stages of the disease in many patients is commented on in Chap. 20.\n\nWe emphasize here the common and vexing problem encountered so often in practice of an elderly person with gait disturbance but minimal dementia and without an obvious etiology. Factor and colleagues identify this as a primary freezing gait disorder of many etiologies and it conforms to \u201clower-half Parkinson\u201d pattern as discussed earlier. Walking deteriorates over a period of months or years in an elderly individual, sometimes while residing in a nursing home, so that the tempo is unclear. The disturbance has most of the features of NPH or of a frontal gait disorder, but frontal atrophy is\n\nTremor in extremities and head and orofacial dyskinesia; ataxia of arms > legs, gait ataxia; dysarthria; nystagmus; psychiatric symptoms; cognitive defect; MRI: cerebellar atrophy; genetic testing available\n\nExtremity and gait ataxia; dysarthria; nystagmus; ophthalmoparesis; leg hyperreflexia and extensor plantar responses; MRI: cerebellar atrophy\n\nCandidate gene ODZ3; gait ataxia, dysarthria, saccades; nystagmus, brisk tendon reflexes in legs; MRI: cerebellar atrophy\n\nPentanucleotide (TGGAA)n repeat insertions; previously called SCA4; gait ataxia; limb dysmetria; MRI: cerebellar atrophy"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'pathological findings in Lewy body dementia'", "log": "The observation provides insights into the relationship between gait disturbances and cognitive impairment in elderly individuals, particularly in the context of neurodegenerative diseases. However, it does not explicitly confirm the presence of Lewy bodies or provide definitive evidence for the pathological findings related to the symptoms described in the scenario. \n\n1. **Reassess the options**: \n   - **A: Drug abuse** - Still ruled out due to negative drug screen.\n   - **B: Lewy bodies** - The observation hints at cognitive deficits and gait disturbances, which could align with Lewy body pathology.\n   - **C: Pick bodies** - Still less likely given the symptoms presented.\n   - **D: Amyloid plaques** - This remains a possibility, but the ataxic gait is not typical for Alzheimer's disease.\n\n2. **Evaluate the relevance of Lewy bodies**: Given that Lewy bodies are associated with cognitive fluctuations, parkinsonism, and gait disturbances, this option continues to be the most plausible in light of the symptoms.\n\nAction: search_docs  \nAction Input: 'pathological findings in Lewy body dementia'  ", "type": "AgentAction"}}, "For possible major neurocognitive disorder with Lewy bodies, code 331.9(631.9) possible major neurocognitive disorder with Lewy bodies. (Note: Do not use the additional code for\n\nLewy body disease. Behavioral disturbance cannot be coded but should still be indicated in writing.)\n\nFor mild neurocognitive disorder with Lewy bodies, code 331.83 (631.84). (Note: Do not use the additional code for Lewy body disease. Behavioral disturbance cannot be coded but should still be indicated in writing.)\n\nLewy body) they were not readily appreciated. Aggreagated \u03b1-synuclein is the main component of the Lewy body an observation that will prove important in understanding both Parkinson disease and Lewy-body dementia.\n\nBloody or yellow tap on lumbar puncture Xanthochromia (due to subarachnoid hemorrhage) 513 Eosinophilic cytoplasmic inclusion in neuron Lewy body (Parkinson disease and Lewy body dementia) 520 Extracellular amyloid deposition in gray matter of brain Senile plaques (Alzheimer disease)\n\nDepigmentation of neurons in substantia nigra Parkinson disease (basal ganglia disorder: rigidity, resting 520 tremor, bradykinesia)\n\nSilver-staining spherical aggregation of tau proteins in Pick bodies (Pick disease: progressive dementia, changes 520 neurons in personality)\n\nAs already emphasized, numerous observations have implicated the nuclear and synaptic protein \u03b1-synuclein, the main component of Lewy bodies in both the sporadic and inherited forms of Parkinson disease, as well as in Lewy body disease. Synuclein, a normal component of the synapse, exists in a soluble unfolded form, but in high concentrations it aggregates into filaments, which are the main (but not the only) constituent of the Lewy body. Immunostaining techniques disclose additional less-specific proteins, such as ubiquitin and tau within the Lewy bodies. Furthermore, in families with a rare"]]},"15": {"question": "A 58-year-old man is brought to the emergency department after a witnessed tonic-clonic seizure. His wife says he has had a persistent dry cough for 6 months. During this time period, he has also had fatigue and a 4.5-kg (10-lb) weight loss. The patient has no history of serious illness and does not take any medications. He has smoked 1 pack of cigarettes daily for 35 years. He is confused and oriented only to person. Laboratory studies show a serum sodium concentration of 119 mEq/L and glucose concentration of 102 mg/dL. An x-ray of the chest shows an irregular, poorly demarcated density at the right hilum. Microscopic examination of this density is most likely to confirm which of the following diagnoses?", "options": {"A": "Squamous cell lung carcinoma", "B": "Small cell lung carcinoma", "C": "Large cell lung carcinoma", "D": "Bronchial carcinoid tumor"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "hyponatremia small cell lung carcinoma symptoms\"\n", "log": "To solve this question, I need to analyze the clinical presentation of the patient and the findings from the laboratory studies and imaging. The key points are:\n\n1. The patient is a 58-year-old male with a significant smoking history (1 pack/day for 35 years).\n2. He presents with a tonic-clonic seizure, persistent dry cough, fatigue, weight loss, and confusion.\n3. His lab results show hyponatremia (serum sodium concentration of 119 mEq/L), which can be indicative of certain malignancies or paraneoplastic syndromes.\n4. The chest x-ray shows an irregular density at the right hilum, suggesting a possible lung mass.\n\nNext, I need to determine which type of lung cancer is most likely given these symptoms and the x-ray findings. Squamous cell lung carcinoma is often associated with paraneoplastic syndromes like hypercalcemia and can cause cough and weight loss. Small cell lung carcinoma is also associated with paraneoplastic syndromes, such as the syndrome of inappropriate antidiuretic hormone secretion (SIADH), which could explain the hyponatremia. Large cell lung carcinoma and bronchial carcinoid tumors are less likely given the patient's age and smoking history.\n\nSince the patient's presentation aligns more closely with small cell lung carcinoma, particularly because of the confusion (which could be due to paraneoplastic effects) and the hyponatremia, I will search for more information to confirm this diagnosis.\n\nAction: search_docs\nAction Input: \"hyponatremia small cell lung carcinoma symptoms\"\n", "type": "AgentAction"}}, "The four major histologic types of carcinomas of the lung are adenocarcinoma, squamous cell carcinoma, small cell carcinoma (a subtype of neuroendocrine carcinoma), and large cell carcinoma (\n\ncell carcinoma (SQCC) morphology, the diagnosis can be firmly established. If there is neuroendocrine (NE) morphology, the tumor may be classified as small cell carcinoma (SCLC) or non\u2013small cell lung carcinoma (NSCLC), probably large cell neuroendocrine carcinoma (LCNEC) according to standard criteria (+ = positive, \u2013 = negative, and \u00b1 = positive or negative). If there is no clear ADC or SQCC morphology, the tumor is regarded as NSCLC\u2014not otherwise specified (NOS). Step 2: NSCLC-NOS can be further classified based on (a) immunohistochemical stains, (b) mucin (DPAS or mucicarmine) stains, or\n\nSquamous cell carcinoma of oropharynx and upper esophagus, and hepatocellular carcinoma\n\nSquamous cell carcinoma of skin, lung cancer, and angiosarcoma of liver\n\nCarcinoma of oropharynx, esophagus, lung, kidney, bladder, and pancreas\n\nUrothelial carcinoma of bladder\n\nAngiosarcoma of liver\n\nNasopharyngeal carcinoma, Burkitt lymphoma, and CNS lymphoma in AIDS\n\nSquamous cell carcinoma ofvulva, vagina, anus, and cervix; adenocarcinoma of cervix\n\nAML, CML, and papillary carcinoma of the thyroid\n\nBasal cell carcinoma, squamous cell carcinoma, and melanoma of skin\n\nTable 13.6 ). In some cases, there is a combination of histologic patterns (e.g., small cell carcinoma and adenocarcinoma). Squamous cell and small cell carcinomas have the strongest association with smoking, but there is also an association with adenocarcinoma. In fact, possibly because of changes in smoking patterns in the United States, adenocarcinoma has replaced squamous cell carcinoma as the most common primary lung tumor in recent years. Adenocarcinomas also are by far the most common primary tumors arising in women, in never-smokers, and in individuals younger than 45 years of age."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "small cell lung carcinoma hyponatremia clinical presentation\"\n", "log": "The information obtained does not specifically confirm the likelihood of small cell lung carcinoma in relation to the patient's symptoms and lab findings. However, it does highlight the strong association of both squamous cell and small cell carcinomas with smoking. \n\nTo further clarify the relationship between hyponatremia and small cell lung carcinoma, I will conduct another search focusing specifically on the association of small cell lung carcinoma with hyponatremia and its clinical manifestations.\n\nAction: search_docs\nAction Input: \"small cell lung carcinoma hyponatremia clinical presentation\"\n", "type": "AgentAction"}}, "The four major histologic types of carcinomas of the lung are adenocarcinoma, squamous cell carcinoma, small cell carcinoma (a subtype of neuroendocrine carcinoma), and large cell carcinoma (\n\ncell carcinoma (SQCC) morphology, the diagnosis can be firmly established. If there is neuroendocrine (NE) morphology, the tumor may be classified as small cell carcinoma (SCLC) or non\u2013small cell lung carcinoma (NSCLC), probably large cell neuroendocrine carcinoma (LCNEC) according to standard criteria (+ = positive, \u2013 = negative, and \u00b1 = positive or negative). If there is no clear ADC or SQCC morphology, the tumor is regarded as NSCLC\u2014not otherwise specified (NOS). Step 2: NSCLC-NOS can be further classified based on (a) immunohistochemical stains, (b) mucin (DPAS or mucicarmine) stains, or\n\nSquamous cell carcinoma of oropharynx and upper esophagus, and hepatocellular carcinoma\n\nSquamous cell carcinoma of skin, lung cancer, and angiosarcoma of liver\n\nCarcinoma of oropharynx, esophagus, lung, kidney, bladder, and pancreas\n\nUrothelial carcinoma of bladder\n\nAngiosarcoma of liver\n\nNasopharyngeal carcinoma, Burkitt lymphoma, and CNS lymphoma in AIDS\n\nSquamous cell carcinoma ofvulva, vagina, anus, and cervix; adenocarcinoma of cervix\n\nAML, CML, and papillary carcinoma of the thyroid\n\nBasal cell carcinoma, squamous cell carcinoma, and melanoma of skin\n\nTable 13.6 ). In some cases, there is a combination of histologic patterns (e.g., small cell carcinoma and adenocarcinoma). Squamous cell and small cell carcinomas have the strongest association with smoking, but there is also an association with adenocarcinoma. In fact, possibly because of changes in smoking patterns in the United States, adenocarcinoma has replaced squamous cell carcinoma as the most common primary lung tumor in recent years. Adenocarcinomas also are by far the most common primary tumors arising in women, in never-smokers, and in individuals younger than 45 years of age."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "small cell lung carcinoma SIADH hyponatremia neurological symptoms\" \n", "log": "The information retrieved again does not provide specific details on the association between small cell lung carcinoma and hyponatremia. It reiterates the general classifications of lung carcinomas and their associations with smoking but lacks direct evidence linking small cell lung carcinoma to the clinical presentation of this patient.\n\nGiven the patient's symptoms\u2014particularly the hyponatremia and the neurological symptoms (confusion and seizure)\u2014which are known to be associated with small cell lung carcinoma due to paraneoplastic syndromes like SIADH, I need to gather more focused information that directly connects these elements.\n\nI will perform another search, this time specifically targeting the relationship between small cell lung carcinoma, hyponatremia, and neurological symptoms.\n\nAction: search_docs\nAction Input: \"small cell lung carcinoma SIADH hyponatremia neurological symptoms\" \n", "type": "AgentAction"}}, "The four major histologic types of carcinomas of the lung are adenocarcinoma, squamous cell carcinoma, small cell carcinoma (a subtype of neuroendocrine carcinoma), and large cell carcinoma (\n\nretain water, and their body fluids become progressively hypoosmotic. In addition, their urine is more hyperosmotic than expected based on the low body-fluid osmolality. SIADH can be caused by infections and neoplasms of the brain, drugs (e.g., antitumor drugs), pulmonary diseases, and carcinoma of the lung. Many of these conditions stimulate AVP secretion by altering neural input to the AVP secretory cells. By contrast, small cell carcinoma of the lung produces and secretes a number of peptides including AVP. Recently, AVP receptor antagonists (e.g., the nonpeptide antagonists conivaptan\n\ncell carcinoma (SQCC) morphology, the diagnosis can be firmly established. If there is neuroendocrine (NE) morphology, the tumor may be classified as small cell carcinoma (SCLC) or non\u2013small cell lung carcinoma (NSCLC), probably large cell neuroendocrine carcinoma (LCNEC) according to standard criteria (+ = positive, \u2013 = negative, and \u00b1 = positive or negative). If there is no clear ADC or SQCC morphology, the tumor is regarded as NSCLC\u2014not otherwise specified (NOS). Step 2: NSCLC-NOS can be further classified based on (a) immunohistochemical stains, (b) mucin (DPAS or mucicarmine) stains, or\n\nthe distinction between SIADH and cerebral salt wasting is of more than theoretical importance, insofar as fluid restriction to correct hyponatremia may be dangerous in patients with salt wasting, particularly in those with vasospasm after ruptured intracranial aneurysms."]]},"16": {"question": "A 55-year-old man presents to the physician with tiredness, lethargy, bone pain, and colicky right abdominal pain for 1 month. He has no comorbidities. He does not have any significant past medical history. His height is 176 cm (5 ft 7 in), weight is 88 kg (194 lb), and his BMI is 28.47 kg/m2. The physical examination is normal, except for mild right lumbar region tenderness. Laboratory studies show:\nHemoglobin 13.5 g/dL\nSerum TSH 2.2 mU/L\nSerum calcium 12.3 mg/dL\nSerum phosphorus 1.1 mg/dL\nSerum sodium 136 mEq/L\nSerum potassium 3.5 mEq/L\nSerum creatinine 1.1 mg/dL\nUrine calcium Elevated\nAn ultrasound of the abdomen reveals a single stone in the right ureter without hydroureteronephrosis. Clinically, no evidence of malignancy was observed. An X-ray of the long bones reveals diffuse osteopenia with subperiosteal bone resorption. The serum parathyroid hormone level is tested and it is grossly elevated. What is the most appropriate next step in his management?", "options": {"A": "99mTc sestamibi scan with ultrasound of the neck", "B": "CT scan of the neck", "C": "Bone scan (DEXA)", "D": "Sestamibi scan only"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of primary hyperparathyroidism imaging options\" \n", "log": "To solve this question, I need to analyze the clinical presentation and laboratory findings of the patient. The key points include:\n\n1. The patient has symptoms of tiredness, lethargy, bone pain, and abdominal pain.\n2. Laboratory results show elevated serum calcium, low serum phosphorus, elevated urine calcium, and elevated parathyroid hormone (PTH) levels.\n3. The ultrasound shows a single stone in the right ureter and X-ray findings indicate diffuse osteopenia with subperiosteal bone resorption.\n\nThese findings suggest primary hyperparathyroidism, likely due to a parathyroid adenoma, which is consistent with the elevated PTH and calcium levels. \n\nThe next step in management typically involves imaging to localize the parathyroid adenoma. Options include a sestamibi scan, which is used to identify overactive parathyroid glands, often in conjunction with neck ultrasound. \n\nNow, I need to determine the most appropriate next step from the provided options.\n\nAction: search_docs\nAction Input: \"management of primary hyperparathyroidism imaging options\" \n", "type": "AgentAction"}}, "Much attention has been paid in recent years to the manifestations of and optimum management strategies for asymptomatic hyperparathyroidism. This is now the most prevalent form of the disease. Asymptomatic primary hyperparathyroidism is defined as biochemically confirmed hyperparathyroidism (elevated or inappropriately normal PTH levels despite hypercalcemia) with the absence of signs and symptoms typically associated with more severe hyperparathyroidism such as features of renal or bone disease.\n\nPrimary hyperparathyroidism usually is a disease of adults and is much more common in women than in men (gender ratio of nearly 4:1). The most common manifestation of primary hyperparathyroidism is an increase in serum ionized calcium. In fact, primary hyperparathyroidism is the most common cause of clinically silent hypercalcemia. Other conditions also may produce hypercalcemia (\n\nTable 20.4 ). The most common cause of clinically apparent hypercalcemia\n\nTable20.4CausesofHypercalcemia\n\nMetab. 2009;94:335-339.\t77.\tRubin MR, Bilezikian JP, McMahon DJ, et al. The natu-ral history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93:3462-3470.\t78.\tMarcocci C, Bollerslev J, Khan AA, Shoback DM. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocri-nol Metab. 2014;99:3607-3618.\t79.\tPasieka JL, Parsons L, Jones J. The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year\n\nEven before elucidation of the pathophysiology of FHH, abundant clinical evidence served to separate the disorder from primary hyperparathyroidism; these clinical features are still useful in differential diagnosis. Patients with primary hyperparathyroidism have <99% renal calcium reabsorption, whereas most patients with FHH have >99% reabsorption. The hypercalcemia in FHH is often detectable in affected members of the kindreds in the first decade of life, whereas hypercalcemia rarely occurs in patients with primary hyperparathyroidism or the MEN syndromes who are age <10 years. PTH may be"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "sestamibi scan neck ultrasound primary hyperparathyroidism management\" \n", "log": "The observation did not directly answer the question regarding the most appropriate next step in the management of primary hyperparathyroidism. However, it indicated that imaging is essential for localizing the parathyroid adenoma. \n\nNext, I will refine my search to look for specific guidelines or recommendations regarding imaging studies for primary hyperparathyroidism, particularly focusing on the efficacy of the sestamibi scan and neck ultrasound in this context.\n\nAction: search_docs\nAction Input: \"sestamibi scan neck ultrasound primary hyperparathyroidism management\" \n", "type": "AgentAction"}}, "operative time, decreased accuracy in multiple-gland diseaseCT = computed tomography; FNAB = fine-needle aspiration biopsy; IV = intravenous; MRI = magnetic resonance imaging; PTH = parathyroid hormone; SPECT = single-photon emission computed tomography.Brunicardi_Ch38_p1625-p1704.indd   167201/03/19   11:21 AM 1673THYROID, PARATHYROID, AND ADRENALCHAPTER 38ABFigure 38-31.\u2002A. Sestamibi scan in a patient with primary hyperparathyroidism showing persistent uptake suggesting a left lower hypercel-lular parathyroid gland. B. Neck ultrasound in a patient with primary hyperparathyroidism showing a\n\nmagnified visualization, refined ergonomic control, more freedom of motion with multi-articulated instruments, and improved cosmetic result as a result of incision placement in the axilla.Studies have shown that if both sestamibi scan and neck ultrasound studies independently identify the same, enlarged parathyroid gland, and no other gland, it is indeed the abnormal gland in approximately 95% of cases. These patients with spo-radic PHPT are candidates for a focused neck exploration, an approach that is most commonly referred to as minimally inva-sive parathyroidectomy. A standard bilateral\n\nfocused surgical approaches.91 Although not absolutely necessary, preoperative sestamibi scan and ultrasound can be obtained in patients with inherited HPT to identify potential ectopic glands. A standard bilateral neck exploration is performed, along with a bilateral cervical thymectomy, regardless of the results of localization studies. Both subtotal parathyroidectomy and total parathyroid-ectomy with autotransplantation are appropriate, and parathy-roid tissue also should be cryopreserved. If an adenoma is found in patients with familial HPT, the adenoma and the ipsilateral normal\n\nis usually mild, and severe hypercalcemia or parathyroid cancer is a rare occurrence. Additional differences in the primary hyperparathyroidism of patients with MEN 1, as opposed to those without MEN 1, include an earlier age at onset (20\u201325 years vs 55 years) and an equal male-to-female ratio (1:1 vs 1:3). Preoperative imaging (e.g., neck ultrasound with 99mTc-sestamibi parathyroid scintigraphy) is of limited benefit because all parathyroid glands may be affected, and neck exploration may be required irrespective of preoperative localization studies."]]},"17": {"question": "An 8-year-old boy is brought to the emergency department because of shortness of breath and dry cough for 2 days. His symptoms began after he helped his father clean the basement. He is allergic to shellfish. Respirations are 26/min. Physical examination shows diffuse end-expiratory wheezing and decreased inspiratory-to-expiratory ratio. This patient's symptoms are most likely being caused by inflammation of which of the following structures?", "options": {"A": "Pleural cavity", "B": "Alveoli", "C": "Distal trachea", "D": "Terminal bronchioles"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "inflammation of terminal bronchioles causes wheezing in children", "log": "To answer the question, I need to analyze the clinical scenario provided. The boy is experiencing shortness of breath and wheezing after cleaning the basement, which suggests a possible allergic reaction or exposure to an irritant. The symptoms of wheezing and the respiratory rate indicate an issue with airflow, likely due to inflammation or obstruction in the airways.\n\nNext, I should consider the options given:\n- A: Pleural cavity - This is unlikely as pleural inflammation typically doesn't cause wheezing.\n- B: Alveoli - While inflammation here could affect gas exchange, it doesn't typically cause wheezing.\n- C: Distal trachea - This might cause some issues, but wheezing is more associated with smaller airways.\n- D: Terminal bronchioles - Inflammation here can cause wheezing due to bronchoconstriction or obstruction.\n\nThe most likely site of inflammation causing wheezing in this scenario would be the terminal bronchioles, as they are involved in the airway resistance and can lead to the symptoms described.\n\nAction: search_docs\nAction Input: \"inflammation of terminal bronchioles causes wheezing in children\"", "type": "AgentAction"}}, "Bronchioles are air-conducting ducts that measure 1 mm or less in diameter. The larger bronchioles represent branches of the segmental bronchi. These ducts branch repeatedly, giving rise to the smaller terminal bronchioles that also branch. The terminal bronchioles finally give rise to the respiratory bronchioles.\n\nCartilage plates and glands are not present in bronchioles.\n\nRetinopathy of prematurity, Intraventricular hemorrhage, Bronchopulmonary dysplasia (RIB).\n\nConducting zone Large airways consist of nose, pharynx, larynx, trachea, and bronchi. Airway resistance highest in the largeto medium-sized bronchi. Small airways consist of bronchioles that further divide into terminal bronchioles (large numbers in parallel \u008e least airway resistance).\n\nIn the conducting airways, the mucociliary clearance system transports deposited particles from the terminal bronchioles to the major airways, where they are coughed up and either expectorated or swallowed. Deposited particles can be removed in a matter of minutes to hours. In the trachea and main bronchi, the rate of particle clearance is 5 to 20 \u00b5m/minute, but it is slower in the bronchioles (0.5 to 1 \u00b5m/minute). In general, the longer an inhaled material remains in the airways, the greater is the probability that the material will cause lung damage. The region from the terminal bronchioles\n\nFIGURE 19.11 \u2022 Photomicrograph showing the respiratory portion of the bronchial tree. In this photomicrograph a terminal bronchiole (TB) is shown longitudinally sectioned as it branches into two respiratory bronchioles (RB). The terminal bronchiole is the most distal part of the conducting portion of the respiratory system and is not engaged in gas exchange. The respiratory bronchiole engages in gas exchange and is the beginning of the respiratory portion of the bronchial tree. Respiratory bronchioles give rise to alveolar ducts (AD), which are elongate airways that have almost no walls, only"]]},"18": {"question": "A 79-year-old man is brought to the emergency department after he noted the abrupt onset of weakness accompanied by decreased sensation on his left side. His symptoms developed rapidly, peaked within 1 minute, and began to spontaneously resolve 10 minutes later. Upon arrival in the emergency room 40 minutes after the initial onset of symptoms, they had largely resolved. The patient has essential hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, and a 50 pack-year smoking history. He also had an ST-elevation myocardial infarction 3 years ago. His brain CT scan without contrast is reported as normal. Carotid duplex ultrasonography reveals 90% stenosis of the right internal carotid. His transthoracic echocardiogram does not reveal any intracardiac abnormalities. Which of the following interventions is most appropriate for this patient's condition?", "options": {"A": "Aspirin and clopidogrel", "B": "Warfarin", "C": "Carotid stenting", "D": "Hypercoagulability studies"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of TIA with significant carotid stenosis", "log": "To solve this question, I need to analyze the patient's symptoms and medical history to determine the most appropriate intervention. The key points are:\n\n1. The patient experienced abrupt weakness and decreased sensation on one side, which resolved quickly.\n2. The CT scan is normal, indicating no acute hemorrhage or stroke.\n3. The carotid duplex ultrasonography shows significant stenosis (90%) of the right internal carotid artery.\n4. The patient has multiple risk factors for vascular disease (hypertension, diabetes, smoking, and previous myocardial infarction).\n\nGiven these factors, the patient likely experienced a transient ischemic attack (TIA) due to the severe carotid stenosis. The management of TIA typically involves antiplatelet therapy and possibly surgical intervention if the stenosis is significant.\n\nI need to evaluate the options provided:\n- A: Aspirin and clopidogrel (antiplatelet therapy)\n- B: Warfarin (anticoagulation, typically for atrial fibrillation or other specific conditions)\n- C: Carotid stenting (surgical intervention for significant carotid stenosis)\n- D: Hypercoagulability studies (not typically indicated in the acute management of TIA)\n\nThe most appropriate immediate intervention for TIA with significant carotid stenosis is usually antiplatelet therapy. However, given the significant stenosis, carotid stenting may also be considered.\n\nI will search for guidelines or recommendations regarding the management of TIA in patients with significant carotid stenosis to clarify the best option.\n\nAction: search_docs\nAction Input: \"management of TIA with significant carotid stenosis\"", "type": "AgentAction"}}, "supported the contention that it is prudent to fol-low a conservative course in the management of asymptomatic patients presenting with a cervical bruit.One of the first randomized clinical trials on the treatment of asymptomatic carotid artery stenosis was the Asymptomatic Carotid Atherosclerosis Study (ACAS), which evaluated the benefits of medical management with antiplatelet therapy versus carotid endarterectomy.25 Over a 5-year period, the risk of ipsi-lateral stroke in individuals with a carotid artery stenosis greater than 60% was 5.1% in the surgical arm. On the other hand, the risk\n\nstenosis where blood flow is reduced. It is well known that occlusion of the ipsilateral internal carotid artery can lead to a \u201cfalsely\u201d elevated velocity on the contralat-eral side due to an increase in compensatory blood flow. In the presence of a high-grade stenosis or occlusion of the internal carotid artery, the ipsilateral common carotid artery displays high flow resistance waveforms, similar to those seen in the external carotid artery. If there is a significant stenosis in the proximal common carotid artery, its waveforms may be damp-ened with low velocities.The Doppler grading\n\nCarotid disease can be classified by whether the stenosis is symptomatic or asymptomatic and by the degree of stenosis (percent narrowing of the narrowest segment compared to a nondiseased segment). Symptomatic carotid disease implies that the patient has experienced a stroke or TIA within the vascular distribution of the artery, and it is associated with a greater risk of subsequent stroke than asymptomatic stenosis, in which the patient is symptom free and the stenosis is detected through screening. Greater degrees of arterial narrowing are generally associated with a higher risk of stroke,\n\na contralateral carotid stenosis but that operated patients (on the side of symptomatic stenosis) still had fewer strokes than those treated with medication alone. In those with bilateral carotid disease, the risk of stroke after 2 years was 69 percent, and if operated, 22 percent. As to the timing of endarterectomy, opinions have diverged but a meta-analysis reported by Rothwell and colleagues (2004) has suggested that the maximum benefit is accrued if surgery is performed within 2 weeks of a TIA or minor stroke."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "guidelines TIA management carotid stenosis", "log": "The information gathered indicates that the management of symptomatic carotid stenosis, particularly in the context of a transient ischemic attack (TIA), can involve both medical management with antiplatelet therapy and surgical intervention, such as carotid endarterectomy or stenting. Given that the patient has significant carotid stenosis (90%) and experienced a TIA, the options of antiplatelet therapy and surgical intervention are both relevant.\n\nNext, I need to weigh the options again based on the information from the search:\n\n- **A**: Aspirin and clopidogrel - This is appropriate for preventing stroke in patients with TIA.\n- **B**: Warfarin - This is not typically indicated for TIA unless there are specific indications like atrial fibrillation.\n- **C**: Carotid stenting - This may be indicated for significant stenosis, especially in symptomatic patients.\n- **D**: Hypercoagulability studies - These are not indicated in the acute management of TIA.\n\nGiven that both antiplatelet therapy and surgical intervention are valid considerations, I will look for more specific guidelines regarding the immediate management of TIA with significant carotid stenosis to determine if one of these options is preferred over the other.\n\nAction: search_docs\nAction Input: \"guidelines TIA management carotid stenosis\"", "type": "AgentAction"}}, "reevaluate the lumen of the internal carotid artery (using ultrasonography) at 6to 12-month intervals. If the stenosis is advancing or becomes narrowed to about 2 mm or less, or if there is an event that could be construed as a TIA referable to the stenotic side, then surgery or endovascular treatment is considered.\n\nsupported the contention that it is prudent to fol-low a conservative course in the management of asymptomatic patients presenting with a cervical bruit.One of the first randomized clinical trials on the treatment of asymptomatic carotid artery stenosis was the Asymptomatic Carotid Atherosclerosis Study (ACAS), which evaluated the benefits of medical management with antiplatelet therapy versus carotid endarterectomy.25 Over a 5-year period, the risk of ipsi-lateral stroke in individuals with a carotid artery stenosis greater than 60% was 5.1% in the surgical arm. On the other hand, the risk\n\nCarotid disease can be classified by whether the stenosis is symptomatic or asymptomatic and by the degree of stenosis (percent narrowing of the narrowest segment compared to a nondiseased segment). Symptomatic carotid disease implies that the patient has experienced a stroke or TIA within the vascular distribution of the artery, and it is associated with a greater risk of subsequent stroke than asymptomatic stenosis, in which the patient is symptom free and the stenosis is detected through screening. Greater degrees of arterial narrowing are generally associated with a higher risk of stroke,\n\nshown to reduce stroke recurrence rate in sev-eral large clinical trials.19Symptomatic Carotid Stenosis.\u2002Currently, most stroke neu-rologists prescribe both aspirin and clopidogrel for secondary 1Brunicardi_Ch23_p0897-p0980.indd   91027/02/19   4:14 PM 911ARTERIAL DISEASECHAPTER 23stroke prevention in patients who have experienced a TIA or stroke.19 In patients with symptomatic carotid stenosis, the degree of stenosis appears to be the most important predic-tor in determining risk for an ipsilateral stroke. The risk of a recurrent ipsilateral stroke in patients with severe carotid ste-nosis"]]},"19": {"question": "A 65-year-old woman comes to the physician because of a 2-month history of persistent pain in her right shoulder. The pain is localized to the top of the shoulder and is worse with movement. She has stiffness in the right shoulder that is worse in the morning and usually lasts 20 minutes. The patient reports that she is unable to brush her hair and has stopped going to her regular tennis lessons because of the pain. She does not recall any fall or trauma. When her right arm is passively abducted in an arc, there is pain between 60 and 120 degrees of abduction. When asked to lower the right arm slowly from 90 degrees of abduction, she is unable to hold her arm up and it drops to her side. Passive range of motion is normal. Injection of 5 mL of 1% lidocaine into the right subacromial space does not relieve the pain or improve active range of motion of the right arm. Which of the following is the most likely diagnosis?", "options": {"A": "Cervical radiculopathy", "B": "Rotator cuff tear", "C": "Subacromial bursitis", "D": "Biceps tendinitis"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "65-year-old woman shoulder pain rotator cuff tear symptoms", "log": "To determine the most likely diagnosis for the patient's symptoms, I need to analyze the provided clinical details. The patient is a 65-year-old woman with persistent right shoulder pain, stiffness worse in the morning, and significant limitations in shoulder movement. The pain is localized to the top of the shoulder and is exacerbated by movement. Notably, passive range of motion is normal, but there is pain during specific movements, particularly between 60 and 120 degrees of abduction, and she cannot hold her arm up when it is abducted.\n\n1. **Cervical radiculopathy** typically presents with pain that radiates down the arm and may involve neurological symptoms, which are not mentioned in this case.\n2. **Rotator cuff tear** could cause weakness and pain, especially with overhead activities, but the normal passive range of motion and the response to lidocaine injection do not strongly support this diagnosis.\n3. **Subacromial bursitis** often presents with pain during abduction and can be associated with pain relief from lidocaine injections. However, the lack of relief from the injection might argue against this.\n4. **Biceps tendinitis** can cause anterior shoulder pain and might present similarly, but the specific pain pattern and the inability to hold the arm up are more indicative of rotator cuff issues.\n\nGiven the age of the patient, the specific pain pattern during movement, and the results of the lidocaine injection, I will lean towards the diagnosis of a rotator cuff tear.\n\nAction: search_docs  \nAction Input: \"65-year-old woman shoulder pain rotator cuff tear symptoms\"  ", "type": "AgentAction"}}, "Rotator cuff tendinitis or tear is a very common cause of shoulder pain. Nearly 30 percent of the elderly will have shoulder pain, with rotator cuff tendinitis or tear as the primary cause. The rotator cuff is formed by four tendons that attach the scapula to the proximal humerus (supraspinatus, infraspinatus, teres minor, and subscapularis tendons). Of these, the supraspinatus muscle is the most commonly damaged. Rotator cuff tendinitis is suggested by pain on active abduction (but not passive abduction), pain over the lateral deltoid muscle,\n\nPain arising from the shoulder can on occasion mimic pain from the spine. If symptoms and signs of radiculopathy are absent, then the differential diagnosis includes mechanical shoulder pain (tendonitis, bursitis, rotator cuff tear, dislocation, adhesive capsulitis, or rotator cuff impingement under the acromion) and referred pain (subdiaphragmatic irritation, angina, Pancoast tumor). Mechanical pain is often worse at night, associated with local shoulder tenderness and aggravated by passive abduction, internal rotation, or extension of the arm. Pain from shoulder disease may radiate into the\n\nshoulder is the most commonly dislocated large joint. Most dislocations are anterior. They are often associated with injuries to the anterior inferior glenoid labrum (Bankart lesion), impac-tion fractures of the humeral head (Hill-Sachs lesion) (Fig. 43-7), and rotator cuff tears in the elderly. The axillary nerve is at risk of being injured in shoulder dislocation. If the patient is unable to raise the arm after reduction of shoulder dislocation, then it is most likely due to a rotator cuff tear in the elderly and axillary nerve injury in the young.There is a high recurrence rate that\n\nTendinitis of the rotator cuff is the major cause of a painful shoulder andiscurrentlythoughttobecausedbyinflammationofthetendon(s). The rotator cuff consists of the tendons of the supraspinatus, infraspinatus, subscapularis, and teres minor muscles, and inserts on the humeral tuberosities. Of the tendons forming the rotator cuff, the supraspinatustendonis the most often affected,probablybecauseofits repeated impingement (impingement syndrome) between the humeral head and the undersurface of the anterior third of the acromion and coracoacromial ligament above as well as the reduction in its"]]},"20": {"question": "A 72-year-old man presents to the emergency department after a fall. The patient was found lying down on the floor in his room in his retirement community. The patient has a past medical history of Alzheimer dementia and a prosthetic valve. His current medications include donepezil and warfarin. His temperature is 97.7\u00b0F (36.5\u00b0C), blood pressure is 85/50 mmHg, pulse is 160/min, respirations are 13/min, and oxygen saturation is 97% on room air. That patient is started on IV fluids and a type and screen is performed. Laboratory values are ordered as seen below.\n\nHemoglobin: 13 g/dL\nHematocrit: 39%\nLeukocyte count: 5,500 cells/mm^3 with normal differential\nPlatelet count: 225,000/mm^3\n\nINR: 2.5\nAST: 10 U/L\nALT: 12 U/L\n\nA chest radiograph and EKG are performed and are within normal limits. A full physical exam is within normal limits. The patient\u2019s vitals are repeated. His temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 110/70 mmHg, pulse is 90/min, respirations are 10/min, and oxygen saturation is 98% on room air. Which of the following is the best next step in management?", "options": {"A": "CT scan", "B": "Exploratory laparoscopy", "C": "Exploratory laparotomy", "D": "Fresh frozen plasma"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'best next step in management for patient on warfarin with elevated INR after fall'", "log": "To determine the best next step in management for this patient, we need to analyze the clinical scenario and the options provided. The patient is a 72-year-old man who has fallen, has a history of Alzheimer dementia, and is on warfarin. His vital signs indicate hypotension (low blood pressure) and tachycardia (high pulse), which could suggest hypovolemia or bleeding. \n\nThe laboratory values show that his hemoglobin and hematocrit are within normal limits, but his INR is elevated at 2.5, indicating that he is at increased risk for bleeding due to his anticoagulation therapy. Given that he has fallen, there is a possibility of internal bleeding which needs to be addressed.\n\nThe options presented are:\n- A: CT scan\n- B: Exploratory laparoscopy\n- C: Exploratory laparotomy\n- D: Fresh frozen plasma\n\nA CT scan could help identify any internal injuries or bleeding, but given the elevated INR and the potential for significant bleeding, it may be more prudent to address the coagulopathy directly. Fresh frozen plasma (Option D) would be the appropriate choice to reverse the effects of warfarin and manage the risk of bleeding.\n\nThus, the next step in management should focus on correcting the coagulopathy before further imaging or invasive procedures.\n\nAction: search_docs\nAction Input: 'best next step in management for patient on warfarin with elevated INR after fall' ", "type": "AgentAction"}}, "in the INR results. Also complicating INR determination is unreliable reporting of the ISI by thromboplastin manufacturers. Furthermore, every laboratory must establish the mean normal prothrombin time with each new batch of thromboplastin reagent. To accomplish this, the prothrombin time must be measured in fresh plasma samples from at least 20 healthy volunteers using the same coagulometer that is used for patient samples. For most indications, warfarin is administered in doses that produce a target INR of 2.0\u20133.0. An exception is patients with mechanical heart valves, particularly those in\n\nArgatroban is a small molecule thrombin inhibitor that is FDA-approved for use in patients with HIT with or without thrombosis and coronary angioplasty in patients with HIT. It, too, has a short half-life, is given by continuous intravenous infusion, and is monitored by aPTT. Its clearance is not affected by renal disease but is dependent on liver function; dose reduction is required in patients with liver disease. Patients on argatroban will demonstrate elevated INRs, rendering the transition to warfarin difficult (ie, the INR will reflect contributions from both warfarin and argatroban).\n\nrange of 2.5\u20133.5. While a prolonged INR is widely used as an indication of integrity of the coagulation system in liver disease and other disorders, it has been validated only in patients in steady state on chronic warfarin therapy.\n\nwarfarin dosing In an average-size adult, warfarin is often initiated in a dose of 5 mg. The prothrombin time is standardized by calculating the international normalized ratio (INR), which assesses the anticoagulant effect of warfarin (Chap. 78). The target INR is usually 2.5, with a range of 2.0\u20133.0."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'management of elevated INR in patients with trauma or falls'", "log": "The information retrieved does not directly answer the question regarding the best next step in management for a patient on warfarin with elevated INR after a fall. However, it reinforces the importance of addressing the elevated INR in patients at risk for bleeding, particularly in the context of recent trauma.\n\nGiven the clinical scenario, the patient has an elevated INR of 2.5, which indicates a higher risk of bleeding. Since he has fallen and is at risk for potential internal bleeding, the most appropriate management step is to reverse the anticoagulation effect of warfarin.\n\nI will search again with a more focused query to find specific recommendations related to the management of patients on warfarin with elevated INR after falls.\n\nAction: search_docs\nAction Input: 'management of elevated INR in patients with trauma or falls' ", "type": "AgentAction"}}, "the bleeding risk. Thrombin generation has been shown to be normal in many patients with mild to moderate liver dysfunction. Because the PT only measures one aspect of hemostasis affected by liver dysfunction, we likely overestimate the bleeding risk of a mildly elevated INR in this setting.\n\nwith mechanical heart valves, particularly those in the mitral position or older ball and cage valves in the aortic position, where a target INR of 2.5\u20133.5 is recommended. Studies in atrial fibrillation demonstrate an increased risk of cardioembolic stroke when the INR falls to <1.7 and an increase in bleeding with INR values >4.5. These findings highlight the fact that vitamin K antagonists have a narrow therapeutic window. In support of this concept, a study in patients receiving long-term warfarin therapy for unprovoked venous thromboembolism demonstrated a higher rate of recurrent venous\n\nof cardiac disorders; however, evidence indicates some distinctions in the setting of inflammation. For example, elevated proBNP has been detected in septic patients in the absence of myocardial dysfunction and appears to have prognostic significance.235 More recently, investigators examined changes in N-terminal pro-BNP (NT-proBNP) in a cohort of severely injured patients and deter-mined that persistently high level of NT-proBNP in major trauma patients is indicative of poor outcome.236SURGICAL METABOLISMThe initial hours after surgical or traumatic injury are metaboli-cally associated with\n\nin the INR results. Also complicating INR determination is unreliable reporting of the ISI by thromboplastin manufacturers. Furthermore, every laboratory must establish the mean normal prothrombin time with each new batch of thromboplastin reagent. To accomplish this, the prothrombin time must be measured in fresh plasma samples from at least 20 healthy volunteers using the same coagulometer that is used for patient samples. For most indications, warfarin is administered in doses that produce a target INR of 2.0\u20133.0. An exception is patients with mechanical heart valves, particularly those in"]]},"21": {"question": "A 42-year-old man presents for evaluation of vitamin D deficiency with possible osteomalacia. The patient had a pathologic fracture 3 weeks ago and was found to have dangerously low levels of vitamin D with normal serum calcium levels. Bone density has been drastically affected, leading to the fracture this patient experienced. The lack of what compound is most responsible for the formation of this disease?", "options": {"A": "Calcifediol", "B": "Calcitriol", "C": "Vitamin D binding protein", "D": "PTH"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "calcitriol role in osteomalacia and vitamin D deficiency", "log": "To answer the question, I need to identify which compound is most responsible for the formation of osteomalacia in the context of vitamin D deficiency. Osteomalacia is primarily caused by a deficiency in vitamin D, which is crucial for calcium absorption and bone mineralization. \n\n- Calcifediol is a form of vitamin D (25-hydroxyvitamin D) but is not the active form responsible for calcium regulation.\n- Calcitriol (1,25-dihydroxyvitamin D) is the active form of vitamin D that regulates calcium and phosphate metabolism in the body and is essential for bone health.\n- Vitamin D binding protein helps transport vitamin D in the bloodstream but is not directly responsible for the disease process.\n- PTH (parathyroid hormone) regulates calcium levels but is not the primary compound deficient in osteomalacia.\n\nGiven this breakdown, I should focus on the role of calcitriol in the formation of osteomalacia due to vitamin D deficiency.\n\nAction: search_docs\nAction Input: \"calcitriol role in osteomalacia and vitamin D deficiency\"", "type": "AgentAction"}}, "Vitamin D deficiency appears as rickets in children and as osteomalacia in postpubertal adolescents. Inadequate direct sun exposure and vitamin D intake are sufficient causes, butother factors, such as various drugs (phenobarbital, phenytoin) and malabsorption, may increase the risk of developmentof vitamin-deficiency rickets. Breastfed infants, especiallythose with dark-pigmented skin, are at risk for vitamin Ddeficiency.\n\nE. Clinical indications for vitamin D 1. Nutritional rickets: Vitamin D deficiency causes a net demineralization of bone, resulting in rickets in children and osteomalacia in adults (Fig. 28.25). Rickets is characterized by the continued formation of the collagen matrix of bone, but incomplete mineralization results in soft, pliable bones. In osteomalacia, demineralization of preexisting bones increases their susceptibility to fracture. Insufficient exposure to daylight and/or deficiencies in vitamin D consumption occur predominantly in infants and the elderly. Vitamin D deficiency is more\n\nVitamin D deficiency causes rickets in growing children and osteomalacia in adults; these skeletal diseases have worldwide distribution. They may result from diets deficient in calcium and vitamin D, but probably more important is limited exposure to sunlight (for instance, in heavily veiled women; children born to mothers who have frequent pregnancies followed by lactation, which leads to vitamin D deficiency; and inhabitants of northern climates with scant sunlight). Other, less common causes of rickets and osteomalacia include renal disorders causing decreased synthesis of 1,25-(OH)2-D or\n\n(See also Chap. 423) Severe vitamin D deficiency causes rickets in children and osteomalacia in adults. However, there is accumulating evidence that vitamin D insufficiency may be more prevalent than previously thought, particularly among individuals at increased risk such as the elderly; those living in northern latitudes; and individuals with poor nutrition, malabsorption, or chronic liver or renal disease. Dark-skinned individuals are also at high risk of vitamin D deficiency. There is controversy regarding optimal levels of serum 25-hydroxyvitamin D [25(OH)D], with some advocating levels"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "calcitriol deficiency osteomalacia vitamin D", "log": "The observation confirms that vitamin D deficiency leads to osteomalacia in adults due to inadequate mineralization of bone. It highlights the critical role of vitamin D in calcium absorption and bone health. The information aligns with my previous analysis that calcitriol, the active form of vitamin D, is essential for bone mineralization and preventing osteomalacia. \n\nAction: search_docs\nAction Input: \"calcitriol deficiency osteomalacia vitamin D\"", "type": "AgentAction"}}, "Chronic hypocalcemia due to hypoparathyroidism is treated with calcium supplements (1000\u20131500 mg/d elemental calcium in divided doses) and either vitamin D2 or D3 (25,000\u2013100,000 U daily) or calcitriol [1,25(OH)2D, 0.25\u20132 \u03bcg/d]. Other vitamin D metabolites (dihydrotachysterol, alfacalcidiol) are now used less frequently. Vitamin D deficiency, however, is best treated using vitamin D supplementation, with the dose depending on the severity of the deficit and the underlying cause. Thus, nutritional vitamin D deficiency generally responds to relatively low doses of vitamin D (50,000 U, 2\u20133 times\n\nVitamin D deficiency appears as rickets in children and as osteomalacia in postpubertal adolescents. Inadequate direct sun exposure and vitamin D intake are sufficient causes, butother factors, such as various drugs (phenobarbital, phenytoin) and malabsorption, may increase the risk of developmentof vitamin-deficiency rickets. Breastfed infants, especiallythose with dark-pigmented skin, are at risk for vitamin Ddeficiency.\n\nE. Clinical indications for vitamin D 1. Nutritional rickets: Vitamin D deficiency causes a net demineralization of bone, resulting in rickets in children and osteomalacia in adults (Fig. 28.25). Rickets is characterized by the continued formation of the collagen matrix of bone, but incomplete mineralization results in soft, pliable bones. In osteomalacia, demineralization of preexisting bones increases their susceptibility to fracture. Insufficient exposure to daylight and/or deficiencies in vitamin D consumption occur predominantly in infants and the elderly. Vitamin D deficiency is more\n\ndisorders causing decreased synthesis of 1,25-(OH)2-D or phosphate depletion, and malabsorption disorders. Although rickets and osteomalacia rarely occur outside high-risk groups, milder forms of vitamin D deficiency (also called vitamin D insufficiency) leading to bone loss and hip fractures are common among elderly persons. Studies also suggest that vitamin D may be important for preventing demineralization of bones. It appears that certain genetically determined variants of the vitamin D receptor are associated with an accelerated loss of bone minerals with aging and certain familial forms"]]},"22": {"question": "A 22-year-old man comes to the physician because of headaches and blurry vision for the past 6 months. He also reports frequent episodes of vomiting over the last month. His father has died of renal cell carcinoma at the age of 37 years. Examination shows 20/40 vision bilaterally. Fundoscopic examination shows bilateral optic disc swelling and growth of capillary vessels in the temporal peripheral retina. An MRI of the brain shows an infratentorial mass. The patient undergoes surgical resection of the mass. A photomicrograph of the resected specimen is shown. Which of the following is the most likely diagnosis?", "options": {"A": "Medulloblastoma", "B": "Oligodendroglioma", "C": "Hemangioblastoma", "D": "Ependymoma"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Hemangioblastoma symptoms and diagnosis", "log": "To solve this question, I need to analyze the symptoms and findings presented in the case. The key points include:\n\n1. The patient is a 22-year-old man with headaches, blurry vision, and frequent vomiting.\n2. There is a family history of renal cell carcinoma, which may suggest a genetic predisposition to certain tumors.\n3. The examination shows bilateral optic disc swelling and growth of capillary vessels in the retina.\n4. An MRI shows an infratentorial mass.\n5. The options provided for diagnosis are Medulloblastoma, Oligodendroglioma, Hemangioblastoma, and Ependymoma.\n\nNext, I will consider each option in relation to the symptoms and findings. \n\n- **Medulloblastoma**: Common in children but can occur in young adults. It is a type of brain tumor that arises in the cerebellum and can cause increased intracranial pressure, headaches, and vomiting.\n- **Oligodendroglioma**: Typically found in adults, these tumors arise from oligodendrocytes and are associated with seizures and focal neurological deficits rather than the symptoms described.\n- **Hemangioblastoma**: Often associated with von Hippel-Lindau syndrome, these tumors can cause retinal vascular changes and are typically found in the cerebellum. The family history of renal cell carcinoma could suggest a genetic syndrome like VHL.\n- **Ependymoma**: A tumor that arises from ependymal cells and can occur in the infratentorial region but is less common in this age group.\n\nGiven the combination of symptoms, family history, and the specific findings of retinal vascular changes, Hemangioblastoma appears to be the most likely diagnosis.\n\nAction: search_docs\nAction Input: \"Hemangioblastoma symptoms and diagnosis\" ", "type": "AgentAction"}}, "Hemangioblastoma of the Cerebellum\n\nIn the WHO classification, a gliosarcoma is categorized with other gliomas and a granulocytic sarcoma is listed under the hematopoetic tumors but restricting the term to these does not fully capture the range and unusual behaviors of most cranial sarcomas.\n\nPatients Who Present Primarily With Signs of Increased Intracranial Pressure (Medulloblastoma, Ependymoma of the Fourth Ventricle, Hemangioblastoma of the Cerebellum, Pinealoma, Colloid Cyst of the Third Ventricle and Rare Related Tumors)\n\nWhen worrisome symptoms and signs are present (Table 21-2), rapid diagnosis and management are critical.\n\nfood. The presentation may be impressively dramatic and engaging, and the symptoms re- ported inconsistently. In factitious disorder imposed on another, the caregiver describes symptoms consistent with avoidant/restrictive food intake disorder and may induce physical symptoms such as failure to gain weight. As with any diagnosis of factitious dis- order imposed on another, the caregiver receives the diagnosis rather than the affected in- dividual, and diagnosis should be made only on the basis of a careful, comprehensive assessment of the affected individual, the caregiver, and their"]]},"23": {"question": "A 53-year-old woman presents to her primary care physician with joint pain. She reports a 6-month history of progressive pain in her hands that is worse around her knuckles. The pain is symmetric bilaterally and seems to improve after she starts working in the morning at her job in a local grocery store. She has also lost 10 pounds over the past 6 months despite no changes in her weight or exercise regimen. Her past medical history is notable for seasonal allergies, hypertension, and intermittent constipation. She takes losartan and a laxative as needed. She had adolescent idiopathic scoliosis as a child and underwent a spinal fusion at the age of 14. She does not smoke or drink alcohol. Her temperature is 98.6\u00b0F (37\u00b0C), blood pressure is 135/75 mmHg, pulse is 92/min, and respirations are 16/min. On examination, she appears well and is appropriately interactive. Strength is 5/5 and sensation to light touch is intact in the bilateral upper and lower extremities. An examination of her hands demonstrates symmetric swelling of the metacarpophalangeal joints bilaterally. This patient\u2019s condition is most strongly characterized by which of the following?", "options": {"A": "HLA-B27", "B": "HLA-DR2", "C": "HLA-DR3", "D": "HLA-DR4"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "HLA type associations with rheumatoid arthritis", "log": "To answer the question, I need to analyze the clinical presentation of the patient, which suggests a diagnosis of rheumatoid arthritis (RA) due to the symmetric joint pain, swelling of the metacarpophalangeal joints, and improvement of symptoms with activity. The question asks for the HLA type most strongly associated with this condition. \n\nThe next step is to research the HLA associations with rheumatoid arthritis to determine which of the given options (A, B, C, or D) is most relevant. \n\nAction: search_docs \nAction Input: \"HLA type associations with rheumatoid arthritis\"", "type": "AgentAction"}}, "and hemochromatosis are each associated with specific HLA haplotypes. It is now recognized that these genes lie in close proximity to the HLA locus, which explains why HLA associations were identified even before the disease genes were cloned and localized. In other cases, specific HLA associations with diseases such as ankylosing spondylitis (HLA-B27) or type 1 diabetes mellitus (HLA-DR4) reflect the role of specific HLA allelic variants in susceptibility to these autoimmune diseases. The characterization of common SNP haplotypes in numerous populations from different parts of the world\n\nhese indings may reflect the interference of sex hormones with several putative processes involved in arthritis pathogenesis, including immunoregulation (Haupl, 2008a,b). First, Unger and associates (1983) reported that amelioration of rheumatoid arthritis correlated with serum levels of pregnancyassociated apha2-gycoprotein. his compound has immunosuppressive properties. Second, Nelson and coworkers (1993) noted that amelioration of disease was associated with a disparity in HLA class II antigens between mother and fetus. They s\ufffdggested that the maternal immune response to paternal HLA\n\nAlthough the presence of a DR3 haplotype in combination with the DR4-DQB1*0302 haplotype is a very high-risk combination for diabetes susceptibility, the specific gene on the DR3 haplotype that is responsible for this synergy is not yet identified.\n\nRheumatoid Arthritis The HLA genes associated with rheumatoid arthritis (RA) (Chap.\n\nextends across large segments of the MHC region, it is quite possible that combinations of genes may account for the particular associations of HLA haplotypes with disease. For example, on some haplotypes associated with rheumatoid arthritis, both HLA-DRB1 alleles and a particular polymorphism associated with the TNF locus may be contributory to disease risk. Other candidates for similar epistatic effects include the IKBL gene and the MICA locus, potentially in combination with classic HLA class II risk alleles."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "HLA-DR4 association with rheumatoid arthritis", "log": "The search provided information about HLA associations with autoimmune diseases, particularly rheumatoid arthritis (RA). It indicates that HLA-DR4 is commonly associated with RA, which aligns with the patient's presentation of symmetric joint pain and swelling. \n\nNext, I need to confirm that HLA-DR4 is indeed the strongest association with rheumatoid arthritis compared to the other options (HLA-B27, HLA-DR2, and HLA-DR3).\n\nAction: search_docs \nAction Input: \"HLA-DR4 association with rheumatoid arthritis\"", "type": "AgentAction"}}, "allele(s) of HLA-DR4 was not found. Approximately 30% of patients with relapsing polychondritis will have another rheumatologic disorder, the most frequent being systemic vasculitis, followed by rheumatoid arthritis, and systemic lupus erythematosus (SLE). Nonrheumatic aSystemic vasculitis is the most common association, followed by rheumatoid arthritis and systemic lupus erythematosus.\n\nrheumatoid arthritis (RA) and HLA-DR4 to 100 or more for ankylosing spondylitis and HLA-B27. However, how MHC genes influence the development of autoimmunity is still not clear. Notably, most individuals with a susceptibility-related MHC allele never develop disease, and, conversely, individuals without the relevant MHC gene may get it. Expression of a particular MHC gene is therefore but one variable that contributes to autoimmunity.\n\nThe worldwide prevalence of rheumatoid arthritis is 0.5 to 1 percent, women are afected three times more often than men, and peak onset is from 25 to 55 years (Shah, 2015). There is a genetic predisposition, and heritability is estimated at 15 to 30 percent (McInnes, 2011). Genome-wide associated studies have identified more than 30 loci involved in rheumatoid arthritis pathogenesis (Kurka, 2013). There is an association with the\n\nTABLE 59-7. Criteria for Classification of Rheumatoid Arthritis\n\nwith rheumatoid arthritis and other connective tissue diseases."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "HLA associations rheumatoid arthritis HLA-DR4 HLA-DR2 HLA-DR3 HLA-B27", "log": "The search did not yield specific information about HLA-DR4's association with rheumatoid arthritis, but it did mention that HLA-DR4 is commonly associated with the disease. I need to verify this information further to strengthen the conclusion regarding which HLA type is most strongly associated with rheumatoid arthritis. \n\nAction: search_docs \nAction Input: \"HLA associations rheumatoid arthritis HLA-DR4 HLA-DR2 HLA-DR3 HLA-B27\"", "type": "AgentAction"}}, "HLA association. The odds ratio (relative risk) for persons with HLA-DR2 or HLA-DR3 is 2 to 3, and if both haplotypes are present, the risk is about 5.\n\nAs in genome-wide association studies (GWASs), association of MHC with disease is identified by comparing the frequencies of MHC alleles in patients with the disease with the frequencies in the normal population. For type\u00a01 diabetes, this approach demonstrated an association with the HLA-DR3 and HLA-DR4 alleles, identified by serotyping (Fig. 15.38). Such studies also showed that the MHC class II allele HLA-DR2 has a dominant protective\n\nallele(s) of HLA-DR4 was not found. Approximately 30% of patients with relapsing polychondritis will have another rheumatologic disorder, the most frequent being systemic vasculitis, followed by rheumatoid arthritis, and systemic lupus erythematosus (SLE). Nonrheumatic aSystemic vasculitis is the most common association, followed by rheumatoid arthritis and systemic lupus erythematosus.\n\nBoth UC and CD have a tendency to familial aggregation, more so for CD. HLA associations have been weak and inconsistent. HLA-B27 is found in up to 70% of patients with IBD and AS, but in \u226415% of patients with IBD and peripheral arthritis or IBD alone. Three alleles of the NOD2/CARD15 gene on chromosome 16 have been found in approximately one-half of patients with CD. These alleles are not associated with the spondyloarthritides per se. However, they are found significantly more often in (1) CD patients with sacroiliitis than in those without sacroiliitis, and (2) SpA patients with chronic"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "HLA-DR4 rheumatoid arthritis association strength", "log": "The search results indicate that HLA-DR4 is commonly associated with rheumatoid arthritis, but the information is not definitive. I need to ensure that I have a clear understanding of the relative strength of the associations of HLA-DR4, HLA-DR2, HLA-DR3, and HLA-B27 with rheumatoid arthritis.\n\nNext, I will focus on finding more specific data regarding the strength of association for HLA-DR4 in the context of rheumatoid arthritis.\n\nAction: search_docs \nAction Input: \"HLA-DR4 rheumatoid arthritis association strength\"", "type": "AgentAction"}}, "allele(s) of HLA-DR4 was not found. Approximately 30% of patients with relapsing polychondritis will have another rheumatologic disorder, the most frequent being systemic vasculitis, followed by rheumatoid arthritis, and systemic lupus erythematosus (SLE). Nonrheumatic aSystemic vasculitis is the most common association, followed by rheumatoid arthritis and systemic lupus erythematosus.\n\nrheumatoid arthritis (RA) and HLA-DR4 to 100 or more for ankylosing spondylitis and HLA-B27. However, how MHC genes influence the development of autoimmunity is still not clear. Notably, most individuals with a susceptibility-related MHC allele never develop disease, and, conversely, individuals without the relevant MHC gene may get it. Expression of a particular MHC gene is therefore but one variable that contributes to autoimmunity.\n\nThe worldwide prevalence of rheumatoid arthritis is 0.5 to 1 percent, women are afected three times more often than men, and peak onset is from 25 to 55 years (Shah, 2015). There is a genetic predisposition, and heritability is estimated at 15 to 30 percent (McInnes, 2011). Genome-wide associated studies have identified more than 30 loci involved in rheumatoid arthritis pathogenesis (Kurka, 2013). There is an association with the\n\nTABLE 59-7. Criteria for Classification of Rheumatoid Arthritis\n\nwith rheumatoid arthritis and other connective tissue diseases."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "HLA-DR4 rheumatoid arthritis risk factor association study", "log": "The search results continue to indicate an association between HLA-DR4 and rheumatoid arthritis, but specific numerical data regarding the strength of this association is not provided. I need to consolidate the information gathered so far and confirm that HLA-DR4 is indeed the most relevant HLA type for the patient's condition.\n\nNext, I will summarize the findings and check for any definitive sources that directly state the association strength of HLA-DR4 with rheumatoid arthritis compared to the other options.\n\nAction: search_docs \nAction Input: \"HLA-DR4 rheumatoid arthritis risk factor association study\"", "type": "AgentAction"}}, "allele(s) of HLA-DR4 was not found. Approximately 30% of patients with relapsing polychondritis will have another rheumatologic disorder, the most frequent being systemic vasculitis, followed by rheumatoid arthritis, and systemic lupus erythematosus (SLE). Nonrheumatic aSystemic vasculitis is the most common association, followed by rheumatoid arthritis and systemic lupus erythematosus.\n\nEmery P et al: IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomized placebo-controlled trial. Ann Rheum Dis 2008;67:1516.\n\nEmery P et al: The impact of T-cell co-stimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept. Ann Rheum Dis 2010;69:510.\n\nGabay C et al: Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): A randomised, double-blind, controlled phase 4 trial. Lancet 2013;4:381.\n\nGenovese MC et al: Abatacept for rheumatoid arthritis refractory to tumor necrosis factor \u03b1 inhibition. N Engl J Med 2005;353:1114.\n\nGenovese MC et al: Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate. Arthritis Rheum 2011;63:10.\n\n416.\n\nRobinson WH, Genovese MC, Moreland LW. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 2001;44:1977\u20131983.\n\n417.\n\nMossner R, Schon MP, Reich K. Tumor necrosis factor antagonists in the therapy of psoriasis. Clin Dermatol 2008;26:486\u2013502.\n\n418."]]},"24": {"question": "A 34-year-old man presents to a clinic with complaints of abdominal discomfort and blood in the urine for 2 days. He has had similar abdominal discomfort during the past 5 years, although he does not remember passing blood in the urine. He has had hypertension for the past 2 years, for which he has been prescribed medication. There is no history of weight loss, skin rashes, joint pain, vomiting, change in bowel habits, and smoking. On physical examination, there are ballotable flank masses bilaterally. The bowel sounds are normal. Renal function tests are as follows:\nUrea 50 mg/dL\nCreatinine 1.4 mg/dL\nProtein Negative\nRBC Numerous\nThe patient underwent ultrasonography of the abdomen, which revealed enlarged kidneys and multiple anechoic cysts with well-defined walls. A CT scan confirmed the presence of multiple cysts in the kidneys. What is the most likely diagnosis?", "options": {"A": "Autosomal dominant polycystic kidney disease (ADPKD)", "B": "Autosomal recessive polycystic kidney disease (ARPKD)", "C": "Medullary cystic disease", "D": "Acquired cystic kidney disease"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Autosomal dominant polycystic kidney disease (ADPKD) symptoms and diagnosis'\n", "log": "To determine the most likely diagnosis for the patient, we need to analyze several key pieces of information provided in the case:\n\n1. **Age and Symptoms**: The patient is 34 years old and has a history of abdominal discomfort and blood in the urine. He has had similar abdominal discomfort for the past 5 years but does not recall passing blood in the urine before this incident.\n\n2. **Physical Examination**: The presence of ballotable flank masses bilaterally suggests enlarged kidneys, which aligns with cystic kidney diseases.\n\n3. **Ultrasonography and CT Scan Findings**: The imaging studies reveal enlarged kidneys with multiple anechoic cysts that have well-defined walls.\n\n4. **Renal Function Tests**: The patient's urea and creatinine levels indicate some degree of renal impairment, but there is no proteinuria, which is notable.\n\nNow, we will consider the options provided:\n\n- **A: Autosomal dominant polycystic kidney disease (ADPKD)**: This is characterized by multiple cysts in the kidneys, usually presenting in adulthood, and can often lead to hypertension and renal impairment.\n\n- **B: Autosomal recessive polycystic kidney disease (ARPKD)**: This typically presents in childhood and is associated with renal failure at a younger age, making it less likely in this 34-year-old patient.\n\n- **C: Medullary cystic disease**: This condition also presents with kidney cysts but is less common and usually presents with a different clinical picture.\n\n- **D: Acquired cystic kidney disease**: This is often seen in patients with chronic kidney disease, particularly those on dialysis, but the patient's age and presentation are more consistent with ADPKD.\n\nGiven the age of the patient, the symptoms, the presence of bilateral flank masses, and the imaging findings, the most likely diagnosis is:\n\nAction: search_docs\nAction Input: 'Autosomal dominant polycystic kidney disease (ADPKD) symptoms and diagnosis'\n", "type": "AgentAction"}}, "polycystic Kidney Disease and Other Inherited Disorders of tubule growth and Development Jing Zhou, Martin R. Pollak The polycystic kidney diseases are a group of genetically heteroge-339Disorders of the Kidney and Urinary Tract neous disorders and a leading cause of kidney failure. The autosomal dominant form of polycystic kidney disease (ADPKD) is the most common life-threatening monogenic disease, affecting 12 million people worldwide. The autosomal recessive form of polycystic kidney disease (ARPKD) is rarer but affects the pediatric population. Kidney cysts are often seen in a wide range\n\nFIGuRE 339-1 Scheme of the primary cilium and cystic kidney disease proteins. Left. A scheme of the primary cilium. Primary cilia share a \u201c9+0\u201d organization of microtubule doublets. Proteins are transported into the cilium by motor protein kinesin 2 and transported out of the cilium by dynein. The cilium is connected to the basal body through the transition zone. Middle. Topology of autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) proteins polycystin-1, polycystin-2, and fibrocystin/ polyductin (FPC) are shown. PC1 also interacts\n\nFIGuRE 339-2 Photograph showing a kidney from a patient with autosomal dominant polycystic kidney disease. The kidney has been cut open to expose the parenchyma and internal aspects of cysts.\n\nAutosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, occurring in about 1 in 1000 people. Approximately 12.5 million people worldwide have ADPKD, which is caused primarily by mutations in PKD1 (85%\u201390% of cases) or PKD2 (\u224815% of cases). The major phenotype of ADPKD is enlargement of the kidneys due to the presence of hundreds or thousands of space-occupying renal cysts that can be as large as 20 cm in diameter. Cysts are also seen in the liver and other organs in this condition. About 50% of patients with ADPKD progress to renal failure by the age"]]},"25": {"question": "A 40-year-old woman comes to the physician because of a 2-week history of anal pain that occurs during defecation and lasts for several hours. She reports that she often strains during defecation and sees bright red blood on toilet paper after wiping. She typically has 3 bowel movements per week. Physical examination shows a longitudinal, perianal tear. This patient's symptoms are most likely caused by tissue injury in which of the following locations?", "options": {"A": "Posterior midline of the anal canal, distal to the pectinate line", "B": "Anterior midline of the anal canal, distal to the pectinate line", "C": "Posterior midline of the anal canal, proximal to the pectinate line", "D": "Lateral aspect of the anal canal, distal to the pectinate line"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "anal fissure locations anatomy", "log": "To answer the question, I need to analyze the symptoms and physical examination findings of the patient. The key details are:\n\n1. The patient has anal pain during defecation, lasting several hours.\n2. There is bright red blood on toilet paper after wiping, indicating a possible tear or injury.\n3. A longitudinal perianal tear is noted on examination.\n4. The patient strains during defecation and has infrequent bowel movements (3 per week).\n\nThe question asks about the location of tissue injury in relation to the anal canal and the pectinate line. The options provided refer to different anatomical locations within the anal canal.\n\nTo determine the correct answer, I will consider the common locations for anal fissures or tears. Typically, fissures occur in the posterior midline of the anal canal, especially distal to the pectinate line, due to the anatomy and blood supply of the area.\n\nNext, I will check if there are any specific medical references or documents that could provide additional insights or confirm the common anatomical locations of anal fissures.\n\nAction: search_docs\nAction Input: \"anal fissure locations anatomy\"", "type": "AgentAction"}}, "Anatomy and Pathophysiology Trauma to the anal canal occurs following defecation. This injury occurs in the anterior or, more commonly, the posterior anal canal. Irritation caused by the trauma to the anal canal results in an increased resting pressure of the internal sphincter. The blood supply to the sphincter and anal mucosa enters laterally. Therefore, increased anal sphincter tone results in a relative ischemia in the region of the fissure and leads to poor healing of the anal injury. A fissure that is not in the posterior or anterior position should raise suspicion for other causes,\n\nof a hypertrophied anal papilla at the proximal end of the fissure and a sentinel pile or skin tag at the distal end. Often the circular fibers of the hypertrophied internal sphincter are visible within the base of the fissure. If anal manometry is performed, elevation in anal resting pressure and a sawtooth deformity with paradoxical contractions of the sphincter muscles are pathognomonic.\n\nPresentation and Evaluation A fissure can be easily diagnosed on history alone. The classic complaint is pain, which is strongly associated with defecation and is relentless. The bright red bleeding that can be associated with a fissure is less extensive than that associated with hemorrhoids. On examination, most fissures are located in either the posterior or anterior position. A lateral fissure is worrisome because it may have a less benign nature, and systemic disorders should be ruled out. A chronic fissure is indicated by the presence of a hypertrophied anal papilla at the proximal end\n\ntag and/or a hypertrophied anal papilla internally. These fissures are more challenging to treat and may require surgery. A lateral loca-tion of a chronic anal fissure may be evidence of an underlying disease such as Crohn\u2019s disease, HIV, syphilis, tuberculosis, or leukemia. If the diagnosis is in doubt or there is suspicion of another cause for the perianal pain such as abscess or fistula, an examination under anesthesia may be necessary.Treatment.\u2002Therapy focuses on breaking the cycle of pain, spasm, and ischemia thought to be responsible for development of fissure in ano. First-line"]]},"26": {"question": "A 40-year-old G1P0010 presents to the clinic with nausea and vomiting 8 weeks after a spontaneous abortion at 10 weeks gestation. She admits to heavy drinking (7\u20138 glasses of wine per day) for the last 20 years; however, after the pregnancy loss, she increased her drinking to 8\u20139 glasses per day. Hepatomegaly, right upper quadrant pain, and jaundice are noted on abdominal examination. The lungs are clear to auscultation with no abnormalities on chest X-ray. Liver function tests are obtained and a biopsy is performed. Which of the following findings is most likely to be true in her condition?", "options": {"A": "\u2191 NADH/NAD+; AST:ALT \u2265 2:1; \u00df-oxidation \u2193; \u00df-hydroxybutyrate \u2191; lactic acid \u2191", "B": "\u2191 NAD+/NADH; ALT:AST \u2265 2:1; \u00df-oxidation \u2191; \u00df-hydroxybutyrate, no change; lactic acid \u2193", "C": "\u2191 NAD+/NADH; AST:ALT \u2265 2:1; \u00df-oxidation \u2191; \u00df-hydroxybutyrate \u2193; lactic acid \u2193", "D": "\u2191 NADH/NAD+; ALT:AST \u2265 2:1; \u00df-oxidation \u2193; \u00df-hydroxybutyrate \u2193; lactic acid \u2191"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'alcoholic liver disease laboratory findings'", "log": "To solve this question, I need to analyze the clinical scenario presented. The patient has a history of heavy alcohol consumption and presents with signs of liver dysfunction such as hepatomegaly, right upper quadrant pain, and jaundice. After a spontaneous abortion, her alcohol intake increased, which could exacerbate liver damage. \n\nThe liver function tests and biopsy findings will help determine the specific liver condition, likely related to alcoholic liver disease. In alcoholic liver disease, typical laboratory findings include an increased ratio of AST to ALT (often \u2265 2:1), elevated levels of NADH/NAD+, and changes in fatty acid metabolism, such as decreased \u03b2-oxidation and increased levels of certain metabolites like lactic acid and \u03b2-hydroxybutyrate.\n\nGiven the options:\n- A suggests increased NADH/NAD+, a specific AST:ALT ratio, decreased \u03b2-oxidation, increased \u03b2-hydroxybutyrate, and increased lactic acid.\n- B suggests the opposite in terms of NAD+/NADH ratio and changes in ALT/AST, which is less consistent with alcoholic liver disease.\n- C also suggests an increase in NAD+/NADH but with a different profile that doesn't align with alcoholic liver disease.\n- D suggests increased NADH/NAD+, a specific ALT:AST ratio, decreased \u03b2-oxidation, decreased \u03b2-hydroxybutyrate, and increased lactic acid, which aligns with the typical findings seen in alcoholic liver disease.\n\nI need to confirm these findings by searching relevant medical literature or guidelines on alcoholic liver disease to ensure I select the most accurate answer.\n\nAction: search_docs\nAction Input: 'alcoholic liver disease laboratory findings'", "type": "AgentAction"}}, "Differential Diagnosis The differential diagnosis between DIC and severe liver disease is challenging and requires serial measurements of the laboratory parameters of DIC. Patients with severe liver disease are at risk for bleeding and manifest laboratory features including thrombocytopenia (due to platelet sequestration, portal hypertension, or hypersplenism), decreased synthesis of coagulation factors and natural anticoagulants, and elevated levels of FDP due to reduced hepatic clearance. However, in contrast to DIC, these laboratory parameters in liver disease do not change rapidly. Other\n\nparameters in liver disease do not change rapidly. Other important differential findings include the presence of portal hypertension or other clinical or laboratory evidence of an underlying liver disease.\n\nceliac disease and ischemic liver disease, which would be readily distinguishable by clinical and laboratory features from autoimmune hepatitis.\n\nwhere the diagnosis remains unclear despite thorough clinical and laboratory investigation. Liver biopsy can be helpful in diagnosing drug-induced liver disease and acute alcoholic hepatitis."]]},"27": {"question": "A 24-year-old professional athlete is advised to train in the mountains to enhance his performance. After 5 months of training at an altitude of 1.5 km (5,000 feet), he is able to increase his running pace while competing at sea-level venues. Which of the following changes would produce the same effect on the oxygen-hemoglobin dissociation curve as this athlete's training did?", "options": {"A": "Decreased pH", "B": "Decreased temperature", "C": "Decreased 2,3-bisphosphoglycerate", "D": "Increased partial pressure of oxygen"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "altitude training oxygen-hemoglobin dissociation curve effects", "log": "To answer the question, I need to understand how altitude training affects the oxygen-hemoglobin dissociation curve. Training at high altitudes typically leads to physiological adaptations that enhance oxygen delivery to tissues when returning to sea level. This is often associated with increased levels of 2,3-bisphosphoglycerate (2,3-BPG) in red blood cells, which facilitates oxygen release from hemoglobin.\n\nNext, I need to consider each of the options provided to determine which one would have a similar effect on the oxygen-hemoglobin dissociation curve:\n\n- **A: Decreased pH** - This would shift the curve to the right (Bohr effect), promoting oxygen release.\n- **B: Decreased temperature** - This would shift the curve to the left, reducing oxygen release.\n- **C: Decreased 2,3-bisphosphoglycerate** - This would also shift the curve to the left, reducing oxygen release.\n- **D: Increased partial pressure of oxygen** - This would increase hemoglobin saturation but does not directly mimic the adaptations from altitude training.\n\nThe key effect of altitude training is to enhance oxygen release, which is akin to a decrease in pH or an increase in 2,3-BPG. I should focus on the option that would produce a rightward shift in the curve.\n\nSince I need to confirm the physiological effects, I will search for more information regarding the relationship between altitude training and the oxygen-hemoglobin dissociation curve.\n\nAction: search_docs  \nAction Input: \"altitude training oxygen-hemoglobin dissociation curve effects\"  ", "type": "AgentAction"}}, "shift of the oxyhemoglobin dissociation curve to the left (see\n\nare well known driver mutations for many cancers. This is another example of alterations in subatomic particles that directly cause disease.A known example of a change in the subatomic milieu of an element leading to a disease process is that of methemo-globinemia, a disorder characterized by an overabundance of methemoglobin. Methemoglobin contains an oxidized form of iron (carrying an extra electron), as opposed to the reduced form in normal hemoglobin. This results in a shift in the oxygen-hemoglobin dissociation curve to the left, causing hypoxia. Met-hemoglobinemia can be congenital, due\n\nof the curve), shifts in the oxyhemoglobin dissociation curve can dramatically influence O2 transport.\n\nhe propensity of the hemoglobin molecule to release oxygen is described by the oyhemoglobin dissociation curve (Fig. 47-2). For clinical purposes, the curve can be divided into an upper oxygen association curve representing the alveolar-capillary environment and a lower oxygen dissociation portion representing the tissue-capillary environment. Shifts of the curve have their greatest efect at the steep portion because they afect oxygen delivery. A rightward shit is associated with decreased hemoglobin ainity for oxygen and hence increased tissue-capillary oxygen :0 60= :l"]]},"28": {"question": "A 35-year-old man presents to pulmonary function clinic for preoperative evaluation for a right pneumonectomy. His arterial blood gas at room air is as follows:\n\npH: 7.34\nPaCO2: 68 mmHg\nPaO2: 56 mmHg\nBase excess: +1\nO2 saturation: 89%\n\nWhat underlying condition most likely explains these findings?", "options": {"A": "Acute respiratory distress syndrome", "B": "Chronic obstructive pulmonary disease", "C": "Cystic fibrosis", "D": "Obesity"}, "output": "B", "intermediate_steps": []},"29": {"question": "A 48-year old man comes to the physician for the evaluation of an 8-month history of fatigue and profuse, watery, odorless diarrhea. He reports that he has had a 10.5-kg (23-lb) weight loss during this time. Physical examination shows conjunctival pallor and poor skin turgor. Laboratory studies show:\nHemoglobin 9.8 g/dl\nSerum\nGlucose (fasting) 130 mg/dl\nK+ 2.5 mEq/L\nCa2+ 12 mg/dl\nA CT scan of the abdomen with contrast shows a 3.0 \u00d7 3.2 \u00d7 4.4 cm, well-defined, enhancing lesion in the pancreatic tail. Further evaluation of this patient is most likely to show which of the following findings?\"", "options": {"A": "Achlorhydria", "B": "Cholelithiasis", "C": "Deep vein thrombosis", "D": "Episodic hypertension"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'pancreatic tumor achlorhydria symptoms findings'", "log": "To solve this question, I need to analyze the clinical presentation and laboratory findings of the patient. The patient is experiencing fatigue, significant weight loss, and profuse diarrhea, along with electrolyte imbalances indicated by low potassium and elevated calcium levels. The CT scan shows a well-defined lesion in the pancreatic tail, which suggests a possible pancreatic tumor.\n\nNext, I will break down the options provided:\n- A: Achlorhydria - This could be associated with pancreatic insufficiency or certain types of pancreatic tumors.\n- B: Cholelithiasis - Gallstones may not be directly related to the symptoms presented.\n- C: Deep vein thrombosis - This is less likely to be a direct consequence of the symptoms described.\n- D: Episodic hypertension - This could be related to certain tumors, such as those that secrete catecholamines.\n\nGiven the context of a pancreatic tumor, achlorhydria is a common finding in patients with pancreatic exocrine insufficiency, especially if the tumor affects the gland's ability to produce digestive enzymes. \n\nNow, I will search for more information on the typical findings associated with pancreatic tumors, particularly in relation to achlorhydria.\n\nAction: search_docs\nAction Input: 'pancreatic tumor achlorhydria symptoms findings'", "type": "AgentAction"}}, "Endocrine Tumors of the Gastrointestinal Tract and Pancreas\n\nAbbreviations: ACTH, adrenocorticotropic hormone; GRFoma, growth hormone\u2013releasing factor secreting pancreatic endocrine tumor; IGF-II, insulin-like growth factor II; MEN, multiple endocrine neoplasia; pNET, pancreatic neuroendocrine tumor; PPoma, tumor secreting pancreatic polypeptide; PTHrP, parathyroid hormone\u2013related peptide; VIPoma, tumor secreting vasoactive intestinal peptide; WDHA, watery diarrhea, hypokalemia, and achlorhydria syndrome.\n\npylori can cause hypochlorhydria, it is not associated with achlorhydria or pernicious anemia, because the parietal and chief cell damage is not as severe as in autoimmune gastritis.\n\nas well as achlorhydria and hyponatremia. Some of these abnormalities are found in diabetic and amyloid polyneuropathy. They correspond to degeneration of small unmyelinated autonomic fibers in the peripheral nerves.\n\nThe parietal cell\u2013containing gastric gland is preferentially targeted in this form of gastritis, and achlorhydria results. Parietal cells are the source of IF, the lack of which will lead to vitamin B12 deficiency and its sequelae (megaloblastic anemia, neurologic dysfunction)."]]},"30": {"question": "A 74-year-old man presents to the emergency department with sudden-onset abdominal pain that is most painful around the umbilicus. The pain began 16 hours ago and has no association with meals. He has not been vomiting, but he has had several episodes of bloody loose bowel movements. He was hospitalized 1 week ago for an acute myocardial infarction. He has had diabetes mellitus for 35 years and hypertension for 20 years. He has smoked 15\u201320 cigarettes per day for the past 40 years. His temperature is 36.9\u00b0C (98.42\u00b0F), blood pressure is 95/65 mm Hg, and pulse is 95/min. On physical examination, the patient is in severe pain, there is mild periumbilical tenderness, and a bruit is heard over the epigastric area. Which of the following is the definitive test to assess the patient condition?", "options": {"A": "Mesenteric angiography", "B": "CT scanning", "C": "Plain abdominal X-rays", "D": "Colonoscopy"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'definitive test for mesenteric ischemia'", "log": "To determine the definitive test for this patient's condition, I need to analyze the symptoms and clinical history provided. The key points include:\n\n1. Sudden-onset abdominal pain, particularly around the umbilicus.\n2. Bloody loose bowel movements.\n3. Recent hospitalization for an acute myocardial infarction.\n4. Significant risk factors: diabetes, hypertension, and a long history of smoking.\n5. Physical examination shows severe pain, mild periumbilical tenderness, and a bruit over the epigastric area.\n\nGiven these details, the symptoms suggest a possible case of mesenteric ischemia, particularly because of the patient's cardiovascular history and the presence of a bruit, which may indicate vascular compromise. \n\nNow, I need to consider the options for definitive testing:\n- Mesenteric angiography is specifically used to assess blood flow in the mesenteric arteries.\n- CT scanning can provide detailed imaging and could identify ischemia or other abdominal pathologies.\n- Plain abdominal X-rays are less specific and not definitive for vascular issues.\n- Colonoscopy is more focused on the colon and would not assess vascular supply.\n\nSince mesenteric angiography is the gold standard for evaluating mesenteric ischemia, I will proceed with that as the most likely definitive test.\n\nAction: search_docs  \nAction Input: 'definitive test for mesenteric ischemia'  ", "type": "AgentAction"}}, "of the mesenteric vessels has gained in popularity. It is important to perform the test fasting because the presence of increased bowel gas prevents adequate visualization of flow disturbances within the vessels or the lack of a vasodilation response to feeding during the test. This tool is frequently used as a screening test for patients with symptoms suggestive of chronic mesenteric ischemia. The gold standard for confirmation of mesenteric arterial occlusion is mesenteric angiography. Evaluation with mesenteric angiography allows for identification and possible intervention for the\n\nduct stentFat plane between massin head of pancreasand portal veinFigure 33-68.\u2002Computed tomography scan demonstrating resectable pancreatic cancer. SMA = superior mesenteric artery.neoadjuvant clinical trial or before chemotherapy in advanced tumors. EUS is a sensitive test for portal/superior mesenteric vein invasion, although it is somewhat less effective at detect-ing superior mesenteric artery invasion. When all of the current staging modalities are used, their accuracy in predicting resect-ability has improved.As imaging continuously improves and high-quality imag-ing is always obtained\n\nFig. 4.127\u2002Superior mesenteric artery. A. Distribution of the superior mesenteric artery. B. Digital subtraction angiography of the superior mesenteric artery and its branches.\n\nFig. 4.128\u2002Inferior mesenteric artery. A. Distribution of the inferior mesenteric artery. B. Digital subtraction angiography of the inferior mesenteric artery and its branches.\n\nFig. 4.129\u2002Arterial supply to the abdominal parts of the gastrointestinal system and to the spleen.\n\nFig. 4.130\u2002Enlarged marginal artery connecting the superior and inferior mesenteric arteries. Digital subtraction angiogram.\n\nThe superior mesenteric artery (i.e., structures that are part of the abdominal midgut) drains to pre-aortic nodes near the origin of the superior mesenteric artery (Fig. 4.134)\u2014these superior mesenteric nodes also receive lymph from the inferior mesenteric groups of pre-aortic nodes, and lymph from the superior mesenteric nodes drains to the celiac nodes."]]},"31": {"question": "An investigator is studying the principles of cell-to-cell signaling of the autonomic nervous system. It is found that the adrenal medulla has receptors that, when activated, result in the immediate opening of Na+, Ca2+, and K+ channels, which subsequently leads to the secretion of epinephrine and norepinephrine. These receptors are structurally most similar to which of the following receptors?", "options": {"A": "H2 receptors of the stomach", "B": "M2 receptors of heart", "C": "D2 receptors of the basal ganglia", "D": "NM receptors of the quadriceps femoris muscle"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "adrenal medulla receptors similarity NM receptors", "log": "To answer the question, I need to identify the type of receptors in the adrenal medulla that are involved in the signaling process described. The receptors mentioned are responsible for the opening of ion channels and the secretion of epinephrine and norepinephrine. I will compare these characteristics with the options provided to determine which receptor type they are most similar to.\n\n1. **H2 receptors of the stomach**: These are histamine receptors that primarily stimulate gastric acid secretion.\n2. **M2 receptors of the heart**: These are muscarinic receptors that generally inhibit cardiac function.\n3. **D2 receptors of the basal ganglia**: These are dopamine receptors that play a role in neurotransmission.\n4. **NM receptors of the quadriceps femoris muscle**: These are nicotinic acetylcholine receptors that mediate muscle contraction and are known for their role in opening ion channels.\n\nGiven that the adrenal medulla receptors are involved in the secretion of catecholamines (epinephrine and norepinephrine) and are likely to have a similar mechanism of action to NM receptors (which also involve the opening of ion channels), I suspect that option D might be the correct answer. However, I will perform a search to confirm the structural similarities of these receptors.\n\nAction: search_docs  \nAction Input: \"adrenal medulla receptors similarity NM receptors\"  ", "type": "AgentAction"}}, "Many functions of the SNS are similar to those of the adrenal medulla, an endocrine gland. This functional similarity is partly explained by the developmental relationships between the cells of the adrenal medulla and postsynaptic sympathetic neurons. Both are derived from the neural crest, are innervated by presynaptic sympathetic neurons, and produce closely related physiologically active agents, EPI and NE. A major difference is that the sympathetic neurons deliver the agent directly to the effector, whereas the cells of the adrenal medulla deliver the agent indirectly through the\n\nDIRECT-ACTING MUSCARINIC ALKALOIDS OR SYNTHETICS \u2022PilocarpineLike bethanechol, partial agonist Like bethanechol Glaucoma; Sj\u00f6gren\u2019s syndrome Orallozengeandtopical\u2022Toxicity & interactions: Like bethanechol \u2022Cevimeline: Synthetic M3-selective; similar to pilocarpine DIRECT-ACTING NICOTINIC AGONISTS \u2022NicotineAgonist at both NN and NM receptors cessation \u2022 nonmedical Oral gum, patch for smoking cessation \u2022 Toxicity:\n\nrelated peptide hormones such as calcitonin gene\u2013related peptide (CGRP) or amylin. Both of these ligands have specific high-affinity receptors that share considerable structural similarity with the PTH1R and can also bind to and activate calcitonin receptors. The calcitonin receptor shares considerable structural similarity with the PTH1R.\n\nAnswer = A. NE released from the sympathetic nervous system functions as a neurotransmitter that acts on postsynaptic neurons and causes, for example, increased heart rate. It is also released from the adrenal medulla and, along with epinephrine, functions as a counterregulatory hormone that results in mobilization of stored fuels (for example, glucose and triacylglycerols). These actions are mediated by the binding of NE to adrenergic receptors, which are G protein\u2013coupled receptors of the plasma membrane, and not to nuclear receptors like those of steroid hormones or membrane tyrosine"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "structural similarity adrenal medulla receptors NM receptors H2 M2 D2", "log": "The search results indicate that the adrenal medulla shares functional similarities with sympathetic nervous system neurons, particularly in how they release catecholamines (epinephrine and norepinephrine). However, the results did not provide specific structural comparisons of the receptors. Given that the adrenal medulla's receptors are involved in the rapid opening of ion channels similar to NM receptors, I still suspect that option D is correct. \n\nHowever, to be thorough, I will search for more specific information about the structural similarities between adrenal medulla receptors and the options provided.\n\nAction: search_docs  \nAction Input: \"structural similarity adrenal medulla receptors NM receptors H2 M2 D2\"  ", "type": "AgentAction"}}, "related peptide hormones such as calcitonin gene\u2013related peptide (CGRP) or amylin. Both of these ligands have specific high-affinity receptors that share considerable structural similarity with the PTH1R and can also bind to and activate calcitonin receptors. The calcitonin receptor shares considerable structural similarity with the PTH1R.\n\nFIGURE 29\u20133 Correlations between the therapeutic potency of antipsychotic drugs and their affinity for binding to dopamine D1 (top) or D2 receptors (bottom). Potency is indicated on the horizontal axes; it decreases to the right. Binding affinity for D1 receptors was measured by displacing the selective D1 ligand SCH 23390; affinity for D2 receptors was similarly measured by displacing the selective D2 ligand haloperidol. Binding affinity decreases upward. (Reprinted, with permission, of Wiley-Liss, Inc., a subsidiary of John Wiley & Sons, Inc., from Seeman P: Dopamine receptors and the\n\n(COPD) is limited because block of autoinhibitory M2 receptors on postganglionic parasympathetic nerves can oppose the bronchodilation caused by block of M3 receptors on airway smooth muscle. Nevertheless, antimuscarinic agents selective for M3 receptors are valuable in some patients with asthma and in many with COPD.\n\nMetoclopramide and domperidone are dopamine D2-receptor antagonists. Within the gastrointestinal tract, activation of dopamine receptors inhibits cholinergic smooth muscle stimulation; blockade of this effect is believed to be the primary prokinetic mechanism of action of these agents. These agents increase esophageal peristaltic amplitude, increase lower esophageal sphincter pressure, and enhance gastric emptying but have no effect on small intestine or colonic motility. Metoclopramide and domperidone also block dopamine D2 receptors in the chemoreceptor trigger zone of the medulla (area"]]},"32": {"question": "A 27-year-old G1P0 presents to her obstetrician for her normal 30-week obstetric appointment. She reports that she feels well and has no complaints. Her past medical history is notable for intermittent asthma. Her only medications are prenatal vitamins. She has gained 10 pounds, more than expected given her current stage of pregnancy. Abdominal ultrasound reveals the presence of twins with separate amniotic sacs that share a common chorion and placenta. During which time interval following fertilization did the morula divide into two in this mother?", "options": {"A": "Days 4-8", "B": "Days 9-12", "C": "Days 13-15", "D": "Day 16+"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(query: 'morula division timing twins embryology')", "tool_input": "'morula division timing twins embryology'", "log": "To answer the question, I need to understand the stages of embryonic development, specifically when the morula divides into two separate entities. The morula stage occurs shortly after fertilization, and its division into two can lead to the formation of identical twins. \n\n1. The morula is typically formed around 3-4 days after fertilization.\n2. If the morula divides into two, this can happen before implantation, which usually occurs around days 5-6.\n3. The options provided suggest different time intervals post-fertilization for the morula division to occur. \n\nI need to determine which of the provided intervals corresponds to the division of the morula into two.\n\nAction: search_docs(query: 'morula division timing twins embryology')  \nAction Input: 'morula division timing twins embryology'  ", "type": "AgentAction"}}, "search_docs(query: 'morula division timing twins embryology') is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'morula division timing twins embryology'", "log": "To answer the question, I need to gather information on the timing of morula division in embryonic development, especially in the context of twin formation. Since my previous action was not executed properly, I will try again.\n\nAction: search_docs  \nAction Input: 'morula division timing twins embryology'  ", "type": "AgentAction"}}, "Twinning Dizygotic (\u201cfraternal\u201d) twins arise from 2 eggs that are separately fertilized by 2 different sperm (always 2 zygotes) and will have 2 separate amniotic sacs and 2 separate placentas (chorions).\n\nMonozygotic (\u201cidentical\u201d) twins arise from 1 fertilized egg (1 egg + 1 sperm) that splits in early pregnancy. The timing of cleavage determines chorionicity (number of chorions) and amnionicity (number of amnions) (SCAB):\n\nCleavage 0\u20134 days: Separate chorion and amnion\n\nCleavage 4\u20138 days: shared Chorion\n\nCleavage 8\u201312 days: shared Amnion\n\nTiming does not always depend on cell\u2013cell interactions; many developing animal cells have intrinsic developmental programs that play out even in isolated cells in culture. Neuroblasts in Drosophila embryos, for example, go through set programs of asymmetric divisions, generating different neural cell types at each division with a predictable sequence and timing, through a cascade of gene switching events. Studies in both vertebrates and invertebrates show that such programs are rarely governed by the timing of cell division and can unfold even when cell division is blocked. MicroRNAs\n\nSeveral factors afect this timing and include gestational age, fetal growth, lung maturity, and presence of maternal complications. As measured by determination of the lecithin-sphingomyelin ratio, pulmonary maturation is usually synchronous in twins (Leveno, 1984). Moreover, although this ratio usually does not exceed 2.0 until 36 weeks in singleton pregnancies, it oten exceeds this value by approximately 32 weeks in multifetal pregnancies. Similar increased values of surfactant have been noted in twins after 31 weeks' gestation (McElrath, 2000). In a comparison of respiratory morbidity in\n\ncan unfold even when cell division is blocked. MicroRNAs produced at critical moments sharpen developmental transitions by blocking the translation and promoting the degradation of specific sets of mRNAs. Global coordination of developmental timing is achieved by hormones: as a tadpole grows, for example, thyroid hormone levels surge and trigger its metamorphosis into a frog. Environmental control of developmental timing is especially striking in plants and reveals the presence of molecular timers that act over the long term. In vernalization, for example, prolonged cold induces changes in"]]},"33": {"question": "A 72-year-old man is brought to the emergency department with increasing fever and abdominal pain over the past week. The pain is constant and limited to the lower right part of his abdomen. He has nausea but no vomiting or diarrhea. His past medical history is unremarkable for any serious illnesses. He takes acetaminophen for knee arthritis. He is fully alert and oriented. His temperature is 39.5\u00b0C (103.1\u00b0F), pulse is 89/min, respirations are 15/min, and blood pressure is 135/70 mm Hg. Abdominal examination shows a tender mass in the right lower quadrant. CT shows obstruction of the appendiceal neck with a fecalith and the appendiceal tip leading to an irregular walled-off fluid collection. Stranding of the surrounding fat planes is also noted. Intravenous hydration is initiated. Which of the following is the most appropriate next step in management?", "options": {"A": "Antibiotics + CT-guided drainage", "B": "Antibiotics + interval appendectomy", "C": "Appendectomy within 12 hours", "D": "Early surgical drainage + interval appendectomy"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of appendiceal abscess in adults", "log": "To determine the most appropriate next step in management for this patient, I need to analyze the clinical scenario presented. The patient is showing signs of acute appendicitis complicated by an abscess formation due to obstruction of the appendiceal neck. The CT scan indicates there is a walled-off fluid collection, which suggests the need for intervention beyond just antibiotics.\n\nThe options available are:\n- A: Antibiotics + CT-guided drainage\n- B: Antibiotics + interval appendectomy\n- C: Appendectomy within 12 hours\n- D: Early surgical drainage + interval appendectomy\n\n1. **Antibiotics + CT-guided drainage (Option A)**: This is a common approach for treating appendiceal abscesses, especially in patients who are not stable enough for immediate surgery.\n2. **Antibiotics + interval appendectomy (Option B)**: This is usually considered after initial conservative management and is not the immediate next step.\n3. **Appendectomy within 12 hours (Option C)**: This is typically indicated for acute appendicitis without complications, but the presence of an abscess complicates the situation.\n4. **Early surgical drainage + interval appendectomy (Option D)**: This suggests a more aggressive approach, which may not be necessary given that CT-guided drainage is often sufficient.\n\nGiven that the patient has a tender mass and a confirmed abscess, it would be prudent to start with antibiotics and consider CT-guided drainage to manage the abscess effectively.\n\nAction: search_docs\nAction Input: \"management of appendiceal abscess in adults\" ", "type": "AgentAction"}}, "FIGURE 54-4 Anterior-posterior magnetic resonance image of a periappendiceal abscess in a midtrimester pregnancy. The abscess is approximately 5 x 6 cm, and the appendiceal lumen (arow) is visible within the right-lower quadrant mass. The gravid uterus is seen to the right of this mass.\n\nCHARACTERISTICS OF THE MOST COMMON GI-NETs (CARCINOIDS) Appendiceal NETs (Carcinoids) Appendiceal NETs (carcinoids) occur in 1 in every 200\u2013300 appendectomies, usually in the appendiceal tip, have an incidence of 0.15/100,000 per year, comprise 2\u20135% of all GI-NETs (carcinoids), and comprise 32\u201380% of all appendiceal tumors. Most (i.e., >90%) are <1 cm in diameter without metastases in older studies, but more recently, 2\u201335% have had metastases (Table 113-3). In the SEER data of 1570 appendiceal carcinoids, 62% were localized, 27% had regional metastases, and 8% had distant metastases. The\n\nas the first step. Bowel obstructions and infertility are infrequent but reported.Stump AppendicitisAn uncommon complication after surgery is the development of appendicitis in an incompletely excised appendiceal stump (greater than 0.5 cm stump length). Optimal management requires reexcision of the appendiceal base, but diagnosis can be difficult and requires careful assessment of the patient\u2019s history, physical exam, and imaging studies.92 Use of the \u201cappendiceal critical view\u201d (appendix placed at 10 o\u2019clock, taenia coli/libera at 3 o\u2019clock, and terminal ileum at 6 o\u2019clock) and\n\nSyndromePatients with appendiceal mucinous neoplasms develop perito-neal dissemination leading to pseudomyxoma peritonei (PMP) syndrome. This can occur in gastric, ovarian, pancreatic, and colorectal primary tumors as well.111 Patients with this syn-drome can have varied prognosis ranging from curative to pal-liative. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) are considered the standard of care for patients with PMP syndrome from appendiceal primaries.113-115Early detection and management of limited peritoneal dis-ease is favorable and preferred as opposed to"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "appendiceal abscess treatment guidelines", "log": "The search did not yield specific information regarding the management of appendiceal abscesses in adults, particularly in the context of the options provided. However, based on my initial analysis, the management of an appendiceal abscess typically involves the use of antibiotics and often requires some form of drainage. \n\nGiven the patient's condition, the presence of a walled-off abscess, and the options available, it would still seem that starting with antibiotics and considering CT-guided drainage (Option A) is appropriate. \n\nTo confirm this and ensure I have the most accurate information, I will search again with a more focused query. \n\nAction: search_docs\nAction Input: \"appendiceal abscess treatment guidelines\" ", "type": "AgentAction"}}, "FIGURE 54-4 Anterior-posterior magnetic resonance image of a periappendiceal abscess in a midtrimester pregnancy. The abscess is approximately 5 x 6 cm, and the appendiceal lumen (arow) is visible within the right-lower quadrant mass. The gravid uterus is seen to the right of this mass.\n\nand fast-track care in patients undergoing colonic surgery. Gastroenterology. 2011;141(3):872-880.e1-e4.\t18.\tMentula P, Sammalkorpi H, Lepp\u00e4niemi A. Laparo-scopic surgery or conservative treatment for appendiceal abscess in adults? A randomized controlled trial. Ann Surg. 2015;262(2):237-242.\t19.\tThe American Board of Surgery. American Board of Surgery CME requirements for recertification. Available at: http://www.absurgery.org/default.jsp? Accessed June 15, 2018.\t20.\tKohn LT, Corrigan J, Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press;\n\nDL, Stormont JM. The volcano sign of appendiceal mucocele. Gastrointest Endosc. 1989;35(5):453-456.\t109.\tStocchi L, Wolff BG, Larson DR, Harrington JR. Sur-gical treatment of appendiceal mucocele. Arch Surg. 2003;138(6):585-589; discussion 589-590.\t110.\tSmith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer. 1992;70(2):396-401.\t111.\tHinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg. 1998;85(10):1332-1339.\t112.\tCarr NJ, Cecil TD, Mohamed F, et al. A consensus for\n\nof Canada. he use of magnetic resonance imaging in the obstetric patient. J Obstet Gynaecol Can 36(4):349, 2014 Pearl JP, Price RR, Tonkin E, et al: SAGES guidelines for the use of laparoscopy during pregnancy. Surg Endosc 31t(10):3767,t20t1 Pedrosa I, Lafornara M, Pandharipande PV, et al: Pregnant patients suspected of having acute appendicitis: efect of MR imaging on negative laparotomy rate and appendiceal rate. Radiology 250(3):749, 2009"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "appendiceal abscess management recommendations", "log": "The search did not yield specific treatment guidelines for appendiceal abscesses in adults, but it reinforced the idea that the management typically involves antibiotics and drainage. Given the patient's condition, the presence of an abscess, and the options available, I still believe that starting with antibiotics and considering CT-guided drainage (Option A) is the most appropriate next step.\n\nI will perform one more focused search to see if there are any specific guidelines or recommendations regarding the management of appendiceal abscesses that could help confirm my choice.\n\nAction: search_docs\nAction Input: \"appendiceal abscess management recommendations\" ", "type": "AgentAction"}}, "FIGURE 54-4 Anterior-posterior magnetic resonance image of a periappendiceal abscess in a midtrimester pregnancy. The abscess is approximately 5 x 6 cm, and the appendiceal lumen (arow) is visible within the right-lower quadrant mass. The gravid uterus is seen to the right of this mass.\n\nSyndromePatients with appendiceal mucinous neoplasms develop perito-neal dissemination leading to pseudomyxoma peritonei (PMP) syndrome. This can occur in gastric, ovarian, pancreatic, and colorectal primary tumors as well.111 Patients with this syn-drome can have varied prognosis ranging from curative to pal-liative. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) are considered the standard of care for patients with PMP syndrome from appendiceal primaries.113-115Early detection and management of limited peritoneal dis-ease is favorable and preferred as opposed to\n\nas the first step. Bowel obstructions and infertility are infrequent but reported.Stump AppendicitisAn uncommon complication after surgery is the development of appendicitis in an incompletely excised appendiceal stump (greater than 0.5 cm stump length). Optimal management requires reexcision of the appendiceal base, but diagnosis can be difficult and requires careful assessment of the patient\u2019s history, physical exam, and imaging studies.92 Use of the \u201cappendiceal critical view\u201d (appendix placed at 10 o\u2019clock, taenia coli/libera at 3 o\u2019clock, and terminal ileum at 6 o\u2019clock) and\n\npmol/L). Evaluate the management of her past history of hyperthyroidism and assess her current thyroid status. Identify your treatment recommendations to maximize control of her current thyroid status."]]},"34": {"question": "A 29-year-old man comes to the physician because of a 3-month history of fatigue, weight loss, and multiple painless swellings on his neck and axilla. He reports that his swellings become painful after he drinks alcohol. Physical examination shows nontender cervical and axillary lymphadenopathy. A lymph node biopsy specimen shows giant binucleate cells. Which of the following is the most likely diagnosis?", "options": {"A": "Hodgkin lymphoma", "B": "Diffuse large B-cell lymphoma", "C": "Adult T-cell lymphoma", "D": "Acute lymphocytic leukemia"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Hodgkin lymphoma symptoms and diagnosis'", "log": "To solve this question, I need to analyze the symptoms and the findings from the lymph node biopsy. The patient is a 29-year-old man with symptoms of fatigue, weight loss, and painless swellings in the neck and axilla. The key detail here is that the swellings become painful after alcohol consumption, which is a classic symptom associated with Hodgkin lymphoma. Additionally, the presence of giant binucleate cells in the biopsy is characteristic of Reed-Sternberg cells, which are indicative of Hodgkin lymphoma.\n\nNow, I will confirm this information by searching for relevant medical literature or documents that discuss the characteristics of Hodgkin lymphoma and its differentiation from other lymphomas mentioned in the options.\n\nAction: search_docs\nAction Input: 'Hodgkin lymphoma symptoms and diagnosis'", "type": "AgentAction"}}, "With all of these regimens, over 80% of previously untreated patients with advanced Hodgkin\u2019s lymphoma (stages III and IV) are expected to go into complete remission, with disappearance of all disease-related symptoms and objective evidence of disease. In general, approximately 50\u201360% of all patients with Hodgkin\u2019s lymphoma are cured of their disease.\n\nEnteropathy-type intestinal T-cell lymphoma is a rare disorder that occurs in patients with untreated gluten-sensitive enteropathy. Patients are frequently wasted and sometimes present with intestinal perforation. The prognosis is poor. Hepatosplenic \u03b3\u03b4 T-cell lymphoma is a systemic illness that presents with sinusoidal infiltration of the liver, spleen, and bone marrow by malignant T cells. Tumor masses generally do not occur. The disease is associated with systemic symptoms and is often difficult to diagnose. Treatment outcome is poor. Subcutaneous panniculitis-like T-cell lymphoma is a\n\nPrimary diffuse large B-cell lymphoma of the brain is being diagnosed with increasing frequency. Other unusual subtypes of diffuse large B-cell lymphoma such as pleural effusion lymphoma and intravascular lymphoma have been difficult to diagnose and associated with a very poor prognosis.\n\nLymphoplasmacytic lymphoma is an incurable progressive disease. Because most IgM is intravascular, symptoms caused by the high IgM levels (e.g., hyperviscosity and hemolysis) can be alleviated temporarily by plasmapheresis. Tumor growth can be controlled with low doses of chemotherapeutic drugs and immunotherapy with anti-CD20 antibody, and recent work has shown that BTK inhibitors are also effective. Transformation to large-cell lymphoma occurs but is uncommon. Median survival is about 4 years."]]},"35": {"question": "A 33-year-old primigravid visits the clinic at the 22 weeks\u2019 gestation with concerns about several episodes of loose watery stool over the past 4 months, which are sometimes mixed with blood. Use of over-the-counter antidiarrheal medications has not been helpful. She also reports having painful ulcers in her mouth for the last 2 months. Pregnancy has been otherwise uncomplicated so far. On physical examination, the blood pressure is 110/60 mm Hg, the pulse rate is 90/min, the respiratory rate is 19/min, and the temperature is 36.6\u00b0C (97.8\u00b0F). There is bilateral conjunctival redness. Abdominal examination shows minimal tenderness but no guarding or rebound tenderness. Fundal height is proportionate to 22 weeks of gestation, and fetal heart sounds are audible. Colonoscopy shows focal areas of inflammation in the ileum, separated by normal mucosa, with rectal sparing. Based on the colonoscopy results, which of the following complications is the patient at risk for?", "options": {"A": "Metastasis to the liver", "B": "Carcinoid syndrome", "C": "Intestinal obstruction", "D": "Paralytic ileus"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "complications of Crohn's disease", "log": "To answer the question, I need to analyze the clinical presentation and colonoscopy findings of the patient. The key details include the patient's age, pregnancy status, gastrointestinal symptoms (loose watery stool with blood, painful mouth ulcers), and colonoscopy results indicating focal inflammation in the ileum with rectal sparing. \n\n1. **Identify the condition**: The description suggests a possible inflammatory bowel disease, such as Crohn's disease, particularly due to the inflammation in the ileum and rectal sparing.\n  \n2. **Consider complications**: Common complications of Crohn's disease include intestinal obstruction due to strictures, abscess formation, and fistulas. Other options like metastasis to the liver and carcinoid syndrome are less likely based on the information provided.\n\n3. **Evaluate the options**: \n   - **A: Metastasis to the liver** - more relevant to malignancies, not typical for Crohn's.\n   - **B: Carcinoid syndrome** - associated with neuroendocrine tumors, unlikely here.\n   - **C: Intestinal obstruction** - a known complication of Crohn's disease due to strictures.\n   - **D: Paralytic ileus** - a condition where the intestine doesn't work properly, but not directly a complication of Crohn's.\n\nGiven the colonoscopy findings of inflammation in the ileum, the most relevant complication the patient is at risk for is intestinal obstruction. \n\nNow, I will proceed to confirm this by searching for more information on complications related to Crohn's disease.\n\nAction: search_docs  \nAction Input: \"complications of Crohn's disease\"  ", "type": "AgentAction"}}, "Lichtenstein Gc, Hanauer SB, Sandborn W], et al: Management of Crohn's disease in adults. Am] Gastroenterol 104(2):465,2009\n\nLudvigsson ]F, Lebwohl B, Ekbom A, et al: Outcomes of pregnancies for women undergoing endoscopy while they were pregnant: a nationwide cohort study. Gastroenterology 152:554, 2017\n\nLyell D]: Adhesions and peri operative complications of repeat cesarean delivery. Am] Obstet Gynecols205(6 Suppi):Sll, 2011\n\nMahadevan U: Fertiliry and pregnancy in the patient with inflammatory bowel disease. Gut 55:1198, 2006a\n\nWilasrusmee CSukrat B, McEvoy M, et al: Systematic review and meta-analysis of safety laparoscopic versus open appendectomy for suspected appendicitis in pregnancy. Br J Surg 99(11):1470,s2012\n\nWoolfson K, Cohen Z, McLeod RS: Crohn's disease and pregnancy. Dis Colon Rectum 33:869, 1990\n\nYost NP, McIntire DD, Wians FH Jr, et al: A randomized, placebo-controlled trial of corticosteroids for hyperemesis due to pregnancy. Obstet Gynecol 102: 1250, 2003\n\nZara G, Codemo V, Palmieri A, et al: Neurological complications in hyperemesis gravidarum. Neurol Sci 33(1):133, 2012\n\nTakahashi K, Funayama Y, Fukushima K, et al: Pregnancy and delivery in patients with enterostomy due to anorectal complications from Crohn's disease. Int] Colorectal Dis 22:313, 200\n\nTan PC, Jacob R, Quek KF, et al: he fetal sex ratio and metabolic, biochemical, haematological and clinical indicators of severiry of hyperemesis gravidarum. B]OG 113:733,2006\n\nTan PC, Norazilah MJ, Omar SZ: Dextrose saline compared with normal saline rehydration of hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecols121(2 Ptl):291, 2013\n\ninflammatory mediators Chemicals such as cytokines produced by immune cells that act on target cells to promote defense against microbes.\n\ninflammatory monocytes An activated form of monocyte producing a variety of pro-in\ufb02ammatory cytokines.\n\ninflammatory response See inflammation.\n\ninfliximab   Chimeric antibody to TNF-\u03b1 used in the treatment of in\ufb02ammatory diseases, such as Crohn's disease and rheumatoid arthritis.\n\ninherited immunodeficiency diseases See primary immunodeficiencies."]]},"36": {"question": "A 25-year-old woman has dysuria, pyuria, increased frequency of urination, and fever of 1-day duration. She is sexually active. Urine cultures show gram-positive bacteria in clusters that are catalase-positive and coagulase-negative. The patient is started on trimethoprim-sulfamethoxazole. Which of the following characteristics is used to identify the offending organism?", "options": {"A": "Beta hemolysis", "B": "Sensitivity to novobiocin", "C": "Sensitivity to bacitracin", "D": "Resistance to novobiocin"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Staphylococcus saprophyticus identification characteristics novobiocin sensitivity resistance'", "log": "To solve this question, I need to analyze the clinical scenario presented, which involves a 25-year-old woman with urinary symptoms and a urine culture showing gram-positive cocci in clusters that are catalase-positive and coagulase-negative. The treatment initiated is trimethoprim-sulfamethoxazole. \n\nThe organism described is likely a type of Staphylococcus, specifically Staphylococcus saprophyticus, which is known to cause urinary tract infections, especially in young sexually active women. \n\nNow, I need to determine which characteristic is used to identify this organism among the provided options. The key characteristics for differentiating Staphylococcus saprophyticus from other coagulase-negative staphylococci (like Staphylococcus epidermidis) include sensitivity to novobiocin.\n\nThe options are:\n- A: Beta hemolysis (not applicable, as this is not a characteristic for staphylococci)\n- B: Sensitivity to novobiocin (this is a characteristic used to differentiate Staphylococcus saprophyticus, which is resistant)\n- C: Sensitivity to bacitracin (this is more relevant for streptococci)\n- D: Resistance to novobiocin (this is indeed the characteristic of Staphylococcus saprophyticus)\n\nThus, the correct answer pertains to the resistance to novobiocin.\n\nAction: search_docs\nAction Input: 'Staphylococcus saprophyticus identification characteristics novobiocin sensitivity resistance' ", "type": "AgentAction"}}, "presented as sensitivity and specificity. The sensitivity and specificity represent the characteristics of a given diagnostic test and do not vary by population characteristics. In contrast the negative and positive predictive values of a test do vary with the baseline characteristics of a population such as prevalence of a disease (Fig. 4.4).\n\nDescriptive studies, case reports and case series, do not include comparison groups.\n\nCalculating sensitivity and specificity requires selection of a threshold value or cut point above which the test is considered \u201cpositive.\u201d Making the cut point \u201cstricter\u201d (e.g., raising it) lowers sensitivity but improves specificity, whereas making it \u201claxer\u201d (e.g., lowering it) raises sensitivity but lowers specificity. This dynamic trade-off between more accurate identification of subjects with disease versus those without disease is often displayed graphically as a receiver operating characteristic (ROC) curve (Fig. 3-1) by plotting sensitivity (y axis) versus 1 \u2013 specificity (x axis).\n\nAnalyze fluid for \u2022 Appearance, viscosity\u2022 WBC count, differential\u2022 Gram stain, culture, and sensitivity (if indicated)\u2022 Crystal identification by polarized microscopyInflammatory ornoninflammatoryarticular condition Consider\u2022 Trauma or mechanical derangement\u2022 Coagulopathy\u2022 Neuropathic arthropathy\u2022 OtherIs the WBC > 2000/\u02dcL? Consider otherinflammatoryor septic arthritides \u2022 Gram stain, culture mandatoryIs the % PMNs > 75%? Are crystals present? Considernoninflammatoryarticular conditions \u2022 Osteoarthritis\u2022 Trauma\u2022 OtherIs the WBC > 50,000/\u02dcL? Crystal identification for specific diagnosis \u2022\n\nFecal immunochemical tests appear to have higher sensitivity for colorectal cancer than nonrehydrated FOBT tests. Fecal DNA testing is an emerging testing modality; it may have increased sensitivity and comparable specificity to FOBT and could potentially reduce harms associated with follow-up of false-positive tests. The body of evidence on the operating characteristics and effectiveness of fecal DNA tests in reducing colorectal cancer mortality is limited."]]},"37": {"question": "A 9-year-old boy, otherwise healthy, presents with persistent bleeding following tooth extraction. The patient\u2019s mother states that yesterday, the patient had a tooth extracted that was complicated intraoperatively by persistent bleeding that continued postoperatively. She also says he has had no bleeding issues in the past. The past medical history is unremarkable. The patient is fully immunized and has been meeting all developmental milestones. The vital signs include: temperature 37.0\u00b0C (98.6\u00b0F), blood pressure 101/65 mm Hg, pulse 101/min, respirations 22/min, and oxygen saturation 98% on room air. The physical examination is significant for a wound consistent with the extraction of the second upper right molar, which is slowly oozing blood with no sign of a stable clot. There are no signs of infection. The laboratory findings are significant for the following:\nSodium 141 mEq/L\nPotassium 4.1 mEq/L\nChloride   101 mEq/L\nBicarbonate 25 mEq/L\nBUN 12 mg/dL\nCreatinine 1.0 mg/dL\nGlucose (fasting) 80 mg/dL\n   Bilirubin, conjugated 0.2 mg/dL\nBilirubin, total 1.0 mg/dL\nAST (SGOT) 11 U/L\nALT (SGPT) 12 U/L\nAlkaline Phosphatase 45 U/L\n   Prothrombin Time (PT) 14 s\nPartial Thromboplastin Time (PTT) 35 s\n  WBC 8,500/mm3\nRBC 4.00 x 106/mm3\nHematocrit 37.5%\nHemoglobin 13.1 g/dL\nPlatelet Count 225,000/mm3\nThis patient\u2019s condition would most likely also present with which of the following symptoms?", "options": {"A": "Epistaxis", "B": "Hemarthrosis", "C": "Purpura fulminans", "D": "Intracranial hemorrhage"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'persistent bleeding after tooth extraction in children'", "log": "To solve this question, I need to analyze the case of the 9-year-old boy who is experiencing persistent bleeding after a tooth extraction. The key details to consider include the lack of previous bleeding issues, the normal laboratory findings, and the specific symptoms of bleeding. \n\nI should determine which of the listed options (A, B, C, D) is most likely associated with the condition that would cause prolonged bleeding in this scenario. \n\n1. **Epistaxis (A)**: This refers to nosebleeds, which can occur in various bleeding disorders but may not be directly linked to the context of dental extraction.\n2. **Hemarthrosis (B)**: This is bleeding into joints, commonly associated with hemophilia or other bleeding disorders, which could be relevant given the bleeding history.\n3. **Purpura fulminans (C)**: This is a severe condition characterized by rapid onset of purpura and is often associated with infections or severe coagulopathies, which do not seem to fit this case.\n4. **Intracranial hemorrhage (D)**: This is a serious condition but is less likely to be a direct symptom of the bleeding that occurs in a dental procedure.\n\nGiven the context of the patient's bleeding following dental surgery and the normal lab results, hemarthrosis (B) seems the most relevant as it indicates a bleeding disorder that could lead to prolonged bleeding in various areas, including post-operative sites.\n\nAction: search_docs  \nAction Input: 'persistent bleeding after tooth extraction in children'  ", "type": "AgentAction"}}, "Hematologic and Nutritional Disease Internists are more likely to encounter patients with acquired, rather than congenital, bleeding disorders. Bleeding should stop 15 min after minor trauma and within an hour after tooth extraction if local pressure is applied. More prolonged bleeding, if not due to continued injury or rupture of a large vessel, should lead to investigation for a clotting abnormality. In addition to bleeding, petechiae and ecchymoses are prone to occur at the vibrating line between the soft and hard palates in patients with platelet dysfunction or thrombocytopenia.\n\ntrauma or sur-gery. Since platelet function is normal in hemophiliacs, patients may not bleed immediately after an injury or minor surgery as they have a normal response with platelet activation and forma-tion of a platelet plug. At times, the diagnosis of hemophilia is not made in these patients until after their first minor procedure (e.g., tooth extraction or tonsillectomy).Patients with hemophilia A or B are treated with factor VIII or factor IX concentrate, respectively. Recombinant factor VIII is strongly recommended for patients not treated previously and is generally recommended for\n\nPatients undergoing tooth extraction or alveolar and gingival surgery rarely experience uncontrolled bleeding when warfarin anticoagulation is maintained within the therapeutic range currently recommended for prevention of venous thrombosis, atrial fibrillation, or mechanical heart valve. Embolic complications and death, however, have been reported during subtherapeutic anticoagulation. Therapeutic anticoagulation should be confirmed before and continued through the procedure. Likewise, low-dose aspirin (e.g., 81\u2013325 mg) can safely be continued. For patients taking aspirin and another\n\n(RR 1.4; 95% CI 1.2\u20131.6) and the restoration of bony continuity with osteoradionecrosis (ORN) (RR 1.4; 95% CI 1.1\u20131.8); HBO2T prevents the development of ORN following tooth extraction from a radiation field (RR 1.4; 95% CI 1.08\u20131.7) and reduces the risk of wound dehiscence following grafts and flaps in the head and neck (RR 4.2; 95% CI 1.1\u201316.8). Conversely, there was no evidence of benefit in established radiation brachial plexus lesions or brain injury."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'hemophilia symptoms in children'", "log": "The information retrieved highlights the importance of understanding bleeding disorders in the context of dental procedures, particularly tooth extractions. It indicates that prolonged bleeding can be a sign of a clotting abnormality, and in children, conditions like hemophilia may not be diagnosed until after minor surgical procedures. The mention of bleeding disorders and the association with symptoms such as petechiae and ecchymoses is particularly relevant.\n\nNext, I need to analyze the options again in light of this new information:\n\n1. **Epistaxis (A)**: While it can occur in various bleeding disorders, it is not directly related to tooth extraction.\n2. **Hemarthrosis (B)**: This is indeed associated with bleeding disorders like hemophilia, which aligns with the case of the boy experiencing prolonged bleeding after extraction.\n3. **Purpura fulminans (C)**: This severe condition does not fit the scenario presented.\n4. **Intracranial hemorrhage (D)**: This is a serious condition but unlikely to be a direct symptom of the bleeding that occurs from a dental procedure.\n\nGiven the new insights about bleeding disorders potentially leading to symptoms like hemarthrosis, I will proceed to confirm this understanding.\n\nAction: search_docs  \nAction Input: 'hemophilia symptoms in children'  ", "type": "AgentAction"}}, "Specify current severity:\n\nMild: Few, it any, symptoms in excess of those required to make the diagnosis are present, and symptoms result in no more than minor impairments in social or occupa- tional functioning.\n\nModerate: Symptoms or functional impairment between \u201cmild\" and \u201csevere\" are present.\n\nSevere: Many symptoms in excess of those required to make the diagnosis, or several symptoms that are particularly severe, are present, or the symptoms result in marked impairment ih social or occupational functioning.\n\nSpecify current severity:\n\nMild: Evidence of mild distress over the symptoms in Criterion A.\n\nModerate: Evidence of moderate distress over the symptoms in Criterion A.\n\nSevere: Evidence of severe or extreme distress over the symptoms in Criterion A.\n\nBeyond these common symptoms of IC/BPS, additional urinary and other symptoms may be present. Among the urinary symptoms are difficulty in starting urine flow, perceptions of difficulty in emptying the bladder, and bladder spasms. Other symptoms include the manifestations of comorbid FSSs as well as symptoms that do not constitute recognized syndromes, such as numbness, muscle spasms, dizziness, ringing in the ears, and blurred vision.\n\nModerate: Evidence of moderate distress over the symptoms in Criterion A.\n\nSevere: Evidence of severe or extreme distress over the symptoms in Criterion A."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "Final answer", "tool_input": "None", "log": "The retrieved information does not seem to directly address the symptoms associated with hemophilia in children. However, I need to focus on the symptoms that are typically seen in children with bleeding disorders, particularly hemophilia, which is relevant to the case of the boy experiencing prolonged bleeding after a tooth extraction.\n\nGiven that hemophilia can lead to various bleeding manifestations, including hemarthrosis (bleeding into joints), this aligns with the scenario presented. The other options do not fit well with the context of the case.\n\nNow, I will consolidate my findings to finalize my answer.\n\nAction: Final answer  \nAction Input: None  ", "type": "AgentAction"}}, "Final answer is not a valid tool, try one of [search_docs]."]]},"38": {"question": "A 74-year-old man presents to the emergency department with shortness of breath that started about 30 mins ago. He is also experiencing chest pain on deep inspiration. He has several significant medical conditions including obstructive pulmonary disease, hypertension, and dyslipidemia. He used to smoke about 3 packs of cigarettes every day until last year when he quit. He was in the emergency room 2 weeks ago for a hemorrhagic stroke which was promptly treated. He currently weighs 97.5 kg (215 lb). His respirations are 20/min, the blood pressure is 110/ 80 mm Hg, and the pulse is 105/min. On physical examination, Homan\u2019s sign is positive. An ECG and chest X-ray are performed. His current oxygen saturation is at 87% and D-dimer results are positive. He is wheeled in for a CT scan. Which of the following treatments would this patient be an ideal candidate for?", "options": {"A": "Greenfield filter", "B": "Unfractionated heparin", "C": "Subcutaneous fondaparinux", "D": "Warfarin"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "ideal treatment for suspected pulmonary embolism in patient with recent hemorrhagic stroke", "log": "To determine the ideal treatment for this patient, I need to analyze his symptoms and medical history. The patient has shortness of breath, chest pain, a history of smoking, and positive Homan\u2019s sign, which suggests the possibility of a deep vein thrombosis (DVT) or pulmonary embolism (PE). The positive D-dimer also supports this suspicion.\n\nNext, I will consider the treatment options:\n- **Greenfield filter**: This is used for patients with DVT or PE who cannot be anticoagulated.\n- **Unfractionated heparin**: This is a standard treatment for acute DVT and PE.\n- **Subcutaneous fondaparinux**: This is also an anticoagulant used for DVT and PE.\n- **Warfarin**: This is typically used for long-term anticoagulation but is not ideal for acute treatment.\n\nGiven that the patient is likely experiencing an acute event related to DVT or PE, I will focus on the anticoagulants. The patient\u2019s recent hemorrhagic stroke raises concerns about using anticoagulants, especially unfractionated heparin or fondaparinux, but these may still be considered depending on the severity of the condition.\n\nNow, I will search for more information regarding the best treatment options for a patient with suspected PE or DVT, particularly in the context of recent hemorrhagic stroke.\n\nAction: search_docs  \nAction Input: \"ideal treatment for suspected pulmonary embolism in patient with recent hemorrhagic stroke\"  ", "type": "AgentAction"}}, "and sensitive in diagnosing pulmonary embolism or obscure fractures, often in the setting of initially equivocalfindings. High-resolutionCTcan beadvocated in the evaluation of suspected or established infiltrative lung disease (e.g., scleroderma or rheumatoid lung). The recent use of hybrid (positron emission tomography [PET] or single-photon emission CT [SPECT]) CT scans in metastatic evaluations has incorporated CT to provide better anatomic localization of scintigraphic abnormalities.\n\nFIGURE 52-5 The American Thoracic Society and Society of Thoracic Radiology diagnostic algorithm for suspected pulmonary embolism during pregnancy. CTPA = computed tomographic pulmonary angiography; CUS = compression ultrasonography; CXR = chest x-ray; PE = pulmonary embolism; V/O = ventilation/perfusion scintigraphy. (Modified with permission from Leung AN, Bull TM, jaeschke R, et al: An oficial American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline: Evaluation of suspected pulmonary embolism in pregnancy, Am j Respir Crit Care Med. 2011 Nov\n\nAbsolute contraindications include prior history of ischemic or hemorrhagic stroke within 3 months, head trauma within 3 months, neurologic surgery within 6 months, known intra-cranial neoplasm, internal bleeding within 6 weeks, active or known bleeding disorder, traumatic cardiopulmonary resuscita-tion within 3 weeks or suspected aortic dissection. Fortunately, serious remote bleeding is uncommon, and intracranial hem-orrhage rarely occurs. The majority of bleeding complications are limited to the venous access site. Symptomatic pulmonary embolism occurs uncommonly and is very rarely\n\nWhen there is a compelling reason after an embolic stroke in a non-fibrillator to anticoagulate a patient for secondary stroke prevention (e.g., mechanical heart valve, known left ventricular thrombus, hypercoagulable state, and perhaps patent foramen ovale with deep venous thrombosis), opinions vary about the use and precise timing of instituting an anticoagulant. In a patient with atrial fibrillation who has had a recent embolic stroke, the concern for risk of hemorrhagic transformation of the ischemic area has led to the practice of a delay of up to several weeks in starting treatment."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Greenfield filter use in patients with recent hemorrhagic stroke", "log": "The information retrieved did not provide a clear answer regarding the treatment options for a patient with suspected pulmonary embolism (PE) who has a recent history of hemorrhagic stroke. However, it does mention that there are absolute contraindications for anticoagulation in patients with a history of hemorrhagic stroke within the past three months. This suggests that the use of anticoagulants like unfractionated heparin and fondaparinux might not be appropriate in this case.\n\nSince the Greenfield filter is used for patients who cannot be anticoagulated, it may be a viable option for this patient given his recent hemorrhagic stroke. Warfarin is typically used for long-term management rather than acute treatment, and given the acute nature of the patient\u2019s symptoms, it may not be the best immediate choice.\n\nNow, I will search for more information specifically regarding the use of the Greenfield filter in patients with recent hemorrhagic stroke and its appropriateness in treating suspected PE.\n\nAction: search_docs  \nAction Input: \"Greenfield filter use in patients with recent hemorrhagic stroke\"  ", "type": "AgentAction"}}, "Several trials have confirmed that statin drugs reduce the risk of 2569 stroke even in patients without elevated LDL or low HDL. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial showed benefit in secondary stroke reduction for patients with recent stroke or TIA who were prescribed atorvastatin, 80 mg/d. The primary prevention trial, Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER), found that patients with low LDL (<130 mg/dL) caused by elevated C-reactive protein benefitted by daily use of this\n\nWhen there is a compelling reason after an embolic stroke in a non-fibrillator to anticoagulate a patient for secondary stroke prevention (e.g., mechanical heart valve, known left ventricular thrombus, hypercoagulable state, and perhaps patent foramen ovale with deep venous thrombosis), opinions vary about the use and precise timing of instituting an anticoagulant. In a patient with atrial fibrillation who has had a recent embolic stroke, the concern for risk of hemorrhagic transformation of the ischemic area has led to the practice of a delay of up to several weeks in starting treatment.\n\nischemic stroke or events, or hemorrhagic stroke were observed.\n\nThe only Food and Drug Administration\u2013approved indication for PE fibrinolysis is massive PE. For patients with submassive PE, who have preserved systolic blood pressure but moderate or severe RV dysfunction, use of fibrinolysis remains controversial. Results of a 1006-patient European multicentered randomized trial of submassive PE, using the thrombolytic agent tenecteplase, were published in 2014. Death or hemodynamic collapse within 7 days of randomization was reduced by 56% in the tenecteplase group. However, hemorrhagic stroke occurred in 2% of tenecteplase patients versus 0.2% in"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Greenfield filter contraindications recent hemorrhagic stroke", "log": "The information retrieved still does not provide a direct answer to the use of the Greenfield filter in patients with recent hemorrhagic stroke, nor does it clarify the best treatment approach for suspected pulmonary embolism (PE) in such patients. However, it reiterates the concerns regarding anticoagulation in those with a history of hemorrhagic stroke.\n\nThe Greenfield filter is designed for patients who cannot be anticoagulated, which aligns with the patient's condition. Given the patient's recent hemorrhagic stroke, anticoagulants like unfractionated heparin and fondaparinux would likely be contraindicated. Warfarin, while it is an anticoagulant, is not appropriate for acute treatment.\n\nAs such, the Greenfield filter seems to be the most suitable option for this patient, considering the circumstances. However, to ensure a comprehensive understanding, I will conduct one more search to confirm the appropriateness of the Greenfield filter in this specific clinical scenario.\n\nAction: search_docs  \nAction Input: \"Greenfield filter contraindications recent hemorrhagic stroke\"  ", "type": "AgentAction"}}, "If the patient presents within three hours, PCI cannot be performed within 90 minutes, and there are no contraindications to thrombolysis (e.g., a history of hemorrhagic stroke or recent ischemic stroke, severe heart failure, or cardiogenic shock), thrombolysis with tPA, reteplase, or streptokinase should be performed instead of PCI.\n\nischemic stroke or events, or hemorrhagic stroke were observed.\n\nRelative contraindications to fibrinolytic therapy, which require assessment of the risk-to-benefit ratio, include current use of anticoagulants (international normalized ratio \u22652), a recent (<2 weeks) invasive or surgical procedure or prolonged (>10 min) cardiopulmonary resuscitation, known bleeding diathesis, pregnancy, a hemorrhagic ophthalmic condition (e.g., hemorrhagic diabetic retinopathy), active peptic ulcer disease, and a history of severe hypertension that is currently adequately controlled. Because of the risk of an allergic reaction, patients should not receive streptokinase if\n\nvena cava filters are reserved for patients with absolute contraindications to anticoagulation such as recent craniotomy."]]},"39": {"question": "An investigator performs a twin study to evaluate the effects of a novel drug that decreases serum glucose by inhibiting a transporter on the basolateral membrane of proximal convoluted tubule cells. The results of the study are shown.\nTest Control\nSerum glucose (mg/dL) 82.4 99\nDipstick urine glucose negative negative\nUrine anion gap positive negative\nThe drug most likely inhibits transport of which of the following substrates?\"", "options": {"A": "Glutamine", "B": "Sodium", "C": "Alanine", "D": "Leucine"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "effects of drug inhibiting transporter on basolateral membrane of proximal convoluted tubule cells", "log": "To solve this question, I need to analyze the effects of the novel drug mentioned in the twin study. The drug decreases serum glucose levels and has specific effects on urine glucose and the urine anion gap. The question is asking which substrate the drug inhibits transport for, among the given options. \n\nFirst, I will consider the physiological roles of the substrates listed in the options:\n- Glutamine: Involved in various metabolic processes, including gluconeogenesis.\n- Sodium: Plays a crucial role in renal function and glucose reabsorption.\n- Alanine: Also involved in gluconeogenesis and amino acid metabolism.\n- Leucine: An essential amino acid that does not have a direct role in glucose transport.\n\nGiven that the drug is decreasing serum glucose levels, it is likely that it inhibits a transporter that is involved in glucose reabsorption. Sodium-glucose transporters (SGLTs) are primarily responsible for glucose reabsorption in the proximal tubule, which relies on sodium transport.\n\nNext, I will search for more information on how the drug works and its effects on the substrates listed, particularly focusing on sodium and glucose transport mechanisms in the kidneys.\n\nAction: search_docs\nAction Input: \"effects of drug inhibiting transporter on basolateral membrane of proximal convoluted tubule cells\"", "type": "AgentAction"}}, "In well-fixed histologic preparations, the basal striations and the apical brush border help to distinguish the cells of the proximal convoluted tubule from those of the other tubules.\n\nAt the very base of the proximal convoluted tubule cell, in the interdigitating processes, bundles of 6-nm microfilaments\n\nFIGURE 20.17 \u2022 Drawing of proximal convoluted tubule cells.\n\nIn the normal individual, the proximal convoluted tubule reabsorbs almost all of the glucose filtered by the glomeruli. Ninety percent of the glucose reabsorption occurs through SGLT2 (Figure 15\u20132), but inhibiting this transporter using the currently available drugs will result in glucose excretion of only 30\u201350% of the amount filtered. Although we have known about the proximal tubule sodium/glucose cotransporter for many years, the inhibitors of this transport channel were developed only recently. Four SGLT2 inhibitors (dapagliflozin, canagliflozin, empagliflozin, and ipragliflozin\n\nOnly about 10% of the filtered NaCl is reabsorbed in the distal convoluted tubule (DCT). Like the TAL of Henle\u2019s loop, this segment is relatively impermeable to water, and NaCl reabsorption further dilutes the tubular fluid. The mechanism of NaCl\n\nFIGURE 15\u20134 Ion transport pathways across the luminal and basolateral membranes of the distal convoluted tubule cell. As in all tubular cells, Na+/K+-ATPase is present in the basolateral membrane. NCC is the primary sodium and chloride transporter in the luminal membrane. R, parathyroid hormone (PTH) receptor.\n\nfacilitated by intracellular carbonic anhydrase. After dissociation of H2CO3, the H+ is available for transport by the Na+/H+ exchanger, and the HCO3\u2212 is transported out of the cell by a basolateral membrane transporter (Figure 15\u20132). Bicarbonate reabsorption by the proximal tubule is thus dependent on carbonic anhydrase activity. This enzyme"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "sodium-glucose cotransporter SGLT2 mechanism", "log": "The information I retrieved discusses the role of sodium-glucose transporters (SGLTs) in glucose reabsorption in the proximal convoluted tubule. It specifically mentions that SGLT2 is responsible for the majority of glucose reabsorption and that inhibiting this transporter leads to increased glucose excretion. Since the drug in question decreases serum glucose levels, it is likely inhibiting the SGLT2 transporter, which relies on sodium for glucose reabsorption.\n\nNow, I need to confirm the relationship between sodium transport and glucose reabsorption, as the inhibition of a sodium-dependent transporter would directly affect glucose levels in serum and urine.\n\nAction: search_docs\nAction Input: \"sodium-glucose cotransporter SGLT2 mechanism\"", "type": "AgentAction"}}, "Glucose is freely filtered by the renal glomeruli and is reabsorbed in the proximal tubules by the action of sodium-glucose transporters (SGLTs). Sodium-glucose transporter 2 (SGLT2) accounts for 90% of glucose reabsorption, and its inhibition causes glycosuria and lowers glucose levels in patients with type 2 diabetes. SGLT2 inhibitors lower glucose levels by changing the renal threshold and not by insulin action. The SGLT2 inhibitors canagliflozin, dapagliflozin, and empagliflozin, all oral medications, are approved for clinical use.\n\ncan be inhibited by acetazolamide and other carbonic anhydrase inhibitors.\n\nMore recently, inhibitors of the sodium-glucose cotransporter, isoform 2 (SGLT2; Figure 15\u20132) have been approved to treat diabetes mellitus. The sodium-glucose cotransporter is responsible for reabsorbing much of the glucose that is filtered by the glomeruli. Although not indicated as diuretic agents, these drugs have diuretic properties accompanied by increased sodium and glucose excretion (see below). The diuretic properties are thought to result from mainly osmotic diuresis.\n\nIn the normal individual, the proximal convoluted tubule reabsorbs almost all of the glucose filtered by the glomeruli. Ninety percent of the glucose reabsorption occurs through SGLT2 (Figure 15\u20132), but inhibiting this transporter using the currently available drugs will result in glucose excretion of only 30\u201350% of the amount filtered. Although we have known about the proximal tubule sodium/glucose cotransporter for many years, the inhibitors of this transport channel were developed only recently. Four SGLT2 inhibitors (dapagliflozin, canagliflozin, empagliflozin, and ipragliflozin\n\nmonosaccharides glucose, galactose, and fructose before being absorbed by the intestinal  epithelium. These hydrolytic reactions are catalyzed by salivary and pancreatic amylase and by enterocyte brush border hydrolases.LUMENTight junctionTight junctionBLOOD SGLT1GLUT5GLUT5GLUT2FructoseFructoseNa+GlucoseGalactoseGlucoseGalactoseNa+Figure 28-7.\u2002Hexose transporters. Glucose and galactose enter the enterocyte through secondary active transport via the sodium-glucose cotransporter (SGLT1) located on the apical (brush border) membrane. Fructose enters through facilitated diffusion via glucose"]]},"40": {"question": "A 24-year-old gravida 1 is admitted to the hospital after a tonic-clonic seizure at 37 weeks gestation. At the time of presentation, she complains of a severe headache, double vision, and nausea. Her vital signs are as follows: blood pressure, 165/90 mm Hg; heart rate, 91/min; respiratory rate, 9/min; and temperature, 37.0\u2103 (98.6\u2109). The rapid dipstick test performed on admission unit shows 3+ proteinuria. The fetal heart rate is 118/min. On examination, the patient is lethargic (GCS 12/15). There is 2+ pitting leg edema. The neurologic examination is significant for left eye deviation towards the nose, paralysis of the left conjugate gaze with a paralytic left eye, and right hemiplegia. Meningeal signs are negative. Which of the following findings would be expected if a head CT scan is performed?", "options": {"A": "Regions of hyperdensity within the cerebellar hemispheres", "B": "Hyperattenuating material in the subarachnoid space", "C": "Regions of hyperdensity in the left pons", "D": "Subcortical hypodense region with surrounding irregular hyperdense margins"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "head CT scan findings in preeclampsia and stroke\"  \n", "log": "To answer the question, I need to analyze the clinical presentation of the patient, which includes a seizure, severe headache, double vision, and neurological deficits. The vital signs indicate hypertension, and the proteinuria suggests possible preeclampsia. The neurological examination shows signs of a stroke, specifically right hemiplegia and left eye deviation. \n\nGiven these symptoms, I need to consider what a head CT scan would reveal in such a scenario. The presence of hyperdensity could indicate hemorrhage or other abnormalities. I will evaluate the options provided to determine which is most consistent with the clinical picture.\n\nAction: search_docs  \nAction Input: \"head CT scan findings in preeclampsia and stroke\"  \n", "type": "AgentAction"}}, "Ultrasonography or CT scan of the abdomen and pelvis 3.\n\nCT or magnetic resonance imaging (MRI) scan of the head\n\nWhen the pelvic examination and chest radiographic findings are negative, metastatic involvement of other sites is uncommon.\n\nno radiographic abnormality exists on CT scan. Positive findings on a positron emission tomography (PET) scan correlate with viable seminoma in residua and mandate surgical excision or biopsy.\n\nWith the current focus on the cost-effective use of ancillary studies, criteria that justify obtaining a cranial CT following minor forms of head trauma have been developed as discussed in the next paragraph. We have generally advised a CT in cases of head injury that was associated with loss of consciousness (more than 1 min), severe and persisting headache, nausea and vomiting, a confusional state, and any new, objective neurologic signs, but these are admittedly arbitrary criteria. The CT scan may be particularly important in elderly patients with minor head trauma, in whom the presence of\n\nwill demonstrate findings on a sinus CT scan, and many patients with presumed sinusitis will have negative findings.19 CT scan has excellent negative predic-tive value when performed in the setting of active symptoms. Thus, if a patient complains of rhinosinusitis-like symptoms but has no specific physical (endoscopic) findings, and the scan Figure 18-6.\u2002 Nasal endoscopy is commonly performed in the clinic setting to aid in the diagnosis and management of rhinosinusitis.Brunicardi_Ch18_p0613-p0660.indd   61801/03/19   5:22 PM 619DISORDERS OF THE HEAD AND NECKCHAPTER 18Figure"]]},"41": {"question": "A 45-year-old male presents to your office following a diagnosis of an autosomal dominant disease. He has started therapy and has a strong family support system. He endorses a decrease in appetite over the last two weeks that he attributes to sadness surrounding his diagnosis and a depressed mood but denies any suicidal ideation. He continues to enjoy working in the yard and playing with his children. On physical examination you notice involuntary quick jerky movements of his hands and feet. Which of the following would you expect to see in this patient?", "options": {"A": "Caudate and putamen atrophy", "B": "Depigmentation of the substantia nigra pars compacta", "C": "Atrophy of the subthalamic nucleus", "D": "Lesion in the vermis"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Huntington's disease caudate putamen atrophy", "log": "To answer the question, I need to analyze the clinical presentation of the patient. The patient is a 45-year-old male with an autosomal dominant disease, experiencing decreased appetite and a depressed mood, but no suicidal ideation. The key symptoms to note are the involuntary quick jerky movements of his hands and feet, which suggest a movement disorder. \n\nGiven the age and symptoms, this presentation is indicative of Huntington's disease, a condition characterized by chorea (the jerky movements described) and is associated with atrophy of certain brain structures. The caudate nucleus and putamen are part of the basal ganglia, which are known to atrophy in Huntington's disease.\n\nNow, I will check the options provided to confirm which one aligns with the expected findings in this condition.\n\nAction: search_docs\nAction Input: \"Huntington's disease caudate putamen atrophy\"", "type": "AgentAction"}}, "Gross atrophy bilaterally of the head of the caudate nucleus and putamen is the characteristic abnormality, usually accompanied by a moderate degree of gyral atrophy in the frontal and temporal regions. The caudate atrophy alters the configuration of the frontal horns of the lateral ventricles in that the inferolateral borders do not show the usual bulge formed by the head of the caudate nucleus. In addition, the ventricles are diffusely enlarged (Fig. 38-4); in CT scans, the bicaudate-to-cranial ratio is increased, which corroborates the clinical diagnosis in the moderately advanced case.\n\nFIGURE 449-8 Huntington\u2019s disease. A. Coronal fluid attenuated inversion recovery (FLAIR) magnetic resonance imaging shows enlargement of the lateral ventricles reflecting typical atrophy (arrows). B. Axial FLAIR image demonstrates abnormal high signal in the caudate and putamen (arrows).\n\nMedial to the internal capsule is the caudate nucleus. The caudate nucleus is a large C-shaped structure divided into a head, body, and tail, which closely follows the shape of the lateral ventricle (eFig. 9.58). Rostrally, the head of the caudate has a large rounded shape that contributes to the lateral wall of the anterior horn of the lateral ventricle (eFig. 9.58). Also at this level, the head of the caudate is continuous with the putamen (eFig. 9.59). Because of this close relationship the putamen and caudate are referred to collectively as the striatum. At the level of the\n\nabnormalities (e.g., hypothalamic dysfunction). A clinical diagnosis of HD can be strongly suspected in cases of chorea with a positive family history, but genetic testing provides the ultimate confirmation of the diagnosis. The disease predominantly affects the striatum. Progressive atrophy of the heads of the caudate nuclei, which form the lateral margins of the lateral ventricles, can be visualized by MRI (Fig. 449-8), but the putamen can be equally or even more severely affected. More diffuse cortical atrophy is seen in the middle and late stages of the disease. Supportive studies include"]]},"42": {"question": "A 69-year-old man with hypertension and congestive heart failure is brought to the emergency department because of a 9-day history of worsening shortness of breath and swelling of his legs. His respirations are 25/min, and blood pressure is 160/98 mm Hg. Pulse oximetry on 5 L O2 via nasal cannula shows an oxygen saturation of 92%. Examination shows 2+ pretibial edema bilaterally. Crackles are heard at both lung bases. The patient's symptoms are due in part to an increase in the rate of bradykinin breakdown. The substance responsible for bradykinin breakdown is primarily produced in which of the following?", "options": {"A": "Pulmonary endothelium", "B": "Liver", "C": "Atria", "D": "Zona glomerulosa"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Where is angiotensin-converting enzyme produced?'", "log": "To answer the question, I need to identify where the substance that primarily breaks down bradykinin is produced. Bradykinin is a peptide that plays a role in vasodilation and inflammation, and its breakdown is important in various physiological processes. \n\n1. **Identify the substance responsible for bradykinin breakdown**: The primary enzyme responsible for the breakdown of bradykinin is angiotensin-converting enzyme (ACE).\n  \n2. **Determine the site of production for this enzyme**: ACE is predominantly produced in the pulmonary endothelium.\n\n3. **Review the options**: \n   - A: Pulmonary endothelium\n   - B: Liver\n   - C: Atria\n   - D: Zona glomerulosa\n\nGiven that ACE is produced in the pulmonary endothelium, I will proceed to confirm this information through a search.\n\nAction: search_docs  \nAction Input: 'Where is angiotensin-converting enzyme produced?'  ", "type": "AgentAction"}}, "if the woman is already taking drugs when she presents for prenatal care. Exceptions are discontinuation of angiotensin-converting enzyme inhibitors and receptor blockers.\n\nPersistent HTN usually responds to angiotensin-converting enzyme inhibitors.\n\nColleges ABG arterial blood gas ABI ankle-brachial index ABVD Adriamycin (doxorubicin), bleomycin, vinblastine, dacarbazine AC abdominal circumference ACA anterior cerebral artery ACC American College of Cardiology ACE angiotensin-converting enzyme ACEI angiotensin-converting enzyme (protocol) ACTH adrenocorticotropic hormone AD Alzheimer\u2019s disease ADA American Diabetes Association,\n\n\u0081 The modulation of blood \ufb02ow and vascular resistance is achieved by the secretion of vasoconstrictors (endothelins, angiotensin-converting enzyme [ACE], prostaglandin H2, thromboxane A2) and vasodilators (nitrous oxide [NO], prostacyclin). This subject is discussed in more depth in the next section."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Angiotensin-converting enzyme production site'", "log": "The search results confirm that angiotensin-converting enzyme (ACE) is associated with the modulation of blood flow and vascular resistance. However, it does not explicitly state the primary site of production for ACE. Based on my prior knowledge, ACE is predominantly produced in the pulmonary endothelium.\n\nTo finalize my conclusion, I will reaffirm that ACE is indeed produced in the pulmonary endothelium and that this aligns with the question regarding bradykinin breakdown.\n\nAction: search_docs  \nAction Input: 'Angiotensin-converting enzyme production site'  ", "type": "AgentAction"}}, "of proteins whose production is induced includes the enzyme tyrosine aminotransferase, mentioned above. When the hormone is no longer present, the production of these proteins drops to its normal, unstimulated level in liver cells.\n\nCAH represents a group of autosomal recessive disorders, each characterized by a hereditary defect in an enzyme involved in adrenal steroid biosynthesis, particularly cortisol. In these conditions, decreased cortisol production results in a compensatory increase in ACTH secretion due to absence of feedback inhibition. The resultant adrenal hyperplasia causes increased production of cortisol precursor steroids, which are then channeled into synthesis of androgens with virilizing activity. Certain enzyme defects also may impair aldosterone secretion, adding salt loss to the virilizing syndrome.\n\nis complex, involving calcium, phosphate, and a variety of hormones, the most important of which are PTH, which stimulates, and FGF23, which inhibits the production of 1,25(OH)2D by the kidney while reciprocally inhibiting or promoting the production of 24,25(OH)2D. The importance of CYP24A1, the enzyme that 24-hydroxylates 25(OH)D and 1,25(OH)2D, is well demonstrated in children lacking this enzyme who have high levels of calcium and 1,25(OH)2D resulting in kidney damage from nephrocalcinosis and stones. Of the natural metabolites, vitamin D, 25(OH)D (calcifediol) and 1,25(OH)2D (as\n\nParaneoplastic Syndromes: Endocrinologic/Hematologic 610 Another relatively common cause of HHM is excess production of 1,25-dihydroxyvitamin D. Like granulomatous disorders associated with hypercalcemia, lymphomas can produce an enzyme that converts 25-hydroxyvitamin D to the more active 1,25-dihydroxyvitamin D, leading to enhanced gastrointestinal calcium absorption. Other causes of HHM include tumor-mediated production of osteolytic cytokines and inflammatory mediators."]]},"43": {"question": "An anxious mother brings her daughter into the clinic on her 5th birthday. She was forwarded a recent email by her aunt that stated that the pesticide-coated fruit in school lunches is the number one killer in children in the modern era. You assure her that that pesticides are not the number one killer, nor are they even in the top three killers of children in this age group. What are the top causes of death of American children aged 5-9, in order from most common to least?", "options": {"A": "Heart disease, malignant neoplasms, chronic lower respiratory disease", "B": "Unintentional injury, malignant neoplasms, congenital anomalies", "C": "Malignant neoplasms, heart disease, unintentional injury", "D": "Unintentional injury, suicide, malignant neoplasms"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "top causes of death American children aged 5-9\" \n", "log": "To answer the question, I need to find the most recent and accurate statistics on the leading causes of death for American children aged 5-9. The options provided suggest different rankings of causes, so I will look for reliable sources that outline these statistics. \n\nThe first step is to search for the top causes of death for children in this age group. I will use the search function to find relevant documents that give this information.\n\nAction: search_docs\nAction Input: \"top causes of death American children aged 5-9\" \n", "type": "AgentAction"}}, "are the major causes of morbidity and death in serious burn injury. More than 3000 patients in the United States die of burn-related infections each year, and 6 of the top 10 complications recently identified by the American Burn Association\u2019s 10-year review are infectious: pneumonia (4.6%), septicemia (2.7%), cellulitis/traumatic injury (2.6%), respiratory failure (2.5%), wound infection (2.2%), another infection (2.0%), renal failure (1.5%), line infection (1.4%), acute respiratory distress syndrome (1.2%), and arrhythmia (1.0%).\n\nInfectious diseases are an important health problem in the United States and worldwide despite the availability of effective vaccines and antibiotics for many types of infections. Influenza and pneumonia combined are the eighth leading cause of death in the United States. In low-income countries, limited access to healthcare, unsanitary living conditions, and malnutrition contribute to a massive burden of infectious diseases. Lower-respiratory infections, HIV/AIDS, and diarrheal diseases are the top three causes of death in developing countries, and malaria and tuberculosis are among the top\n\nCause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a slight improvement in the rate of death from all causes.\n\nin sub-Saharan Africa (Table 2-2). In second place\u2014causing 11.1% of global mortality\u2014was cerebrovascular disease, which accounted for 9.9% of deaths in high-income countries, 10.5% in developing countries, and 4.0% in sub-Saharan Africa. Although the third leading cause of death in high-income countries was lung cancer (accounting for 5.6% of all deaths), this condition did not figure among the top 10 causes in lowand middle-income countries. Among the 10 leading causes of death in sub-Saharan Africa, 6 were infectious diseases, with malaria and HIV/AIDS ranking as the dominant contributors"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "leading causes of death American children 5-9 years old\" \n", "log": "The information obtained from the search did not provide a clear ranking of the top causes of death for American children aged 5-9. It mentioned various causes of death in children but didn't specifically address the age group in question or rank them. I need to refine my search to focus specifically on the leading causes of death for children aged 5-9 in the United States.\n\nAction: search_docs\nAction Input: \"leading causes of death American children 5-9 years old\" \n", "type": "AgentAction"}}, "FIgURE 6e-1 Death rates per 100,000 population for 2007 by 5-year age groups in U.S. women. Note that the scale of the y axis is increased in the graph on the right compared with that on the left. Accidents and HIV/AIDS are the leading causes of death in young women 20\u201334 years of age. Accidents, breast cancer, and ischemic heart disease (IHD) are the leading causes of death in women 35\u201349 years of age. IHD becomes the leading cause of death in women beginning at age 50 years. In older women, IHD remains the leading cause of death, cerebrovascular disease becomes the second leading cause of\n\nDrowning deaths overall have decreased over the past decade; however, drowning is still a significant cause of morbidity and mortality. In 2010, drowning was the leading cause of injury death for children 1 to 4 years of age and the second leading cause of injury death for children 1 to 18 years of age. Boys are four times more likely than girls to drown. The most common location of drowning varies by age, with drowning in natural bodies of water becoming more frequent in older age groups.\n\nCause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a slight improvement in the rate of death from all causes.\n\nor self-help groups, there is at least a 20% chance of spontaneous remission with long-term abstinence. However, should the alcoholic continue to drink heavily, the life span is shortened by ~10 years on average, with the leading causes of death being heart disease, cancer, accidents, and suicide."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "leading causes of death children 5-9 years old USA statistics\" \n", "log": "The search did not yield specific information about the leading causes of death for American children aged 5-9, but it did mention that accidents (unintentional injuries) are a significant cause of death among children. I need to try another search to find more precise statistics that focus on the specific age group of 5-9 years.\n\nAction: search_docs\nAction Input: \"leading causes of death children 5-9 years old USA statistics\" \n", "type": "AgentAction"}}, "FIgURE 6e-1 Death rates per 100,000 population for 2007 by 5-year age groups in U.S. women. Note that the scale of the y axis is increased in the graph on the right compared with that on the left. Accidents and HIV/AIDS are the leading causes of death in young women 20\u201334 years of age. Accidents, breast cancer, and ischemic heart disease (IHD) are the leading causes of death in women 35\u201349 years of age. IHD becomes the leading cause of death in women beginning at age 50 years. In older women, IHD remains the leading cause of death, cerebrovascular disease becomes the second leading cause of\n\nDrowning deaths overall have decreased over the past decade; however, drowning is still a significant cause of morbidity and mortality. In 2010, drowning was the leading cause of injury death for children 1 to 4 years of age and the second leading cause of injury death for children 1 to 18 years of age. Boys are four times more likely than girls to drown. The most common location of drowning varies by age, with drowning in natural bodies of water becoming more frequent in older age groups.\n\nCause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a slight improvement in the rate of death from all causes.\n\nmiddle-ear effusion in children 6 months to 2 years of age. Treatment is typically indicated for patients <6 months old; for children 6 months to 2 years old who have mid-dle-ear effusion and signs/symptoms of middle-ear inflammation; for all patients >2 years old who have bilateral disease, TM perforation, immunocompromise, or emesis; and for any patient who has severe symptoms, including a fever \u226539\u00b0C or moderate to severe otalgia (Table 44-2)."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "CDC leading causes of death children 5 to 9 years old\"  \n", "log": "The previous searches have not provided a clear ranking of the leading causes of death for American children aged 5-9. I will refine my search further to focus specifically on statistics from reputable sources such as the CDC or other health organizations that provide detailed mortality data for children in this specific age group.\n\nAction: search_docs  \nAction Input: \"CDC leading causes of death children 5 to 9 years old\"  \n", "type": "AgentAction"}}, "Drowning deaths overall have decreased over the past decade; however, drowning is still a significant cause of morbidity and mortality. In 2010, drowning was the leading cause of injury death for children 1 to 4 years of age and the second leading cause of injury death for children 1 to 18 years of age. Boys are four times more likely than girls to drown. The most common location of drowning varies by age, with drowning in natural bodies of water becoming more frequent in older age groups.\n\nThe short-term prognosis is determined by the magnitude of the femoral head deformity after healing has completed. It is improved by early diagnosis, good follow-up, and compliance with the treatment plan. Older children and children with a residual femoral head deformity are more likely to develop osteoarthritis (OA). The incidence of OA in patients who developed LCPD after 10 years of age is close to 100%; it is negligible in children with onset before 5 years of age. Patients between 6 and 9 years of age have a risk of OA of less than 40%.\n\nAvailable @ StudentConsult.com\n\nCause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a slight improvement in the rate of death from all causes.\n\nFIgURE 6e-1 Death rates per 100,000 population for 2007 by 5-year age groups in U.S. women. Note that the scale of the y axis is increased in the graph on the right compared with that on the left. Accidents and HIV/AIDS are the leading causes of death in young women 20\u201334 years of age. Accidents, breast cancer, and ischemic heart disease (IHD) are the leading causes of death in women 35\u201349 years of age. IHD becomes the leading cause of death in women beginning at age 50 years. In older women, IHD remains the leading cause of death, cerebrovascular disease becomes the second leading cause of"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "CDC statistics leading causes of death children ages 5 to 9\"  \n", "log": "The observations so far have not yielded specific and clear information on the leading causes of death for American children aged 5-9. The repeated searches have provided some information about general causes of death in children but not focused on the specific age group requested.\n\nSince the information has not been fruitful, I will make one last attempt to find a reliable source that specifically lists the leading causes of death for children aged 5-9 in the United States.\n\nAction: search_docs  \nAction Input: \"CDC statistics leading causes of death children ages 5 to 9\"  \n", "type": "AgentAction"}}, "that matters; most diseases or conditions cause significant disability and suffering even when nonfatal, so this measure of burden captures nonfatal outcomes using statistical weighting. As Table 93e-3 shows, the \u201cmodern plagues\u201d of chronic noncommunicable diseases are already among the leading causes of premature death and disability even in low-income countries. This is due to a mix of factors\u2014lower fertility rates mean fewer infants and children at prime ages of susceptibility to infections; more people reaching older ages when chronic disease incidence is high; and often changing\n\nUnintentional injury is the leading cause of death for children ages 1 to 18; however, many of these deaths occur in the field, immediately after the injury. Once admitted to the hospital, mortality rates are much lower. Morbidities are numerous and include hypoxic-ischemic brain injury, loss of limbs, and psychological dysfunction.\n\nSEE CHAPTER 41.\n\nIn children ages 6 to 11 years of age (late preoperational to concrete operational), the finality of death gradually comes to be understood. Magical thinking gives way to a need for detailed information to gain a sense of control. Older children in this range have a strong need to control their emotions by compartmentalizing and intellectualizing.\n\nLocation of the burn 4.\n\nAssociation with other injuries\n\nMore than 100,000 children sustain a burn injury each year. Burns are the third leading cause of injury-related death for children ages 1 to 9 and are a major cause of morbidity. Boys are more likely to sustain a burn injury, as are children age 6 and under. Scald burns are more common in younger children as compared to older children. Overall, thermal burns secondary to scald or flame are much more common than electrical or chemical burns. Most fire-related childhood deaths and injuries occur in homes."]]},"44": {"question": "A 3-year-old boy is brought to the emergency room by his mother with fever and difficulty breathing after receiving the BCG vaccine. He has never had a reaction to a vaccine before. He has a history of 2 salmonella infections over the past 2 years. He was born at 35 weeks\u2019 gestation and spent one day in the neonatal intensive care unit. His parents' family histories are unremarkable. His temperature is 101\u00b0F (38.3\u00b0C), blood pressure is 80/55 mmHg, pulse is 135/min, and respirations are 24/min. On examination, he appears acutely ill. He has increased work of breathing with intercostal retractions. A petechial rash is noted on his trunk and extremities. A serological analysis in this patient would most likely reveal decreased levels of which of the following cytokines?", "options": {"A": "Interferon alpha", "B": "Interferon gamma", "C": "Interleukin 1", "D": "Tumor necrosis factor alpha"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'cytokine levels BCG vaccine children immunocompromised'", "log": "To answer the question, I need to analyze the clinical presentation of the 3-year-old boy, particularly focusing on his vaccination history, symptoms, and potential underlying conditions. The key points from the case are:\n\n1. The boy has a history of receiving the BCG vaccine and is now experiencing fever, difficulty breathing, and a petechial rash. \n2. He has had two salmonella infections, which may suggest some underlying immunocompromised state or susceptibility to infections.\n3. The boy's premature birth (at 35 weeks) might also contribute to his immune system's development.\n\nGiven these details, I need to determine which cytokine levels are likely to be decreased in this context. The options provided are related to immune responses:\n\n- Interferon alpha and gamma are important in antiviral responses and immune regulation.\n- Interleukin 1 plays a role in inflammatory responses.\n- Tumor necrosis factor alpha is involved in systemic inflammation.\n\nThe symptoms of difficulty breathing, petechial rash, and acute illness suggest a possible viral infection or a severe immune response. Since the boy has a history of salmonella infections, it may indicate a compromised immune response.\n\nI will now search for information on cytokine levels associated with BCG vaccination and any related immunological responses in children, particularly focusing on decreased cytokine levels in the context of infections or immune deficiencies.\n\nAction: search_docs\nAction Input: 'cytokine levels BCG vaccine children immunocompromised'", "type": "AgentAction"}}, "strains of BCG have evolved. The level of protection afforded by the BCG vaccine is extremely variable, ranging from none in some countries, such as Malawi, to 50\u201380% in the UK.\n\nthe protection of infants and young children from serious disseminated forms of childhood TB, such as tuberculous meningitis and miliary TB. BCG vaccine is safe and rarely causes serious complications. The local tissue response begins 2\u20133 weeks after vaccination, with scar formation and healing within 3 months. Side effects\u2014most commonly, ulceration at the vaccination site and regional lymphadenitis\u2014occur in 1\u201310% of vaccinated persons. Some vaccine strains have caused osteomyelitis in ~1 case per million doses administered. Disseminated BCG infection (\u201cBCGitis\u201d) and death have occurred in\n\nBCG vaccine is recommended for routine use at birth in countries with high TB prevalence. However, because of the low risk of transmission of TB in the United States and other high-income countries, the unreliable protection afforded by BCG, and its impact on the TST, the vaccine is not recommended for general use. HIV-infected adults and children should not receive BCG vaccine. Moreover, infants whose HIV status is unknown but who have signs and symptoms consistent with HIV infection or who are born to HIV-infected mothers should not receive BCG.\n\nSimilar approaches have been used for bacterial vaccine development. The most important example of an attenuated vaccine is that of BCG, which is quite effective at protecting against serious disseminated tuberculosis in children, but is not protective against adult pulmonary tuberculosis. The current BCG vaccine, which remains the most widely used vaccine in the world, was obtained from a pathogenic isolate of Mycobacterium bovis and passaged in a laboratory at the beginning of the 20th century. Since then, several genetically diverse strains of BCG have evolved. The level of protection"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'decreased cytokines BCG vaccine immunocompromised children'", "log": "The search did not yield specific information regarding cytokine levels associated with BCG vaccination and the immune response in children, particularly in the context of decreased levels in immunocompromised individuals. However, I can still utilize my understanding of the immune responses related to the case.\n\nGiven the symptoms presented by the boy, including fever, difficulty breathing, and a petechial rash, it is possible that he is experiencing an immune response that is not functioning optimally. The history of salmonella infections may suggest an underlying immunodeficiency. \n\nInterferon gamma is crucial for immune responses against intracellular pathogens and is often decreased in cases of immunocompromise, particularly in those who might have a weakened response to vaccines like BCG. \n\nWhile I did not find specific documentation on cytokine levels from my search, I will proceed with the informed reasoning based on the clinical context. Interferon gamma is likely to be decreased due to the boy's symptoms and history.\n\nAction: search_docs\nAction Input: 'decreased cytokines BCG vaccine immunocompromised children'", "type": "AgentAction"}}, "strains of BCG have evolved. The level of protection afforded by the BCG vaccine is extremely variable, ranging from none in some countries, such as Malawi, to 50\u201380% in the UK.\n\nSimilar approaches have been used for bacterial vaccine development. The most important example of an attenuated vaccine is that of BCG, which is quite effective at protecting against serious disseminated tuberculosis in children, but is not protective against adult pulmonary tuberculosis. The current BCG vaccine, which remains the most widely used vaccine in the world, was obtained from a pathogenic isolate of Mycobacterium bovis and passaged in a laboratory at the beginning of the 20th century. Since then, several genetically diverse strains of BCG have evolved. The level of protection\n\nthe protection of infants and young children from serious disseminated forms of childhood TB, such as tuberculous meningitis and miliary TB. BCG vaccine is safe and rarely causes serious complications. The local tissue response begins 2\u20133 weeks after vaccination, with scar formation and healing within 3 months. Side effects\u2014most commonly, ulceration at the vaccination site and regional lymphadenitis\u2014occur in 1\u201310% of vaccinated persons. Some vaccine strains have caused osteomyelitis in ~1 case per million doses administered. Disseminated BCG infection (\u201cBCGitis\u201d) and death have occurred in\n\nBCG vaccine is recommended for routine use at birth in countries with high TB prevalence. However, because of the low risk of transmission of TB in the United States and other high-income countries, the unreliable protection afforded by BCG, and its impact on the TST, the vaccine is not recommended for general use. HIV-infected adults and children should not receive BCG vaccine. Moreover, infants whose HIV status is unknown but who have signs and symptoms consistent with HIV infection or who are born to HIV-infected mothers should not receive BCG."]]},"45": {"question": "A 67-year-old man presents to the surgical clinic with swelling of his right leg, fever, and chills for 2 days. The maximum recorded temperature was 38.3\u00b0C (101.0\u00b0F) at home. His right leg is red and swollen from the dorsum of the foot to the thigh with an ill-defined edge. Venous stasis ulcers are present in both of his limbs, but those on the right have a yellow discharge. His vitals include the following: blood pressure is 120/78 mm Hg, heart rate is 94/min, temperature is 38.3\u00b0C (101.0\u00b0F), and respiratory rate is 16/min. On physical examination, there is tenderness and warmth compared with his normal leg. Dorsalis pedis pulses are present on both of the ankles. What is the most likely cause of the right shift of the hemoglobin dissociation curve for his condition?", "options": {"A": "Decrease in 2,3-DPG", "B": "Increase in temperature", "C": "Decrease in temperature", "D": "Increase in CO production"}, "output": "B", "intermediate_steps": []},"46": {"question": "A 75-year-old Caucasian man presents to the emergency department with abdominal pain. The patient states he was at home eating dinner when he began to experience severe abdominal pain. The patient has a past medical history of diabetes, hypertension, and atherosclerosis. He lives at home alone, smokes cigarettes, and drinks 1 to 2 alcoholic drinks per day. The patient is given IV morphine and an ultrasound is obtained demonstrating a dilated abdominal aorta. The patient states that his father died of a similar finding and is concerned about his prognosis. Which of the following is the greatest risk factor for this patient's presentation?", "options": {"A": "Atherosclerosis", "B": "Caucasian race", "C": "Cigarette smoking", "D": "Family history"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "greatest risk factor for abdominal aortic aneurysm", "log": "To determine the greatest risk factor for this patient's presentation of a dilated abdominal aorta, I need to consider the risk factors associated with abdominal aortic aneurysm (AAA). The patient's age, race, smoking history, and family history are all relevant. \n\n1. Atherosclerosis is a known risk factor for vascular diseases, including AAA.\n2. The patient's Caucasian race is also a risk factor, as AAAs are more common in Caucasian individuals.\n3. Cigarette smoking is a significant risk factor for AAA development and progression.\n4. Family history can indicate a genetic predisposition to vascular conditions, including AAA.\n\nNext, I should evaluate which of these factors is generally considered the most significant risk factor for AAA in clinical literature.\n\nAction: search_docs \nAction Input: \"greatest risk factor for abdominal aortic aneurysm\"", "type": "AgentAction"}}, "the aortic circu-lation (Fig. 23-32). Unlike open surgical repair, the aneurysm BAFigure 23-32.\u2002A. An aortogram dem-onstrating a large infrarenal abdominal aortic aneurysm. B. Following endovas-cular stent graft implantation, the aortic aneurysm is successfully excluded.sac is not resected, which is subjected for potential aneurysm expansion or even rupture. Importantly, aortic branches, such as lumbar arteries or the inferior mesenteric artery (IMA), are occluded, which can lead to persistent aneurysm pressurization and aneurysm expansion. Currently, there are more than fifteen different\n\nIn the clinic\n\nAn abdominal aortic aneurysm is a dilation of the aorta and generally tends to occur in the infrarenal region (the region at or below the renal arteries). As the aorta expands, the risk of rupture increases, and it is now generally accepted that when an aneurysm reaches 5.5\u202fcm or greater an operation will significantly benefit the patient.\n\nWith the aging population, the number of abdominal aortic aneurysms is increasing. Moreover, with the increasing use of imaging techniques, a number of abdominal aortic aneurysms are identified in asymptomatic patients.\n\nAbdominal radiography may demonstrate the calcified outline of the aneurysm; however, about 25% of aneurysms are not calcified and cannot be visualized by x-ray imaging. An abdominal ultrasound can delineate the transverse and longitudinal dimensions of an abdominal aortic aneurysm and may detect mural thrombus. Abdominal ultrasound is useful for serial documentation of aneurysm size and can be used to screen patients at risk for developing an aortic aneurysm. In one large study, ultrasound screening of men age 65\u201374 years was associated with a risk reduction in aneurysm-related death of 42%.\n\nOperative repair of the aneurysm with insertion of a prosthetic graft or endovascular placement of an aortic stent graft (Fig. 301-3) is indicated for abdominal aortic aneurysms of any size that are expanding rapidly or are associated with symptoms. For asymptomatic aneurysms, abdominal aortic aneurysm repair is indicated if the diameter is >5.5 cm. In randomized trials of patients with abdominal aortic aneurysms <5.5 cm, there was no difference in the long-term (5to 8-year) mortality rate between those followed with ultrasound surveillance and those undergoing elective surgical repair. Thus,"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "risk factors for abdominal aortic aneurysm ranking", "log": "The retrieved information did not directly address the specific question regarding the greatest risk factor for abdominal aortic aneurysm (AAA). However, it does mention that AAAs are more common in certain demographics and highlights the importance of various risk factors. To further clarify the significance of each risk factor, especially in relation to the patient's case, I should search for specific studies or clinical guidelines that rank these risk factors for AAA.\n\nAction: search_docs  \nAction Input: \"risk factors for abdominal aortic aneurysm ranking\"  ", "type": "AgentAction"}}, "the aortic circu-lation (Fig. 23-32). Unlike open surgical repair, the aneurysm BAFigure 23-32.\u2002A. An aortogram dem-onstrating a large infrarenal abdominal aortic aneurysm. B. Following endovas-cular stent graft implantation, the aortic aneurysm is successfully excluded.sac is not resected, which is subjected for potential aneurysm expansion or even rupture. Importantly, aortic branches, such as lumbar arteries or the inferior mesenteric artery (IMA), are occluded, which can lead to persistent aneurysm pressurization and aneurysm expansion. Currently, there are more than fifteen different\n\nIn the clinic\n\nAn abdominal aortic aneurysm is a dilation of the aorta and generally tends to occur in the infrarenal region (the region at or below the renal arteries). As the aorta expands, the risk of rupture increases, and it is now generally accepted that when an aneurysm reaches 5.5\u202fcm or greater an operation will significantly benefit the patient.\n\nWith the aging population, the number of abdominal aortic aneurysms is increasing. Moreover, with the increasing use of imaging techniques, a number of abdominal aortic aneurysms are identified in asymptomatic patients.\n\nAbdominal radiography may demonstrate the calcified outline of the aneurysm; however, about 25% of aneurysms are not calcified and cannot be visualized by x-ray imaging. An abdominal ultrasound can delineate the transverse and longitudinal dimensions of an abdominal aortic aneurysm and may detect mural thrombus. Abdominal ultrasound is useful for serial documentation of aneurysm size and can be used to screen patients at risk for developing an aortic aneurysm. In one large study, ultrasound screening of men age 65\u201374 years was associated with a risk reduction in aneurysm-related death of 42%.\n\nAortic aneurysm Localized pathologic dilation of the aorta. May cause abdominal and/or back pain, which is a sign of leaking, dissection, or imminent rupture.\n\nAbdominal aortic Usually associated with atherosclerosis. Risk factors include history of tobacco use, \u008f\u00a0age, male aneurysm sex, family history. May present as palpable pulsatile abdominal mass (arrows in A point to outer dilated calcified aortic wall, with partial crescent-shaped non-opacification of aorta due to flap/ clot). Most often infrarenal (distal to origin of renal arteries)."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "abdominal aortic aneurysm risk factors relative importance", "log": "The retrieved information still does not provide a clear ranking of the risk factors for abdominal aortic aneurysm (AAA). However, it emphasizes the association of AAA with atherosclerosis, tobacco use, age, male sex, and family history. To make a more informed decision on which risk factor is the greatest for this patient, I should search for specific clinical guidelines or studies that detail the relative risks of these factors.\n\nAction: search_docs  \nAction Input: \"abdominal aortic aneurysm risk factors relative importance\"  ", "type": "AgentAction"}}, "In the clinic\n\nAn abdominal aortic aneurysm is a dilation of the aorta and generally tends to occur in the infrarenal region (the region at or below the renal arteries). As the aorta expands, the risk of rupture increases, and it is now generally accepted that when an aneurysm reaches 5.5\u202fcm or greater an operation will significantly benefit the patient.\n\nWith the aging population, the number of abdominal aortic aneurysms is increasing. Moreover, with the increasing use of imaging techniques, a number of abdominal aortic aneurysms are identified in asymptomatic patients.\n\nAortic aneurysm Localized pathologic dilation of the aorta. May cause abdominal and/or back pain, which is a sign of leaking, dissection, or imminent rupture.\n\nAbdominal aortic Usually associated with atherosclerosis. Risk factors include history of tobacco use, \u008f\u00a0age, male aneurysm sex, family history. May present as palpable pulsatile abdominal mass (arrows in A point to outer dilated calcified aortic wall, with partial crescent-shaped non-opacification of aorta due to flap/ clot). Most often infrarenal (distal to origin of renal arteries).\n\nthe aortic circu-lation (Fig. 23-32). Unlike open surgical repair, the aneurysm BAFigure 23-32.\u2002A. An aortogram dem-onstrating a large infrarenal abdominal aortic aneurysm. B. Following endovas-cular stent graft implantation, the aortic aneurysm is successfully excluded.sac is not resected, which is subjected for potential aneurysm expansion or even rupture. Importantly, aortic branches, such as lumbar arteries or the inferior mesenteric artery (IMA), are occluded, which can lead to persistent aneurysm pressurization and aneurysm expansion. Currently, there are more than fifteen different\n\nAbdominal radiography may demonstrate the calcified outline of the aneurysm; however, about 25% of aneurysms are not calcified and cannot be visualized by x-ray imaging. An abdominal ultrasound can delineate the transverse and longitudinal dimensions of an abdominal aortic aneurysm and may detect mural thrombus. Abdominal ultrasound is useful for serial documentation of aneurysm size and can be used to screen patients at risk for developing an aortic aneurysm. In one large study, ultrasound screening of men age 65\u201374 years was associated with a risk reduction in aneurysm-related death of 42%."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "abdominal aortic aneurysm risk factors importance study", "log": "The retrieved information continues to emphasize the association of abdominal aortic aneurysms (AAAs) with various risk factors but does not specifically rank them. It mentions that AAAs are commonly associated with atherosclerosis, tobacco use, age, male sex, and family history. \n\nGiven that I still need to determine which risk factor is the greatest for the patient, I should focus on finding a source that clearly delineates the relative risks of these factors in the context of AAA.\n\nAction: search_docs  \nAction Input: \"abdominal aortic aneurysm risk factors importance study\"  ", "type": "AgentAction"}}, "In the clinic\n\nAn abdominal aortic aneurysm is a dilation of the aorta and generally tends to occur in the infrarenal region (the region at or below the renal arteries). As the aorta expands, the risk of rupture increases, and it is now generally accepted that when an aneurysm reaches 5.5\u202fcm or greater an operation will significantly benefit the patient.\n\nWith the aging population, the number of abdominal aortic aneurysms is increasing. Moreover, with the increasing use of imaging techniques, a number of abdominal aortic aneurysms are identified in asymptomatic patients.\n\nAortic aneurysm Localized pathologic dilation of the aorta. May cause abdominal and/or back pain, which is a sign of leaking, dissection, or imminent rupture.\n\nAbdominal aortic Usually associated with atherosclerosis. Risk factors include history of tobacco use, \u008f\u00a0age, male aneurysm sex, family history. May present as palpable pulsatile abdominal mass (arrows in A point to outer dilated calcified aortic wall, with partial crescent-shaped non-opacification of aorta due to flap/ clot). Most often infrarenal (distal to origin of renal arteries).\n\nthe aortic circu-lation (Fig. 23-32). Unlike open surgical repair, the aneurysm BAFigure 23-32.\u2002A. An aortogram dem-onstrating a large infrarenal abdominal aortic aneurysm. B. Following endovas-cular stent graft implantation, the aortic aneurysm is successfully excluded.sac is not resected, which is subjected for potential aneurysm expansion or even rupture. Importantly, aortic branches, such as lumbar arteries or the inferior mesenteric artery (IMA), are occluded, which can lead to persistent aneurysm pressurization and aneurysm expansion. Currently, there are more than fifteen different\n\nAbdominal radiography may demonstrate the calcified outline of the aneurysm; however, about 25% of aneurysms are not calcified and cannot be visualized by x-ray imaging. An abdominal ultrasound can delineate the transverse and longitudinal dimensions of an abdominal aortic aneurysm and may detect mural thrombus. Abdominal ultrasound is useful for serial documentation of aneurysm size and can be used to screen patients at risk for developing an aortic aneurysm. In one large study, ultrasound screening of men age 65\u201374 years was associated with a risk reduction in aneurysm-related death of 42%."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "importance of risk factors for abdominal aortic aneurysm", "log": "The retrieved information has not provided a clear ranking or specific studies that delineate the importance of each risk factor for abdominal aortic aneurysms (AAAs). I need to continue searching for definitive sources that address the relative significance of the risk factors mentioned: atherosclerosis, Caucasian race, cigarette smoking, and family history.\n\nAction: search_docs  \nAction Input: \"importance of risk factors for abdominal aortic aneurysm\"  ", "type": "AgentAction"}}, "Abdominal radiography may demonstrate the calcified outline of the aneurysm; however, about 25% of aneurysms are not calcified and cannot be visualized by x-ray imaging. An abdominal ultrasound can delineate the transverse and longitudinal dimensions of an abdominal aortic aneurysm and may detect mural thrombus. Abdominal ultrasound is useful for serial documentation of aneurysm size and can be used to screen patients at risk for developing an aortic aneurysm. In one large study, ultrasound screening of men age 65\u201374 years was associated with a risk reduction in aneurysm-related death of 42%.\n\nIn the clinic\n\nAn abdominal aortic aneurysm is a dilation of the aorta and generally tends to occur in the infrarenal region (the region at or below the renal arteries). As the aorta expands, the risk of rupture increases, and it is now generally accepted that when an aneurysm reaches 5.5\u202fcm or greater an operation will significantly benefit the patient.\n\nWith the aging population, the number of abdominal aortic aneurysms is increasing. Moreover, with the increasing use of imaging techniques, a number of abdominal aortic aneurysms are identified in asymptomatic patients.\n\nAortic aneurysm Localized pathologic dilation of the aorta. May cause abdominal and/or back pain, which is a sign of leaking, dissection, or imminent rupture.\n\nAbdominal aortic Usually associated with atherosclerosis. Risk factors include history of tobacco use, \u008f\u00a0age, male aneurysm sex, family history. May present as palpable pulsatile abdominal mass (arrows in A point to outer dilated calcified aortic wall, with partial crescent-shaped non-opacification of aorta due to flap/ clot). Most often infrarenal (distal to origin of renal arteries).\n\nUpper abdominal or thoracic, or abdominal aortic aneurysm surgery\n\nSmoking within 2 months of surgery\n\nUse of pancuronium for general anesthesia\n\nTable 22.20 Predictors of Postoperative Pulmonary Complicationsa"]]},"47": {"question": "A 32-year-old woman presents to her primary care doctor complaining of increased fatigue and cold intolerance after her recent delivery. The patient delivered a healthy 39-week-old boy 3 weeks ago via spontaneous vaginal delivery. Delivery was complicated by postpartum hemorrhage requiring admission to the intensive care unit with blood transfusions. Pregnancy was otherwise uneventful, and the baby is healthy. The mother has had some difficulty with lactation, but is able to supplement her breast milk with formula feeds. On exam, her temperature is 97.7\u00b0F (36.5\u00b0C), blood pressure is 112/78 mmHg, pulse is 62/min, and respirations are 12/min. The patient does not have any neck masses or lymphadenopathy; however, her skin appears dry and rough. Which of the following serum lab abnormalities may be expected?", "options": {"A": "Decreased prolactin", "B": "Decreased thyroid releasing hormone", "C": "Increased follicle stimulating hormone", "D": "Increased luteinizing hormone"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "postpartum thyroiditis lab abnormalities", "log": "To answer this question, I need to analyze the clinical presentation of the patient. The key symptoms include increased fatigue, cold intolerance, and dry skin, which are suggestive of hypothyroidism. Given the context of recent delivery and potential postpartum thyroiditis, it is essential to consider how thyroid hormone levels and other related hormones might be affected in this scenario.\n\nNext, I will evaluate the options provided:\n- **A: Decreased prolactin** - This is unlikely as prolactin levels are often elevated postpartum due to lactation.\n- **B: Decreased thyroid releasing hormone** - This does not align with hypothyroid symptoms, which would typically involve increased TRH due to low thyroid hormone levels.\n- **C: Increased follicle stimulating hormone** - This could occur if there is a disruption in the feedback mechanisms due to low estrogen or thyroid hormones, but it is not the most direct connection to the symptoms.\n- **D: Increased luteinizing hormone** - Similar to FSH, this could be affected by hormonal changes, but again, it does not directly correlate with the symptoms presented.\n\nGiven the symptoms and the context of potential postpartum thyroiditis, I suspect that there may be changes in thyroid hormone levels, which could lead to secondary changes in other hormones. \n\nNow I will search for information related to serum lab abnormalities in postpartum women presenting with symptoms of hypothyroidism.\n\nAction: search_docs  \nAction Input: \"postpartum thyroiditis lab abnormalities\"  ", "type": "AgentAction"}}, "Viral (or granulomatous) thyroiditis Silent thyroiditis (including postpartum thyroiditis) Mycobacterial infection Drug induced (interferon, amiodarone)\n\nAutoimmunity: focal thyroiditis, Hashimoto\u2019s thyroiditis, atrophic thyroiditis Riedel\u2019s thyroiditis Parasitic thyroiditis: echinococcosis, strongyloidiasis, cysticercosis Traumatic: after palpation\n\n(Stagnaro-Green, 2012a). In a Dutch study of 82 women with type 1 diabetes, postpartum thyroiditis developed in 16 percent and was threefold higher than in the general population (Gallas, 2002). Importantly, 46 percent of those identified with overt postpartum thyroiditis had TPO antibodies in the first trimester.\n\nCongenital hypothyroidism: absent or ectopic thyroid gland, dyshormonogenesis, TSH-R mutation\n\nInfiltrative disorders: amyloidosis, sarcoidosis, hemochromatosis, scleroderma, cystinosis, Riedel\u2019s thyroiditis\n\nOverexpression of type 3 deiodinase in infantile hemangioma and other tumors\n\nSilent thyroiditis, including postpartum thyroiditis Subacute thyroiditis Withdrawal of supraphysiologic thyroxine treatment in individuals with an\n\nPostpartum thyroiditis usually begins with a transient hyperthyroid phase between 6 weeks and 6 months postpartum followed by a hypothyroid phase. Only one-fourth of the cases follow this classic clinical picture, and more than one-third have either hyperthyroidism or hypothyroidism alone. Individuals with type 1 diabetes have a threefold increased risk of developing postpartum thyroiditis. Women with a history of postpartum thyroiditis in a previous pregnancy have nearly a 70% chance of recurrence in a subsequent pregnancy. Although psychotic episodes are rare, postpartum thyroid dysfunction"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "postpartum thyroiditis hormone levels changes", "log": "The information obtained from the search indicates that postpartum thyroiditis often begins with a hyperthyroid phase followed by a hypothyroid phase. This aligns with the patient's symptoms of fatigue, cold intolerance, and dry skin, which are consistent with hypothyroidism. \n\nGiven that postpartum thyroiditis can lead to changes in thyroid hormone levels, it is likely that the patient may exhibit elevated levels of Thyroid Stimulating Hormone (TSH) due to low thyroid hormone levels while other hormones such as prolactin may remain elevated due to lactation. Therefore, the most relevant serum lab abnormality in this context would likely not be one of the options provided.\n\nNext, I will evaluate the options again in light of this new information:\n- **A: Decreased prolactin** - Unlikely due to lactation.\n- **B: Decreased thyroid releasing hormone** - Unlikely in hypothyroidism.\n- **C: Increased follicle stimulating hormone** - Possible but not a direct correlation.\n- **D: Increased luteinizing hormone** - Possible but not a direct correlation.\n\nSince none of the options directly correspond to the expected lab findings in postpartum thyroiditis, I will determine which option is the least inconsistent with hypothyroid symptoms. \n\nAction: search_docs  \nAction Input: \"postpartum thyroiditis hormone levels changes\"  ", "type": "AgentAction"}}, "Viral (or granulomatous) thyroiditis Silent thyroiditis (including postpartum thyroiditis) Mycobacterial infection Drug induced (interferon, amiodarone)\n\nAutoimmunity: focal thyroiditis, Hashimoto\u2019s thyroiditis, atrophic thyroiditis Riedel\u2019s thyroiditis Parasitic thyroiditis: echinococcosis, strongyloidiasis, cysticercosis Traumatic: after palpation\n\n(Stagnaro-Green, 2012a). In a Dutch study of 82 women with type 1 diabetes, postpartum thyroiditis developed in 16 percent and was threefold higher than in the general population (Gallas, 2002). Importantly, 46 percent of those identified with overt postpartum thyroiditis had TPO antibodies in the first trimester.\n\nActivating mutation of GS\u03b1 (McCune-Albright syndrome)\n\nDrugs: iodine excess (Jod-Basedow phenomenon)\n\nSubacute thyroiditis Silent thyroiditis Other causes of thyroid destruction: amiodarone, radiation, infarction of adenoma Ingestion of excess thyroid hormone (thyrotoxicosis factitia) or thyroid tissue\n\nThyroid hormone resistance syndrome: occasional patients may have features of thyrotoxicosis Chorionic gonadotropin-secreting tumorsa Gestational thyrotoxicosisa aCirculating TSH levels are low in these forms of secondary hyperthyroidism.\n\nAbbreviations: TSH, thyroid-stimulating hormone.\n\nCongenital hypothyroidism: absent or ectopic thyroid gland, dyshormonogenesis, TSH-R mutation\n\nInfiltrative disorders: amyloidosis, sarcoidosis, hemochromatosis, scleroderma, cystinosis, Riedel\u2019s thyroiditis\n\nOverexpression of type 3 deiodinase in infantile hemangioma and other tumors\n\nSilent thyroiditis, including postpartum thyroiditis Subacute thyroiditis Withdrawal of supraphysiologic thyroxine treatment in individuals with an"]]},"48": {"question": "A 2-day-old male newborn is brought to the physician because he became somnolent and felt cold after breastfeeding. Pregnancy and delivery were uncomplicated. He was born at 40 weeks' gestation and weighed 3538 g (7 lb 13 oz); he currently weighs 3311 g (7 lb 5 oz). Examination shows generalized hypotonia. Serum studies show an ammonia concentration of 150 \u03bcmol/L (N < 50 \u03bcmol/L). Which of the following is the most likely cause of the patient's neurological symptoms?", "options": {"A": "Increased succinyl-CoA concentration", "B": "Increased glutamate concentration", "C": "Decreased acylcarnitine concentration", "D": "Decreased \u03b3-aminobutyric acid concentration"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'newborn hyperammonemia neurological symptoms'", "log": "To solve this question, I need to analyze the clinical scenario presented. The newborn is showing symptoms of somnolence, hypothermia, and generalized hypotonia, along with elevated ammonia levels. Elevated ammonia is indicative of a metabolic disorder, often associated with urea cycle defects or other metabolic issues.\n\nNext, I need to consider the options provided:\n- **A: Increased succinyl-CoA concentration** - This is typically not associated with hyperammonemia.\n- **B: Increased glutamate concentration** - Elevated ammonia can lead to increased glutamate levels, as ammonia is converted to glutamate in the brain.\n- **C: Decreased acylcarnitine concentration** - This is more related to fatty acid oxidation disorders, which do not directly explain the hyperammonemia.\n- **D: Decreased \u03b3-aminobutyric acid concentration** - This could be a consequence of elevated ammonia but is not a primary cause of neurological symptoms in this context.\n\nBased on this analysis, the most likely cause of the patient's neurological symptoms is related to the increased glutamate concentration due to elevated ammonia levels. \n\nHowever, to ensure accuracy, I will search for more information on the relationship between ammonia levels and neurological symptoms in newborns.\n\nAction: search_docs  \nAction Input: 'newborn hyperammonemia neurological symptoms'  ", "type": "AgentAction"}}, "Disorders of the urea cycle Lethal hyperammonemia is common\n\nDisorders of the propionate Severe hyperammonemia may pathway precede acidosis\n\nDisorders of fatty acid catabolism Reye-like syndrome possible and of ketogenesis\n\nTransient neonatal Idiopathic, self-limited hyperammonemia\n\nPortal-systemic shunting Thrombosis of portal vein, cirrhosis, hepatitis\n\nMitochondrial DNA depletion Typically associated with elevated lactate level\n\nDrug intoxication: salicylate, Obtain drug levels valproic acid, acetaminophen\n\nHyperinsulinism/ Clinical hypoglycemia, hyperammonemia syndrome subclinical hyperammonemia\n\nNon-metabolic liver disease Ensure evaluation of hepatic including infections such as function and appropriate herpes, cytomegalovirus infectious disease workup All disorders that cause hypoglycemia: Most hepatic glycogen storage diseases Galactosemia, hereditary fructose intolerance Fructose-1,6-bisphosphatase deficiency Disorders of fatty acid beta oxidation Glucose transporter deficiency\n\nConversion disorder (functional neurological symptom disorder), With\n\nConversion disorder (functional neurological symptom disorder), With\n\nConversion disorder (functional neurological symptom disorder), With\n\nConversion disorder (functional neurological symptom disorder), With\n\nConversion disorder (functional neurological symptom disorder), With\n\nConversion disorder (functional neurological symptom disorder), With mixed\n\nAnorexia nervosa, Restricting type\n\nAnorexia nervosa, Binge-eating/purging type\n\nNumerical Listing of DSM-5 Diagnoses and Codes (|CD-10-CM)\n\nConversion disorder (functional neurological symptom disorder). Conversion disorder is characterized by neurological symptoms that are inconsistent with neurological patho- physiology. Factitious disorder with neurological symptoms is distinguished from con- version disorder by evidence of deceptive falsification of symptoms."]]},"49": {"question": "A 48-year-old woman presents to the emergency room because of severe back pain after a fall. She says that she was walking home from work when she slipped on a patch of ice on the sidewalk. Since she did not have anything to hold onto, she fell backwards and landed on her posterior iliac crests bilaterally. Immediately after the fall, she started experiencing back pain and tenderness that concerned her enough to call for an ambulance. Her past medical history is significant for arthritis, diabetes, and hypertension. On arrival, her temperature is 99\u00b0F (37.2\u00b0C), blood pressure is 129/86 mmHg, pulse is 112/min, respirations are 19/min. Physical exam reveals tenderness to palpation over the middle of her lower back. A drug that may have predisposed this patient to this outcome most likely has which of the following mechanisms?", "options": {"A": "Inhibition of leukotriene and prostaglandin production", "B": "Inhibition of circulating cytokine", "C": "Inhibition of folate processing", "D": "Inhibition of prostaglandin production alone"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "drug mechanisms predispose back pain after fall", "log": "To solve this question, I need to determine which drug mechanism could predispose the patient to severe back pain after a fall. The patient's history of arthritis, diabetes, and hypertension might suggest she is taking medications that could affect bone health or pain perception.\n\nI'll break down the options:\n- **A**: Inhibition of leukotriene and prostaglandin production could relate to anti-inflammatory drugs, which might not directly cause back pain but could affect healing.\n- **B**: Inhibition of circulating cytokine might relate to immunosuppressive drugs, which could affect inflammation but not specifically predispose to back pain.\n- **C**: Inhibition of folate processing is typically associated with certain medications like methotrexate, which is used in arthritis but does not directly relate to back pain.\n- **D**: Inhibition of prostaglandin production alone is characteristic of NSAIDs, which are commonly used for pain relief but can also affect bone healing.\n\nGiven the context of a fall and the patient's background, I suspect that the most relevant mechanism would involve a drug that inhibits prostaglandin production, as this could lead to increased pain perception or delayed healing.\n\nSince I need to confirm which drug mechanism is most likely, I will search for information related to drug mechanisms that could predispose a patient to back pain after a fall.\n\nAction: search_docs  \nAction Input: \"drug mechanisms predispose back pain after fall\"  ", "type": "AgentAction"}}, "Concomitant cigarette smoke\u2013induced loss of cilia in the airway epithelium and impaired macrophage phagocytosis predispose to bacterial infection with neutrophilia. In end-stage lung disease, long after smoking cessation, there remains an exuberant inflammatory response, suggesting that mechanisms of cigarette smoke\u2013induced inflammation that initiate the disease differ from mechanisms that sustain inflammation after smoking cessation.\n\nIt is a safe clinical rule that most patients who complain of low back pain have some type of primary or secondary disease of the spine and its supporting structures or of the abdominal or pelvic viscera. However, even after careful examination, there remains a sizable group of patients in whom no basis for the back pain can be found. Two categories can be recognized: one with postural back pain and pain after injury, and another with aggravating psychiatric illness, but there are always cases where the diagnosis remains obscure.\n\nimmune mechanisms and predispose individuals to infections and increase the risk for cancers.\n\nPain referred to the back may arise from abdominal or pelvic viscera. The pain is usually described as primarily abdominal or pelvic, accompanied by back pain and usually unaffected by posture. The patient may occasionally complain of back pain only."]]},"placeholder": "placeholder"}]